<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article article-type="review-article" dtd-version="1.1" specific-use="sps-1.9" xml:lang="pt" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">Rev Lat Am Enfermagem</journal-id>
			<journal-id journal-id-type="publisher-id">rlae</journal-id>
			<journal-title-group>
				<journal-title>Revista Latino-Americana de Enfermagem</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Rev. Latino-Am. Enfermagem</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0104-1169</issn>
			<issn pub-type="epub">1518-8345</issn>
			<publisher>
				<publisher-name>Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="other">00601</article-id>
			<article-id pub-id-type="doi">10.1590/1518-8345.5636.3551</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artigo de Revisão</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Lesões de pele por Equipamentos de Proteção Individual e medidas preventivas no contexto da COVID-19: revisão integrativa</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-3683-4969</contrib-id>
					<name>
						<surname>Silva</surname>
						<given-names>Lorrany Fontenele Moraes da</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-4411-0354</contrib-id>
					<name>
						<surname>Almeida</surname>
						<given-names>Alana Gomes de Araujo</given-names>
					</name>
					<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-0876-3996</contrib-id>
					<name>
						<surname>Pascoal</surname>
						<given-names>Lívia Maia</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
					<xref ref-type="corresp" rid="c1">*</xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-6105-1886</contrib-id>
					<name>
						<surname>Santos</surname>
						<given-names>Marcelino</given-names>
						<suffix>Neto</suffix>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-7543-6947</contrib-id>
					<name>
						<surname>Lima</surname>
						<given-names>Francisca Elisângela Teixeira</given-names>
					</name>
					<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
					<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-7840-7642</contrib-id>
					<name>
						<surname>Santos</surname>
						<given-names>Floriacy Stabnow</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff1">
				<label>1</label>
				<institution content-type="original"> Universidade Federal do Maranhão, Centro de Ciências Sociais, Saúde e Tecnologia, Imperatriz, MA, Brasil.</institution>
				<institution content-type="normalized">Universidade Federal do Maranhão</institution>
				<institution content-type="orgname">Universidade Federal do Maranhão</institution>
				<institution content-type="orgdiv1">Centro de Ciências Sociais, Saúde e Tecnologia</institution>
				<addr-line>
					<city>Imperatriz</city>
					<state>MA</state>
				</addr-line>
				<country country="BR">Brazil</country>
			</aff>
			<aff id="aff2">
				<label>2</label>
				<institution content-type="original"> Bolsista da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brasil.</institution>
				<institution content-type="orgname">Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)</institution>
				<country country="BR">Brasil</country>
			</aff>
			<aff id="aff3">
				<label>3</label>
				<institution content-type="original"> Universidade Federal do Maranhão, Centro de Ciências Humanas, Naturais, Saúde e Tecnologia, Pinheiro, MA, Brasil.</institution>
				<institution content-type="normalized">Universidade Federal do Maranhão</institution>
				<institution content-type="orgname">Universidade Federal do Maranhão</institution>
				<institution content-type="orgdiv1">Centro de Ciências Humanas, Naturais, Saúde e Tecnologia</institution>
				<addr-line>
					<city>Pinheiro</city>
					<state>MA</state>
				</addr-line>
				<country country="BR">Brazil</country>
			</aff>
			<aff id="aff4">
				<label>4</label>
				<institution content-type="original"> Universidade Federal do Ceará, Departamento de Enfermagem, Fortaleza, CE, Brasil.</institution>
				<institution content-type="normalized">Universidade Federal do Ceará</institution>
				<institution content-type="orgname">Universidade Federal do Ceará</institution>
				<institution content-type="orgdiv1">Departamento de Enfermagem</institution>
				<addr-line>
					<city>Fortaleza</city>
					<state>CE</state>
				</addr-line>
				<country country="BR">Brazil</country>
			</aff>
			<aff id="aff5">
				<label>5</label>
				<institution content-type="original"> Bolsista do Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brasil.</institution>
				<institution content-type="normalized">Conselho Nacional de Desenvolvimento Científico e Tecnológico</institution>
				<institution content-type="orgname">Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)</institution>
				<country country="BR">Brazil</country>
			</aff>
			<author-notes>
				<corresp id="c1">
					<label>*</label> Autor correspondente: Lívia Maia Pascoal. E-mail: <email>livia_mp@hotmail.com</email>
				</corresp>
				<fn fn-type="edited-by" id="fn1">
					<label>Editora Associada</label>
					<p>Maria Lúcia Zanetti.</p>
				</fn>
				<fn fn-type="con" id="fn2">
					<label>Contribuição dos autores</label>
					<p><bold>Concepção e desenho da pesquisa:</bold> Lorrany Fontenele Moraes Da Silva, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Obtenção de dados:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida. <bold>Análise e interpretação dos dados:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Análise estatística:</bold> Alana Gomes de Araujo Almeida, Lívia Maia Pascoal. <bold>Obtenção de financiamento:</bold> Lívia Maia Pascoal. <bold>Redação do manuscrito:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Revisão crítica do manuscrito quanto ao conteúdo intelectual importante:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. Todos os autores aprovaram a versão final do texto.</p>
				</fn>
				<fn fn-type="conflict" id="fn3">
					<label>Conflito de interesse</label>
					<p>Os autores declararam que não há conflito de interesse.</p>
				</fn>
			</author-notes>
			<pub-date date-type="collection" publication-format="electronic">
				<year>2022</year>
			</pub-date>
			<pub-date date-type="pub" publication-format="electronic">
				<day>20</day>
				<month>04</month>
				<year>2022</year>
			</pub-date>
			<volume>30</volume>
			<elocation-id>e3551</elocation-id>
			<history>
				<date date-type="received">
					<day>06</day>
					<month>08</month>
					<year>2021</year>
				</date>
				<date date-type="accepted">
					<day>10</day>
					<month>01</month>
					<year>2022</year>
				</date>
			</history>
			<permissions>
				<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="pt">
					<license-p>Este é um artigo publicado em acesso aberto sob uma licença Creative Commons</license-p>
				</license>
			</permissions>
			<abstract>
				<title>Resumo</title>
				<sec>
					<title>Objetivo</title>
					<p>identificar as evidências científicas sobre os tipos de lesões de pele ocasionadas pelo uso de Equipamento de Proteção Individual em profissionais de saúde durante a pandemia da COVID-19 e verificar as medidas de prevenção recomendadas.</p>
				</sec>
				<sec>
					<title>Método</title>
					<p>trata-se de uma revisão integrativa realizada nas bases de dados MEDLINE, CINAHL, LILACS, SCOPUS<italic>, Science Direct</italic>, <italic>Web of Science</italic> e no banco de dados SciELO. A busca foi realizada de forma pareada, constituindo uma amostra de 17 estudos categorizados quanto aos tipos de lesões de pele e às medidas preventivas.</p>
				</sec>
				<sec>
					<title>Resultados</title>
					<p>os principais tipos de lesões de pele relacionados ao uso de máscara foram lesão por pressão estágio 1, acne e depressão cutânea. Quanto ao uso de óculos e protetor facial, as mais frequentes foram lesão por pressão estágios 1 e 2. Xerose e dermatites de contato irritante ocorreram devido ao uso de luvas e roupas de proteção, respectivamente. As principais medidas preventivas recomendadas foram o uso de curativo de hidrocoloide ou espuma nas regiões de pressão, hidratantes e emolientes. </p>
				</sec>
				<sec>
					<title>Conclusão</title>
					<p>observou-se um número considerável de lesões de pele associadas ao uso dos equipamentos e os dados obtidos podem direcionar os profissionais na identificação de riscos e promoção de medidas preventivas para evitar sua ocorrência.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="pt">
				<title>Descritores:</title>
				<kwd>Equipamento de Proteção Individual</kwd>
				<kwd>Pele</kwd>
				<kwd>Profissionais da Saúde</kwd>
				<kwd>Dermatopatias</kwd>
				<kwd>Prevenção de Doenças</kwd>
				<kwd>COVID-19</kwd>
			</kwd-group>
			<funding-group>
				<award-group award-type="contract">
					<funding-source>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)</funding-source>
					<award-id>Código de Financiamento 001</award-id>
				</award-group>
				<award-group award-type="contract">
					<funding-source>Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão</funding-source>
					<award-id>02424/21</award-id>
				</award-group>
				<funding-statement>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Código de Financiamento 001. Apoio Financeiro da Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão, Processo 02424/21, Brasil.</funding-statement>
			</funding-group>
			<counts>
				<fig-count count="3"/>
				<table-count count="12"/>
				<equation-count count="0"/>
				<ref-count count="48"/>
				<page-count count="0"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<boxed-text id="bx1">
			<sec>
				<title>Destaques</title>
				<p>(1) O principal EPI responsável pela ocorrência de lesão de pele é a máscara.</p>
				<p>(2) Acne e lesões por pressão estágio 1 e 2 são os principais tipos de lesão de pele.</p>
				<p>(3) As principais medidas de prevenção de lesão de pele envolvem cuidados rotineiros.</p>
				<p>(4) Profissionais da saúde normalmente não adotam medidas preventivas ao utilizar EPI.</p>
			</sec>
		</boxed-text>
		<sec sec-type="intro">
			<title>Introdução</title>
			<p>Em janeiro de 2020, a COVID-19, doença ocasionada pelo novo Coronavírus (SARS-CoV-2), foi considerada uma emergência de saúde pública internacional e, em março de 2020, a Organização Mundial de Saúde (OMS) declarou-a como uma pandemia<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. Desde então, os profissionais de saúde têm lidado com muitos desafios, tais como: exposição prolongada; sobrecarga de trabalho; falta de capacitação; dimensionamento pessoal inadequado; precarização do ambiente de trabalho; Equipamentos de Proteção Individual (EPIs) em qualidade e quantidade insuficientes, dentre outros fatores que colocam em risco a biossegurança desses profissionais<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>. </p>
			<p>A COVID-19 tem se destacado pela elevada transmissibilidade e gravidade clínica e, ainda, por apresentar maior incidência entre profissionais de saúde<xref ref-type="bibr" rid="B3"><sup>3</sup></xref>. Para reduzir o risco de exposição dos profissionais que estão na linha de frente no combate à COVID-19, a Agência Nacional de Vigilância Sanitária (ANVISA), em sua Nota Técnica nº 04/2020, recomenda a paramentação de EPI de acordo com o tipo de precaução padrão para gotícula, aerossóis e/ou contato. Assim, para o atendimento aos casos suspeitos ou confirmados de COVID-19, devem-se utilizar óculos de proteção ou protetor facial, gorro, máscara cirúrgica ou N95/PFF2 ou equivalente (dependendo do tipo de precaução), avental e luvas de procedimentos não estéreis<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>. </p>
			<p>Embora a utilização dos EPIs vise à proteção, os profissionais também estão propensos à ocorrência de lesões de pele provocadas pelo uso prolongado deles e pela higiene frequente das mãos, que podem evoluir para lesão por pressão, dermatite aguda e crônica, agravamento de dermatose preexistente e ser porta de entrada para infecções secundárias<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>.</p>
			<p>O contato prolongado com os EPIs afeta a integridade da barreira cutânea em decorrência da força do atrito contínuo ou deslizante e da própria condição estrutural da pele, ocasionando deformações no tecido, o que leva ao processo de morte celular e desencadeia o dano tecidual. Destaca-se, ainda, que fatores como a transpiração excessiva gerada pelo estresse mental e jornadas de trabalho exaustivas, a falta de otimização dos EPIs frente à deformação tecidual, além da adequação realizada pelos profissionais para melhorar a vedação da região facial, em busca de uma superproteção, contribuem, efetivamente, para o dano tecidual<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>. </p>
			<p>Sobre isso, é importante destacar que o dano tecidual é um fator limitante para a assistência, uma vez que os profissionais de saúde, submetidos a extensas jornadas de trabalho com desgaste físico e emocional, tornaram-se população de risco para o desenvolvimento de lesões e depararam-se com a deficiência de equipamentos de proteção adequados, sinais e sintomas agravados das lesões de pele e/ou doenças preexistentes e, na maioria das vezes, sem acesso às medidas de prevenção em virtude da falta de conhecimento e orientação em consequência da escassez de estudos, dos custos desses materiais ou até mesmo da falta de recurso das instituições hospitalares<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>.</p>
			<p>Torna-se necessária, tendo em vista que os equipamentos de proteção utilizados no cuidado à saúde são indispensáveis, a implementação de medidas que auxiliem a preservação da integridade da pele na área exposta ao risco, medidas estas que contribuirão, diretamente, para a proteção do profissional e, consequentemente, para garantir a qualidade do atendimento e a segurança do paciente. Portanto, a justificativa desta revisão baseia-se na contribuição para a prática dos profissionais da saúde, em especial, do enfermeiro, por fornecer informações acerca das lesões de pele associadas ao uso dos EPIs e das medidas que podem ser adotadas para prevenir sua ocorrência, pois, além de favorecer o exercício profissional seguro e promover um cuidado efetivo para a população assistida, orientará os profissionais para situações semelhantes que podem ocorrer, permitindo a elaboração de estratégias de antecipação de riscos para a manutenção da integridade da pele.</p>
			<p>Diante disso, tem-se como objetivo identificar as evidências científicas disponíveis sobre os tipos de lesões de pele ocasionados pelo uso de EPI em profissionais de saúde durante a pandemia da COVID-19 e verificar as medidas de prevenção recomendadas.</p>
		</sec>
		<sec sec-type="methods">
			<title>Método</title>
			<sec>
				<title>Tipo de estudo</title>
				<p>Este estudo consiste em uma revisão integrativa protocolada na plataforma <italic>FigShare</italic><xref ref-type="bibr" rid="B9"><sup>9</sup></xref>. A condução do estudo foi realizada em seis etapas: 1) elaboração da questão de pesquisa; 2) definição das bases de dados e critérios para inclusão e exclusão de estudos; 3) definição das informações a serem extraídas dos estudos selecionados; 4) avaliação dos estudos incluídos na revisão; 5) interpretação dos resultados; 6) apresentação da revisão/síntese do conhecimento<xref ref-type="bibr" rid="B10"><sup>10</sup></xref>. </p>
				<p>Para nortear a busca, foi elaborada a questão de pesquisa utilizando a estratégia PICo (População, Interesse e Contexto): P - Profissionais de saúde; I - Tipos de lesões relacionadas ao uso de EPI e Medidas preventivas; Co - Pandemia da COVID-19. Esse acrônimo possibilita o alcance de uma busca efetiva a partir da elaboração de uma questão de pesquisa esclarecedora para direcionar o estudo de acordo com os objetivos propostos<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. Essa estratégia permitiu formular a seguinte questão norteadora: “Quais os tipos de lesões de pele ocasionados pelo uso de EPI em profissionais de saúde durante a pandemia da COVID-19 e quais as medidas de prevenção recomendadas?”.</p>
				<p>Realizou-se uma busca inicial na base de dados <italic>Medical Literature Analysis and Retrieval System Online</italic> (MEDLINE), via <italic>National Library of Medicine</italic> (PubMed), para verificar os principais descritores ou palavras-chave utilizados nos estudos acerca da temática da questão norteadora. Os vocabulários controlados foram selecionados nos Descritores em Ciências da Saúde (DeCS), <italic>Medical Subject Heading</italic> (MeSH) e MH <italic>Exact Subject Heading</italic> (vocabulário CINAHL), sendo estes: COVID-19; <italic>occupational injury</italic>; <italic>facial injuries</italic>; <italic>personal protective equipment</italic>; <italic>protective devices</italic> e <italic>skin.</italic> Por ser uma temática ainda incipiente, optou-se por utilizar também palavras-chave (vocabulários não controlados) para obter uma estratégia de busca direcionada, a saber: <italic>device related pressure injuries, skin injury</italic> e <italic>skin damage,</italic> sendo utilizadas no idioma espanhol para a base LILACS e banco de dados SciELO. Para realizar cruzamentos entre esses vocábulos, foram utilizados os operadores <italic>booleanos AND</italic> e <italic>OR</italic> (<xref ref-type="table" rid="t1">Figura 1</xref>).</p>
				<p>
					<table-wrap id="t1">
						<label>Figura 1</label>
						<caption>
							<title>Estratégia de busca dos estudos de acordo com as bases/bancos de dados encontradas. Imperatriz, MA, Brasil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left">Base/banco de dados</th>
									<th align="left">Cruzamento</th>
									<th align="center">Quantitativo</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left">MEDLINE</td>
									<td align="left">COVID-19 <italic>AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
									<td align="center">99</td>
								</tr>
								<tr>
									<td align="left">CINAHL</td>
									<td align="left">(MH”<italic>protective devices</italic>”) <italic>OR</italic> (MH”<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> (MH”<italic>facial injuries</italic>”) <italic>OR</italic> (MH “<italic>occupational injury</italic>”) <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”)</td>
									<td align="center">45</td>
								</tr>
								<tr>
									<td align="left">LILACS</td>
									<td align="left">COVID-19 <italic>AND</italic> (“<italic>dispositivos de protección</italic>” <italic>OR</italic> “<italic>equipo de protección personal</italic>”) <italic>AND</italic> (<italic>piel OR</italic> “<italic>lesiones por presión relacionadas con el dispositivo</italic>” <italic>OR</italic> “<italic>lesiones faciales</italic>” <italic>OR</italic> “<italic>lesión ocupacional</italic>” <italic>OR</italic> “<italic>lesión cutánea</italic>” <italic>OR</italic> “<italic>daño cutáneo</italic>”)</td>
									<td align="center">1</td>
								</tr>
								<tr>
									<td align="left">SCOPUS</td>
									<td align="left">COVID-19 <italic>AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
									<td align="center">97</td>
								</tr>
								<tr>
									<td align="left"><italic>Science Direct</italic></td>
									<td align="left">COVID-19 <italic>AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
									<td align="center">566</td>
								</tr>
								<tr>
									<td align="left"><italic>Web of Science</italic></td>
									<td align="left">COVID-19 <italic>AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
									<td align="center">42</td>
								</tr>
								<tr>
									<td align="left">SciELO</td>
									<td align="left">COVID-19 <italic>AND</italic> (“<italic>dispositivos de protección</italic>” <italic>OR</italic> “<italic>equipo de protección personal</italic>”) <italic>AND</italic> (<italic>piel OR</italic> “<italic>lesiones por presión relacionadas con el dispositivo</italic>” <italic>OR</italic> “<italic>lesiones faciales</italic>” OR “<italic>lesión ocupacional</italic>” <italic>OR</italic> “<italic>lesión cutánea</italic>” <italic>OR</italic> “<italic>daño cutáneo</italic>”)</td>
									<td align="center">1</td>
								</tr>
								<tr>
									<td align="left" colspan="2">TOTAL</td>
									<td align="center">851</td>
								</tr>
							</tbody>
						</table>
					</table-wrap>
				</p>
			</sec>
			<sec>
				<title>Coleta de dados</title>
				<p>A busca foi realizada em janeiro de 2021 por meio do Portal de Periódicos da CAPES, pelo acesso à Comunidade Acadêmica Federada (CAFe), com a seleção da instituição de ensino superior Universidade Federal do Maranhão (UFMA), buscando as seguintes bases de dados: <italic>Medical Literature Analysis and Retrieval System Online</italic> (MEDLINE) via <italic>National Library of Medicine</italic> (PubMed); <italic>Cumulative Index to Nursing and Allied Health</italic> (CINAHL); Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS); SCOPUS; <italic>Science Direct</italic> e <italic>Web of Science</italic> e o banco de dados <italic>Scientific Electronic Library Online</italic> (SciELO).</p>
				<p>Para melhorar a qualidade da coleta dos dados, foi utilizado o aplicativo <italic>Rayyan</italic>, desenvolvido pelo <italic>Qatar Computing Research Institute</italic> (QCRI)<xref ref-type="bibr" rid="B12"><sup>12</sup></xref>, para auxiliar o processo de organização e seleção dos estudos, bem como a remoção de duplicatas. Além disso, a busca foi realizada por dois pesquisadores, de maneira independente e simultânea, seguindo um protocolo de busca direcionado para a questão norteadora e os critérios de elegibilidade. Os critérios de inclusão estabelecidos para a seleção dos estudos foram artigos originais que respondessem à questão norteadora, contemplando as lesões e/ou as medidas preventivas, publicados nos idiomas inglês, espanhol ou português. </p>
			</sec>
			<sec>
				<title>Instrumento utilizado para a coleta das informações</title>
				<p>Para a coleta, categorização e interpretação dos dados, utilizou-se um instrumento adaptado<xref ref-type="bibr" rid="B13"><sup>13</sup></xref> com os seguintes itens: título da publicação; autor(es); ano de publicação; periódico; objetivo; tipo de estudo; nível de evidência; tipos de lesões e medidas preventivas. </p>
			</sec>
			<sec>
				<title>Análise dos dados</title>
				<p>O nível de evidência dos artigos incluídos foram classificados da seguinte forma: </p>
				<p>
					<list list-type="simple">
						<list-item>
							<p>Nível 1 - Desenhos de pesquisas experimentais: 1.a) Revisão sistemática de ensaios randomizados controlados; 1.b) Revisão sistemática de ensaios randomizados, controlados e outros desenhos de estudo; 1.c) Ensaio controlado randomizado; 1.d - Pseudoensaios controlados, randomizados; </p>
						</list-item>
						<list-item>
							<p>Nível 2 - Desenhos quase-experimentos: 2.a) Revisão sistemática de estudos quase-experimentais; 2.b) Revisão sistemática de quase-experimento e outros desenhos de estudo de menor evidência; 2.c) Estudos prospectivamente controlados de quase-experimentos; 2.d) Pré-teste e pós-teste ou estudos de grupos controlados históricos retrospectivos; </p>
						</list-item>
						<list-item>
							<p>Nível 3 - Observacional - desenhos analíticos: 3.a) Revisão sistemática de estudos de coortes comparáveis; 3.b) Revisão sistemática de coortes comparáveis e outros desenhos de estudo de menor evidência; 3.c) Estudo de coorte com grupo-controle; 3.d) Estudo de caso-controle; 3.e) Estudos observacionais sem um grupo-controle; </p>
						</list-item>
						<list-item>
							<p>Nível 4 - Observacional - estudos descritivos: 4.a) Revisão sistemática de estudos descritivos; 4.b) Estudo transversal; 4.c) Séries de casos; 4.d) Estudo de caso; </p>
						</list-item>
						<list-item>
							<p>Nível 5 - Opinião de especialistas - Pesquisas de bancada em laboratório: 5.a) Revisão sistemática de opinião de especialistas; 5.b) Consenso de especialistas; 5.c) Pesquisa de bancada de laboratório/opinião de um especialista<xref ref-type="bibr" rid="B14"><sup>14</sup></xref>.</p>
						</list-item>
					</list>
				</p>
				<p>Além disso, foi realizada a análise da qualidade metodológica com o uso dos instrumentos propostos pela JBI<xref ref-type="bibr" rid="B15"><sup>15</sup></xref> que contêm um <italic>checklist</italic> de perguntas para cada tipo de estudo com as seguintes opções de respostas: Sim; Não; Não se aplica ou Não está claro. Após a categorização dos estudos, os dados foram sintetizados para a análise descritiva de acordo com o ano de publicação, idioma, local onde o estudo foi realizado, objetivo, tipo de estudo, nível de evidência, tipos de lesões de pele e medidas preventivas relacionadas ao uso de EPIs em profissionais da saúde. </p>
			</sec>
		</sec>
		<sec sec-type="results">
			<title>Resultados</title>
			<p>Foram identificados 851 artigos e, após a análise de título, resumo e aplicação dos critérios de inclusão e exclusão, foram pré-selecionados 50 artigos para a leitura na íntegra. Entre os 50 artigos analisados, 17 foram incluídos na amostra final desta revisão. A trajetória de busca e seleção dos estudos seguiu as recomendações do grupo PRISMA<xref ref-type="bibr" rid="B15"><sup>15</sup></xref> e pode ser observada no fluxograma a seguir (<xref ref-type="fig" rid="f1">Figura 2</xref>).</p>
			<p>
				<fig id="f1">
					<label>Figura 2</label>
					<caption>
						<title>Fluxograma de seleção dos artigos incluídos no estudo. Imperatriz, MA, Brasil, 2021</title>
					</caption>
					<graphic xlink:href="1518-8345-rlae-30-e3551-gf1.png"/>
					<attrib>Fonte: adaptado do PRISMA<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. </attrib>
				</fig>
			</p>
			<p>Os 17 artigos que compuseram a amostra final foram publicados nos anos de 2020 e 2021 nos idiomas inglês e espanhol. Os estudos foram realizados nos seguintes países: Barém, Brasil, China, Estados Unidos, Índia, Iraque, México, Paris, Tailândia e Turquia, sendo a China (35,5%) o país com o maior número de publicações. Os tipos de estudo foram: coorte prospectivo<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref> (11,8%), ensaio clínico randomizado<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref> (11,8%) e transversal descritivo<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B33"><sup>33</sup></xref> (76,4%). Ao avaliar o nível de evidência, 76,4% das publicações foram classificadas com nível 4b.</p>
			<p>A <xref ref-type="table" rid="t2">Figura 3</xref> apresenta a caracterização dos estudos que fizeram parte da amostra final, considerando objetivo, país onde o estudo foi realizado, idioma, nível de evidência e qualidade metodológica do estudo. </p>
			<p>
				<table-wrap id="t2">
					<label>Figura 3</label>
					<caption>
						<title>Caracterização dos estudos primários incluídos na amostra. Imperatriz, MA, Brasil, 2021</title>
					</caption>
					<table>
						<colgroup>
							<col/>
							<col/>
							<col/>
							<col/>
							<col/>
						</colgroup>
						<thead>
							<tr>
								<th align="left">Autores</th>
								<th align="center">Objetivo</th>
								<th align="center">Idioma/País</th>
								<th align="center">Nível de Evidência</th>
								<th align="center">Qualidade metodológica do estudo</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td align="left">Smart, et al. (2020)<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
								</td>
								<td align="left">Determinar se um curativo à base de silicone usado sob uma máscara N95 é seguro e benéfico para a prevenção de lesões faciais na pele sem comprometer a vedação da máscara.</td>
								<td align="center">Inglês/Barém</td>
								<td align="center">3.c</td>
								<td align="left">Sete de 11 pontos na <italic>checklist</italic> para <italic>Cohort studies</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Yildiz, et al. (2021)<xref ref-type="bibr" rid="B18"><sup>18</sup></xref>
								</td>
								<td align="left">Determinar o efeito do curativo profilático na prevenção de lesões cutâneas pelo uso de EPI em profissionais de saúde que trabalham com pacientes COVID-19.</td>
								<td align="center">Inglês/Turquia</td>
								<td align="center">3.c</td>
								<td align="left">Oito de 11 pontos na <italic>checklist</italic> para <italic>Cohort studies</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Hua, et al. (2020)<xref ref-type="bibr" rid="B19"><sup>19</sup></xref>
								</td>
								<td align="left">Analisar os efeitos de curto prazo dos respiradores N95 e máscaras médicas nas propriedades fisiológicas da pele e relatar reações cutâneas adversas.</td>
								<td align="center">Inglês/China</td>
								<td align="center">1.c</td>
								<td align="left">Oito de 13 pontos na <italic>checklist</italic> para <italic>Randomized controlled trials</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Gasparino, et al. (2021)<xref ref-type="bibr" rid="B20"><sup>20</sup></xref>
								</td>
								<td align="left">Comparar o uso de espuma e do curativo hidrocoloide extrafino na prevenção de lesão por pressão associada ao uso de EPI por profissionais de saúde que atuam na linha de frente contra o Coronavírus.</td>
								<td align="center">Inglês/Brasil</td>
								<td align="center">1.c</td>
								<td align="left">Oito de 13 pontos na <italic>checklist</italic> para <italic>Randomiz ed controlled trials</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Jiang, et al. (2020)<xref ref-type="bibr" rid="B21"><sup>21</sup></xref>
								</td>
								<td align="left">Investigar a prevalência e as características de lesão por pressão entre a equipe de saúde.</td>
								<td align="center">Inglês/China</td>
								<td align="center">4.b</td>
								<td align="left">Seis de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Hu, et al. (2020)<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>
								</td>
								<td align="left">Explorar as reações adversas da pele entre os profissionais de saúde que utilizam EPI.</td>
								<td align="center">Inglês/China</td>
								<td align="center">4.b</td>
								<td align="left">Seis de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Shanshal, et al. (2020)<xref ref-type="bibr" rid="B23"><sup>23</sup></xref>
								</td>
								<td align="left">Examinar, de forma abrangente, o efeito da COVID-19 em diferentes aspectos da prática médica.</td>
								<td align="center">Inglês/Iraque</td>
								<td align="center">4.b</td>
								<td align="left">Quatro de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Xia, et al. (2020)<xref ref-type="bibr" rid="B24"><sup>24</sup></xref>
								</td>
								<td align="left">Identificar efeitos físicos e psicológicos do uso de EPIs e suas respectivas medidas de segurança em profissionais de saúde de Wuhan, China, em resposta à pandemia.</td>
								<td align="center">Inglês/China</td>
								<td align="center">4.b</td>
								<td align="left">Seis de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Pacis, et al. (2020)<xref ref-type="bibr" rid="B25"><sup>25</sup></xref>
								</td>
								<td align="left">Formular procedimentos para proteger a integridade da pele facial dos profissionais de saúde ao cuidar de pacientes com COVID-19.</td>
								<td align="center">Inglês/Estados Unidos</td>
								<td align="center">4.b</td>
								<td align="left">Cinco de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Agarwal, et al. (2020)<xref ref-type="bibr" rid="B26"><sup>26</sup></xref>
								</td>
								<td align="left">Identificar as dificuldades encontradas pelos profissionais de saúde durante o uso de EPI e propor formas e meios para ajudá-los a superar essas dificuldades.</td>
								<td align="center">Inglês/Índia</td>
								<td align="center">4.b</td>
								<td align="left">Quatro de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Yuan, et al. (2020)<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>
								</td>
								<td align="left">Compreender as possíveis reações cutâneas, respiratórias, nervosas e digestivas em profissionais de saúde chineses que usam EPI no combate à COVID-19.</td>
								<td align="center">Inglês/China</td>
								<td align="center">4.b</td>
								<td align="left">Seis de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Jiang, et al.(2020)<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>
								</td>
								<td align="left">Investigar a prevalência, características e <italic>status</italic> preventivo de lesões de pele causadas por EPI na equipe de saúde.</td>
								<td align="center">Inglês/China</td>
								<td align="center">4.b</td>
								<td align="left">Seis de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Daye, et al. (2020)<xref ref-type="bibr" rid="B29"><sup>29</sup></xref>
								</td>
								<td align="left">Avaliar os problemas de pele e a qualidade de vida dermatológica de profissionais de saúde devido ao uso de EPI.</td>
								<td align="center">Inglês/Turquia</td>
								<td align="center">4.b</td>
								<td align="left">Quatro de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Atay, et al. (2020)<xref ref-type="bibr" rid="B30"><sup>30</sup></xref>
								</td>
								<td align="left">Examinar os problemas físicos relacionados aos EPIs e tempo de uso prolongado vivenciados por enfermeiras durante a pandemia da COVID-19.</td>
								<td align="center">Inglês/Turquia</td>
								<td align="center">4.b</td>
								<td align="left">Seis de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Techasatian, et al. (2020)<xref ref-type="bibr" rid="B31"><sup>31</sup></xref>
								</td>
								<td align="left">Analisar a prevalência e os possíveis fatores de risco para prevenir as reações cutâneas relacionadas à máscara facial durante a COVID-19.</td>
								<td align="center">Inglês/Tailândia</td>
								<td align="center">4.b</td>
								<td align="left">Seis de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Masen, et al. (2020)<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>
								</td>
								<td align="left">Fornecer uma solução lubrificante prática para profissionais de saúde da linha de frente da COVID-19 que trabalham em um turno de quatro horas ou mais usando EPI.</td>
								<td align="center">Inglês/Paris</td>
								<td align="center">4.b</td>
								<td align="left">Seis de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
							<tr>
								<td align="left">Erize-Herrera, et al. (2020)<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>
								</td>
								<td align="left">Descrever a frequência das manifestações cutâneas causadas pelo uso de EPI em profissionais de saúde e os fatores de risco para desenvolvê-los.</td>
								<td align="center">Espanhol/México</td>
								<td align="center">4.b</td>
								<td align="left">Quatro de oito pontos na <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> da JBI*</td>
							</tr>
						</tbody>
					</table>
					<table-wrap-foot>
						<fn id="TFN1">
							<label>*</label>
							<p>No <italic>checklist</italic>, algumas respostas foram classificadas como Não se aplica ou Não está claro.</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</p>
			<p>A <xref ref-type="table" rid="t3">Tabela 1</xref> apresenta os tipos de lesões relacionados ao uso de EPI. Os principais EPIs que estiveram associados à ocorrência de lesões de pele foram: máscara cirúrgica ou N95, óculos de proteção, protetor facial, luvas e roupas de proteção. As lesões provocadas pelo uso de máscara mais frequentes foram: lesão por pressão (estágio 1)<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (35,2%); acne<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref> (23,5%); depressão cutânea<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref> (23,5%); dermatite de contato irritante<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref> (17,6%); erupção cutânea<xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref> (17,6%); lesão por pressão (estágio 2)<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref> (11,7%) e lesões associadas à umidade <xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref> (11,7%).</p>
			<p>Sobre as lesões associadas ao uso de óculos de proteção, destacaram-se as lesões por pressão estágio 1<xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (23,5%) e estágio 2<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (17,6%). As lesões relacionadas ao uso de protetor facial, que apresentaram maior frequência, foram as lesões por pressão estágio 1<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (23,5%). Em relação ao uso de luvas, destacaram-se xerose<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref> (23,5%) e fissuras<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref> (17,6%). Quanto às lesões associadas ao uso de roupas de proteção, destacou-se a dermatite de contato irritante<xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref> (11,7%).</p>
			<p>
				<table-wrap id="t3">
					<label>Tabela 1</label>
					<caption>
						<title>Frequência dos tipos de lesões relacionados ao uso de máscara cirúrgica ou N95, óculos de proteção, protetor facial, luvas e roupas de proteção segundo os estudos encontrados. Imperatriz, MA, Brasil, 2021</title>
					</caption>
					<table>
						<colgroup>
							<col/>
							<col/>
							<col/>
							<col/>
						</colgroup>
						<thead>
							<tr>
								<th align="left">Equipamento de Proteção Individual</th>
								<th align="center">Tipos de lesões</th>
								<th align="center">Frequência n (%)*</th>
								<th align="center">Estudos encontrados</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td align="left" rowspan="15">Máscara cirúrgica ou N95</td>
								<td align="left">Lesão por pressão (estágio 1)<sup>†</sup></td>
								<td align="center">6 (35,2)</td>
								<td align="center">17,18,21,23,24,28</td>
							</tr>
							<tr>
								<td align="left">Acne</td>
								<td align="center">4 (23,5)</td>
								<td align="center">22,29,31,33</td>
							</tr>
							<tr>
								<td align="left">Depressão cutânea</td>
								<td align="center">4 (23,5)</td>
								<td align="center">17,19,22,27</td>
							</tr>
							<tr>
								<td align="left">Dermatite de contato irritante</td>
								<td align="center">3 (17,6)</td>
								<td align="center">22,29,33</td>
							</tr>
							<tr>
								<td align="left">Erupção cutânea</td>
								<td align="center">3 (17,6)</td>
								<td align="center">23,26,31</td>
							</tr>
							<tr>
								<td align="left">Lesão por pressão (estágio 2)<sup>†</sup></td>
								<td align="center">2 (11,7)</td>
								<td align="center">21,23</td>
							</tr>
							<tr>
								<td align="left">Lesões associadas à umidade</td>
								<td align="center">2 (11,7)</td>
								<td align="center">18,24</td>
							</tr>
							<tr>
								<td align="left">Maceração</td>
								<td align="center">1 (5,8)</td>
								<td align="center">33</td>
							</tr>
							<tr>
								<td align="left">Queilite</td>
								<td align="center">1 (5,8)</td>
								<td align="center">30</td>
							</tr>
							<tr>
								<td align="left">Lesão por pressão (estágio 3)<sup>†</sup></td>
								<td align="center">1 (5,8)</td>
								<td align="center">21</td>
							</tr>
							<tr>
								<td align="left">Urticária</td>
								<td align="center">1 (5,8)</td>
								<td align="center">22 </td>
							</tr>
							<tr>
								<td align="left">Pústula</td>
								<td align="center">1 (5,8)</td>
								<td align="center">23 </td>
							</tr>
							<tr>
								<td align="left">Pápula</td>
								<td align="center">1 (5,8)</td>
								<td align="center">23 </td>
							</tr>
							<tr>
								<td align="left">Xerose</td>
								<td align="center">1 (5,8)</td>
								<td align="center">33 </td>
							</tr>
							<tr>
								<td align="left">Bolhas</td>
								<td align="center">1 (5,8)</td>
								<td align="center">33 </td>
							</tr>
							<tr>
								<td align="left" rowspan="7">Óculos de proteção</td>
								<td align="left">Lesão por pressão (estágio 1)<sup>‡</sup></td>
								<td align="center">4 (23,5)</td>
								<td align="center">18,23,24,28</td>
							</tr>
							<tr>
								<td align="left">Lesão por pressão (estágio 2)<sup>‡</sup></td>
								<td align="center">3 (17,6)</td>
								<td align="center">21,23,28</td>
							</tr>
							<tr>
								<td align="left">Erupção cutânea</td>
								<td align="center">2 (11,7)</td>
								<td align="center">23,33</td>
							</tr>
							<tr>
								<td align="left">Depressão cutânea</td>
								<td align="center">1 (5,8)</td>
								<td align="center">27</td>
							</tr>
							<tr>
								<td align="left">Lesão por pressão (estágio 3)<sup>‡</sup></td>
								<td align="center">1 (5,8)</td>
								<td align="center">21</td>
							</tr>
							<tr>
								<td align="left">Pápula</td>
								<td align="center">1 (5,8)</td>
								<td align="center">23 </td>
							</tr>
							<tr>
								<td align="left">Pústula</td>
								<td align="center">1 (5,8)</td>
								<td align="center">23 </td>
							</tr>
							<tr>
								<td align="left" rowspan="10">Protetor facial</td>
								<td align="left">Lesão por pressão (estágio 1)<sup>§</sup></td>
								<td align="center">4 (23,5)</td>
								<td align="center">21,23,24,28</td>
							</tr>
							<tr>
								<td align="left">Lesão por pressão (estágio 2)<sup>§</sup></td>
								<td align="center">2 (11,7)</td>
								<td align="center">23, 28</td>
							</tr>
							<tr>
								<td align="left">Erupção cutânea</td>
								<td align="center">2 (11,7)</td>
								<td align="center">20, 23 </td>
							</tr>
							<tr>
								<td align="left">Depressão cutânea</td>
								<td align="center">1 (5,8)</td>
								<td align="center">27 </td>
							</tr>
							<tr>
								<td align="left">Lesões associadas à umidade</td>
								<td align="center">1 (5,8)</td>
								<td align="center">18</td>
							</tr>
							<tr>
								<td align="left">Foliculite</td>
								<td align="center">1 (5,8)</td>
								<td align="center">18</td>
							</tr>
							<tr>
								<td align="left">Lesão por fricção</td>
								<td align="center">1 (5,8)</td>
								<td align="center">18</td>
							</tr>
							<tr>
								<td align="left">Lesão por pressão (estágio 3)<sup>§</sup></td>
								<td align="center">1 (5,8)</td>
								<td align="center">21</td>
							</tr>
							<tr>
								<td align="left">Pápula</td>
								<td align="center">1 (5,8)</td>
								<td align="center">23 </td>
							</tr>
							<tr>
								<td align="left">Pústula</td>
								<td align="center">1 (5,8)</td>
								<td align="center">23 </td>
							</tr>
							<tr>
								<td align="left" rowspan="12">Luvas</td>
								<td align="left">Xerose </td>
								<td align="center">4 (23,5)</td>
								<td align="center">22, 30,31,33</td>
							</tr>
							<tr>
								<td align="left">Fissuras</td>
								<td align="center">3 (17,6)</td>
								<td align="center">22,29,30</td>
							</tr>
							<tr>
								<td align="left">Descamação</td>
								<td align="center">2 (11,7)</td>
								<td align="center">29,33</td>
							</tr>
							<tr>
								<td align="left">Erupção cutânea</td>
								<td align="center">2 (11,7)</td>
								<td align="center">22, 26 </td>
							</tr>
							<tr>
								<td align="left">Dermatite de contato irritante </td>
								<td align="center">1 (5,8) </td>
								<td align="center">26</td>
							</tr>
							<tr>
								<td align="left">Maceração</td>
								<td align="center">1 (5,8)</td>
								<td align="center">33</td>
							</tr>
							<tr>
								<td align="left">Bolhas</td>
								<td align="center">1 (5,8)</td>
								<td align="center">33</td>
							</tr>
							<tr>
								<td align="left">Agravamento de dermatose preexistente</td>
								<td align="center">1 (5,8)</td>
								<td align="center">29</td>
							</tr>
							<tr>
								<td align="left">Lesão por fricção </td>
								<td align="center">1 (5,8)</td>
								<td align="center">18 </td>
							</tr>
							<tr>
								<td align="left">Lesões associadas à umidade</td>
								<td align="center">1 (5,8)</td>
								<td align="center">18 </td>
							</tr>
							<tr>
								<td align="left">Urticária</td>
								<td align="center">1 (5,8)</td>
								<td align="center">22 </td>
							</tr>
							<tr>
								<td align="left">Liquenificação</td>
								<td align="center">1 (5,8)</td>
								<td align="center">29 </td>
							</tr>
							<tr>
								<td align="left" rowspan="4">Roupas de proteção</td>
								<td align="left">Dermatite de contato irritante</td>
								<td align="center">2 (11,7)</td>
								<td align="center">23,26</td>
							</tr>
							<tr>
								<td align="left">Erupções cutâneas</td>
								<td align="center">1 (5,8)</td>
								<td align="center">26</td>
							</tr>
							<tr>
								<td align="left">Lesões associadas à umidade</td>
								<td align="center">1 (5,8)</td>
								<td align="center">18</td>
							</tr>
							<tr>
								<td align="left">Xerose</td>
								<td align="center">1 (5,8)</td>
								<td align="center">22</td>
							</tr>
						</tbody>
					</table>
					<table-wrap-foot>
						<fn id="TFN2">
							<p>*O valor total do “n” corresponde à amostra de 17 artigos. O percentual está acima de 100%, pois houve mais de um tipo de lesão no mesmo artigo incluído na amostra; <sup>†</sup>Frontal, Ponte Nasal, Auricular e/ou mandibular; <sup>‡</sup>Frontal, Ponte Nasal, Auricular; <sup>§</sup>Frontal</p>
						</fn>
					</table-wrap-foot>
				</table-wrap>
			</p>
			<p>As principais medidas preventivas relacionadas às lesões pelo uso de EPI foram agrupadas conforme o tipo de EPI utilizado. Para as lesões decorrentes do uso de máscara, óculos de proteção e protetor facial, a maioria dos artigos<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (27,7%) recomendou o uso de curativo de hidrocoloide ou espuma nas regiões de pressão, mas outras recomendações também foram apontadas como o uso de hidratantes e emolientes para a proteção, especialmente quando não estiverem em atendimento, além do ajuste correto das máscaras e a utilização de alça protetora auricular.</p>
			<p>Como recomendações para o uso de luvas, os estudos citaram: lavar e secar bem as mãos e pés; aplicar um creme de barreira antes e depois do uso do EPI; evitar usar luvas por tempo prolongado e utilizar luvas de algodão ou uma camada de luvas de plástico dentro das luvas de látex. Em relação ao uso de roupas de proteção para evitar lesões, a recomendação consiste em aplicar um creme de barreira antes e depois do uso de EPI para evitar a descamação e o ressecamento da pele (<xref ref-type="table" rid="t4">Figura 4</xref>).</p>
			<p>
				<table-wrap id="t4">
					<label>Figura 4</label>
					<caption>
						<title>Medidas preventivas para a ocorrência de lesões de pele relacionadas ao uso de Equipamento de Proteção Individual. Imperatriz, MA, Brasil, 2021</title>
					</caption>
					<table>
						<colgroup>
							<col/>
						</colgroup>
						<thead>
							<tr>
								<th align="left">Recomendações para a prevenção de lesões relacionadas ao uso de máscara, óculos e protetor facial</th>
							</tr>
						</thead>
						<tbody>
							<tr>
								<td align="left">- Utilize barreira protetora líquida sem álcool em áreas de contato direto com EPI (ex.: nariz, bochechas, testa, atrás das orelhas) para proteger a pele da umidade e do atrito. Antes de aplicar, verifique se a área está livre de maquiagem. Não aplique nos olhos ou pálpebras e deixe secar por 90 segundos antes de colocar o EPI <xref ref-type="bibr" rid="B25">25</xref>.</td>
							</tr>
							<tr>
								<td align="left">- Aplique curativo fino de hidrocoloide ou espuma e ajuste o material na pele sem tensioná-lo no dorso nasal, bochechas e testa, cobrindo a área onde a máscara, protetor facial e os óculos de proteção repousam <xref ref-type="bibr" rid="B17">17</xref><sup>-</sup><xref ref-type="bibr" rid="B18">18</xref><sup>,</sup><xref ref-type="bibr" rid="B20">20</xref><sup>,</sup><xref ref-type="bibr" rid="B23">23</xref><sup>,</sup><xref ref-type="bibr" rid="B28">28</xref>.</td>
							</tr>
							<tr>
								<td align="left">- Use hidratantes à base de acrilato com frequência, especialmente quando não estiver no atendimento direto ao paciente<xref ref-type="bibr" rid="B17">17</xref>.</td>
							</tr>
							<tr>
								<td align="left">- Ajuste a máscara N95 corretamente, fixando o clipe e adicione uma máscara cirúrgica para o alinhamento<xref ref-type="bibr" rid="B22">22</xref>.</td>
							</tr>
							<tr>
								<td align="left">- Utilize uma alça protetora auricular acoplada ao elástico da máscara<xref ref-type="bibr" rid="B23">23</xref>.</td>
							</tr>
							<tr>
								<td align="left"><bold>Recomendações para a prevenção de lesões relacionadas ao uso de luvas e roupas de proteção</bold></td>
							</tr>
							<tr>
								<td align="left">- Lave as mãos com sabão, detergente, sabonetes ou óleos leves, sem perfume e com o menor número de conservantes, seque-as bem e aplique talco nas mãos e nos pés antes de calçar as luvas e botas, visando a proteger a pele do atrito e da hidratação excessiva. Se as luvas estiverem secas, não coloque muito talco<xref ref-type="bibr" rid="B22">22</xref>.</td>
							</tr>
							<tr>
								<td align="left">- Aplique, regularmente, creme específico para as mãos e evite usar luvas por tempo prolongado. O uso de luvas de algodão ou uma camada de luvas de plástico dentro das luvas de látex ajuda a proteger contra o prurido ou a irritação em pessoas com alergia ao látex<xref ref-type="bibr" rid="B21">21</xref>.</td>
							</tr>
							<tr>
								<td align="left">- Aplique um creme de barreira antes e depois do uso de EPI para evitar descamação e ressecamento da pele<xref ref-type="bibr" rid="B28">28</xref><sup>-</sup><xref ref-type="bibr" rid="B29">29</xref>.</td>
							</tr>
						</tbody>
					</table>
				</table-wrap>
			</p>
			<p>Além das recomendações direcionadas para cada categoria de EPI, alguns estudos elencaram recomendações para cuidados gerais na prevenção das lesões. Foram elas a remoção do EPI<xref ref-type="bibr" rid="B26"><sup>26</sup></xref> e a não utilização de emolientes e cremes hidratantes quando o EPI for utilizado por período superior a quatro horas, pois podem resultar em forças de cisalhamento excessivas na pele e, nestes casos, devem ser substituídos por talco, lanolina contendo vaselina ou mistura de óleo de coco, manteiga de cacau e cera de abelha porque fornecem excelente lubrificação de longa duração<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>.</p>
		</sec>
		<sec sec-type="discussion">
			<title>Discussão</title>
			<p>A pandemia da COVID-19 exigiu o uso prolongado de EPIs não apenas pela equipe de profissionais da saúde, mas, também, por todo o corpo hospitalar. Logo, o número de profissionais prestadores de serviços que precisaram utilizar EPI aumentou consideravelmente, assim como as lesões na pele associadas ao uso intensivo desses materiais. Diante da falta de estudos com informações aprofundadas e atualizadas sobre a ocorrência de lesões de pele associadas ao uso de EPIs e estratégias de prevenção, observou-se a preocupação crescente de pesquisadores em produzir conhecimento sobre a temática para auxiliar a equipe multiprofissional<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>.</p>
			<p>Nos estudos identificados nesta revisão, as máscaras cirúrgicas ou N95, os óculos de proteção, protetor facial e luvas foram os principais responsáveis pelo aparecimento de lesões. Uma pesquisa realizada na China identificou que 95,1% dos profissionais da saúde, que usaram regularmente a máscara N95 mais de 12 horas por dia durante 3,5 meses, em média, reclamaram de algum tipo de acometimento da pele<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Outro estudo observou que 47,3% dos entrevistados, que utilizaram EPIs acima de quatro horas, também apresentaram algum tipo comprometimento<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. Esses dados apontam que, além do tipo de EPI, o tempo de utilização dele também é um fator de risco para o surgimento de lesões.</p>
			<p>A OMS orienta que as máscaras do tipo N95, PFF2 ou equivalente não devem ser utilizadas por um período superior a quatro horas pelo risco de desconforto e dor. No entanto, em períodos de emergência de saúde pública e quando há escassez de equipamentos, os mesmos podem ser utilizados, sem removê-los, sem perda da sua eficácia de proteção, por um longo período, ao cuidar de vários pacientes que possuem o mesmo diagnóstico<xref ref-type="bibr" rid="B34"><sup>34</sup></xref>.</p>
			<p>O uso persistente de EPIs, acima do tempo recomendado, exige medidas para evitar ou minimizar a ocorrência de lesões. Entretanto, essa recomendação não foi observada em um estudo realizado na China, visto que apenas 17,7% dos entrevistados fizeram uso de curativos ou loções profiláticas na pele durante a assistência. Os autores acreditam que o fato de 42,8% dos profissionais avaliados terem apresentado lesões de pele esteja relacionado à falta de treinamento ou ao medo de usar coberturas para a proteção e estas impedirem a correta fixação do EPI<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>.</p>
			<p>Dentre os tipos de lesões de pele, a lesão por pressão estágio 1 esteve entre as mais frequentes entre aqueles que utilizaram EPIs. Na China, um estudo identificou a lesão por pressão em 30% dos profissionais entrevistados e, destes, 81,1% estavam no estágio 1 e 18,3%, no estágio 2<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. Outra pesquisa identificou que 25,58% dos profissionais de saúde apresentaram lesão por pressão em face<xref ref-type="bibr" rid="B35"><sup>35</sup></xref>, enquanto outro estudo evidenciou que 68,9% apresentaram lesão por pressão na ponte nasal associada ao uso prolongado de EPI<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</p>
			<p>Tais lesões são formadas a partir de uma carga mecânica sustentada que é aplicada nos tecidos moles próximos de uma proeminência óssea. Destaca-se que a magnitude da carga depende da duração do tempo em que é empregada para causar danos, portanto, uma carga baixa aplicada por um período prolongado causa tanto dano tecidual quanto uma carga alta por um período curto<xref ref-type="bibr" rid="B36"><sup>36</sup></xref>. No caso dos profissionais de saúde atuantes na linha de frente da COVID-19, na tentativa de evitar a infecção respiratória pelo Coronavírus, era comum que eles ajustassem suas máscaras N95 de forma que a borda ficasse em contato excessivamente próximo com a pele e o clipe de metal fixado com firmeza sobre o nariz para garantir total vedação<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Esse fato pode ter contribuído para a formação de lesões em face e ponte nasal destes profissionais.</p>
			<p>Uma pesquisa, que avaliou as medidas protetivas para lesões de pele, verificou que emolientes suaves, creme de silicone e curativo de filme aplicados na região de maior pressão mecânica entre a máscara e a pele foram mais aceitos em detrimento do uso de curativos com espuma, pois estes requerem maior habilidade para aplicar e aderir corretamente. No entanto, os autores destacaram que o uso de cremes e emolientes em grande quantidade pode facilitar a aderência de sujidades, dificultando a reutilização da máscara em um contexto de escassez, enquanto o curativo filme precisa ser removido com cuidado para evitar dor<xref ref-type="bibr" rid="B37"><sup>37</sup></xref>. </p>
			<p>Curativos com espuma e borda de silicone são benéficos quando utilizados corretamente, como demonstrado em um estudo desenvolvido por enfermeiros no Barém. Os profissionais que utilizaram o curativo apresentaram menos reações dermatológicas após uma hora de uso contínuo em relação àqueles que não utilizaram proteção. Antes de usar a máscara facial, recomenda-se preparar e cortar, adequadamente, o curativo com espuma e colocá-lo no nariz, na lateral da face, abaixo do queixo, região central da testa e próximo às orelhas e utilizar hidratantes após a retirada<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. Pesquisas apontaram que o curativo não interfere na vedação das máscaras<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B37"><sup>37</sup></xref>.</p>
			<p>A acne facial também esteve entre os tipos de lesões mais frequentes nos estudos analisados. Uma pesquisa realizada em Singapura com profissionais que estavam na assistência no combate à infecção de <italic>Severe Acute Respiratory Syndrome</italic> (SARS), em 2003, identificou a acne como a principal reação de pele (65%) associada ao uso prolongado da máscara N95<xref ref-type="bibr" rid="B38"><sup>38</sup></xref>. Outra pesquisa realizada na Índia apontou a acne como a quinta dermatose mais comum entre os profissionais de saúde que usaram EPIs acima de oito horas por dia, atrás da dermatite de contato irritante, dermatite alérgica, marcas de pressão e fricção e dermatite de suor<xref ref-type="bibr" rid="B35"><sup>35</sup></xref>. </p>
			<p>O aparecimento da acne pode ser explicado pela obstrução dos ductos pilossebáceos causada pela oclusão prolongada e pressão local sobre a pele devido ao uso da máscara que, juntamente com o estresse mental, a carga de trabalho extremamente pesada e a privação do sono, contribui para o surgimento de acnes ou o agravamento do problema existente. Para o controle da acne, além dos cuidados gerais com a pele, recomenda-se lavar o rosto duas vezes por dia, escolher produtos de limpeza facial adequados, usar cosméticos leves ou evitá-los e, em casos leves a graves, utilizar tratamento medicamentoso apropriado com antibióticos tópicos e/ou pomada retinoide ao tratamento sistêmico, com monociclina ou isotretinoína, conforme orientação médica<xref ref-type="bibr" rid="B39"><sup>39</sup></xref>.</p>
			<p>Outro tipo de lesão de pele que se sobressaiu nos estudos desta revisão foi a depressão cutânea, que pode ocorrer devido ao uso prolongado de máscaras, óculos e protetores faciais<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. Este tipo de lesão costuma regredir espontaneamente<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref>, contudo, um tratamento recomendado para a vermelhidão e o inchaço consiste no uso de compressa hidropática com três a quatro camadas de gazes embebidas em água fria ou soro fisiológico a cada duas horas, seguido da aplicação de hidratantes<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. A prevenção deste tipo de lesão, além das já citadas anteriormente, versa sobre o uso de EPI facial corretamente, com o tamanho adequado, bem encaixado e não apertado<xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B41"><sup>41</sup></xref>, o uso de tiras de máscara N95 por cima da cabeça<xref ref-type="bibr" rid="B41"><sup>41</sup></xref>, além do uso de discos de algodão fixados com fita cirúrgica hipoalergênica na região nasal e zigomática para evitar atrito<xref ref-type="bibr" rid="B42"><sup>42</sup></xref>.</p>
			<p>Foi identificada a presença de dermatites nos profissionais de saúde que utilizaram EPIs, principalmente devido ao uso de máscaras e álcool gel<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B44"><sup>44</sup></xref>. Tais dermatites podem ser divididas em dois tipos: dermatite de contato alérgica e dermatite de contato irritante. Esta última compreende uma resposta não imunológica que afeta comumente mãos e rosto e ocorre em consequência do dano direto na pele por produtos químicos ou agentes físicos de maneira que a pele não consiga se reparar rapidamente. A dermatite de contato alérgica consiste em uma reação de hipersensibilidade retardada do tipo IV a um alérgeno externo que ocorre apenas no indivíduo que foi sensibilizado anteriormente. Esta reexposição ao alérgeno resulta em células T de memória circulante que se dirigem para a pele e provocam uma reação imunológica que causa inflamação de pele, normalmente dentro de 48 horas<xref ref-type="bibr" rid="B45"><sup>45</sup></xref>.</p>
			<p>De maneira geral, a duração da exposição ao conteúdo alergênico e/ou a umidade tem sido apontada como principal fator de risco para as dermatites de contato, de modo que a utilização de máscara e óculos por mais de seis horas ou lavar as mãos mais de dez vezes ao dia pode aumentar o risco de dermatite local. Também é importante considerar a exposição adicional ao material da máscara, bem como a lavagem das mãos repetidas vezes fora do ambiente de trabalho como forma de prevenir a infecção pelo SARS-CoV-2<xref ref-type="bibr" rid="B44"><sup>44</sup></xref>. </p>
			<p>As medidas preventivas das dermatites de contato incluem a aplicação de emolientes antes de usar máscaras e não as utilizar com o material responsável pela ardência e coceira. No entanto, caso não seja possível, recomenda-se a utilização de coberturas e/ou curativos preventivos que impeçam o contato direto da máscara com a pele, além de cuidados extras como evitar o uso de etanol 75% para a limpeza da pele e água muito quente. Erupções cutâneas suaves podem apresentar melhora espontânea após três a cinco dias sem tratamento adicional<xref ref-type="bibr" rid="B43"><sup>43</sup></xref>. Por sua vez, o agravamento de doenças preexistentes, como psoríase, dermatite atópica e reações alérgicas, pode exigir gerenciamento mais complexo, incluindo o afastamento temporário do trabalho desses profissionais da saúde<xref ref-type="bibr" rid="B44"><sup>44</sup></xref>.</p>
			<p>No que diz respeito ao uso de luvas e roupas de proteção, lesões como pele seca, coceira e erupções cutâneas estiveram presentes em profissionais que utilizaram estes EPIs acima de dez horas diárias por, em média, 3,5 meses<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. A xerose foi apontada em uma pesquisa mexicana como uma das principais lesões encontradas em profissionais de saúde (90,35%), seguida de descamação, eritema, fissuras, vesículas e maceração, cuja principal área afetada foram as mãos. Os dados obtidos mostraram associação significativa entre as lesões e o uso de álcool em gel, com um incremento de 1,81 vezes no risco de surgimento da xerose<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>. Esta lesão caracteriza-se pela diminuição da quantidade e/ou qualidade de lipídios e substâncias hidrofílicas na pele. O manejo da xerose é feito a partir do uso regular da combinação de substâncias tópicas que se destinam a melhorar a hidratação, compensar a falta de lipídios e melhorar a função da barreira da pele<xref ref-type="bibr" rid="B46"><sup>46</sup></xref>.</p>
			<p>Uma investigação, que avaliou as principais lesões de pele e seus fatores de risco no contexto da pandemia da COVID-19 na equipe de saúde, verificou que a maceração esteve presente em 52,9% da amostra<xref ref-type="bibr" rid="B47"><sup>47</sup></xref>. Esse tipo de lesão resulta da exposição prolongada à umidade, que faz com que a pele amoleça e se decomponha de modo que a fibra conjuntiva se afaste e a pele exiba, frequentemente, uma aparência branca. De maneira geral, essa lesão pode ser prevenida pela utilização de materiais semipermeáveis, que permitam que o vapor de água escape, e o tratamento indicado consiste no uso de curativos superabsorventes para a redução do excesso de umidade<xref ref-type="bibr" rid="B48"><sup>48</sup></xref>. </p>
			<p>No que diz respeito, especificamente, ao uso de EPIs pelos profissionais da saúde, outras medidas preventivas são recomendadas como a escolha do tamanho adequado de luvas e botas de borracha, aplicação de pó para a ostomia nas mãos e pés, aguardar, após a lavagem das mãos e/ou o uso de álcool gel na pele, que esta seque completamente antes do uso de EPIs, assim como realizar trocas frequentes destes materiais. Estas medidas contribuem para a proteção da pele contra o atrito e a hidratação excessiva. No caso de maceração persistente, o uso de creme adstringente, como o óxido de zinco, auxilia o tratamento deste tipo de lesão<xref ref-type="bibr" rid="B43"><sup>43</sup></xref>. </p>
			<p>Reações cutâneas adversas devido à utilização de capotes e roupas de proteção são menos comuns, entretanto, sua ocorrência pode estar associada à umidade gerada pelos tecidos pesados e à necessidade de utilizá-los por longos períodos. Estratégias, como retirar a roupa por alguns minutos ou trocá-la frequentemente, podem auxiliar a redução dessas reações<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. </p>
			<p>Um trabalho desenvolvido por enfermeiros no Barém utilizou um mnemônico com a palavra HELP para auxiliar os profissionais da saúde a incorporarem cuidados com a pele antes, durante e após o uso de EPIs. De maneira geral, recomendaram-se o consumo de água regularmente, manter a pele limpa e hidratada (principalmente mãos e face), observar o tempo de uso de EPIs, manter uma dieta equilibrada de calorias e proteínas, utilizar cremes de barreira dez minutos antes de usar EPIs e coberturas protetivas nos locais de maior contato da pele com eles<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. </p>
			<p>Apesar do crescente número de publicações sobre a prevalência de lesões, orientações de prevenção e tratamento, ainda são incipientes estudos que utilizaram abordagem metodológica que fornecesse altos níveis de evidência científica. Por tratar-se de um tema emergente a partir de uma nova doença, destaca-se, como limitação deste estudo, a falta de um termo comum, descritores ou palavras-chave específicas para tal, o que pode, eventualmente, ter deixado algum estudo fora do resultado da pesquisa. Além disso, o baixo número de ensaios clínicos randomizados impede a generalização dos resultados.</p>
			<p>Os resultados obtidos podem contribuir para que profissionais de saúde, especialmente o enfermeiro, possam conhecer os tipos de lesões de pele frequentemente associados ao uso dos EPIs e quais medidas podem ser adotadas para prevenir sua ocorrência. E, ainda, subsidiar gestores na realização de treinamentos para a prevenção de possíveis lesões e incorporação das recomendações na rotina da instituição.</p>
		</sec>
		<sec sec-type="conclusions">
			<title>Conclusão</title>
			<p>As lesões de pele causadas pelo uso de EPIs em profissionais da saúde tiveram maior notoriedade durante a pandemia da COVID-19 em que foi possível observar as consequências do seu uso prolongado em maior escala. A maior parte dos profissionais que atuaram na assistência direta aos pacientes infectados pelo novo Coronavírus apresentou algum tipo de comprometimento na pele, principalmente aqueles que utilizaram EPIs por um período diário acima de seis horas. A máscara, especialmente a N95, foi a principal responsável pela ocorrência lesão de pele, seguida pelos óculos de proteção, protetor facial e luvas. Quanto aos tipos de lesão, acne, lesões por pressão (estágios 1 e 2), depressão cutânea e xerose foram observadas, com maior frequência, nos profissionais.</p>
			<p>As principais medidas de prevenção de lesão de pele envolvem cuidados rotineiros, como manter a pele hidratada, consumo de líquidos e uso de hidratantes e emolientes, instituir o hábito de higienização da pele, evitar o uso de maquiagem em excesso, além do uso de coberturas protetoras em proeminências ósseas da face, de preferência, com espuma e bordas de silicones para facilitar a remoção, utilizar EPIs ajustados e de maneira adequada e, se possível, evitar o uso contínuo de EPIs por período prolongado.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>Referências</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Organização Pan-Americana de Saúde. Folha informativa sobre COVID-19 [Internet]. 2020 [cited 2021 Aug 6]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.paho.org/bra/index.php?option=com_content&amp;view=article&amp;id=6101:covid19&amp;Itemid=875">https://www.paho.org/bra/index.php?option=com_content&amp;view=article&amp;id=6101:covid19&amp;Itemid=875</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>Organização Pan-Americana de Saúde</collab>
					</person-group>
					<source>Folha informativa sobre COVID-19</source>
					<comment>Internet</comment>
					<year>2020</year>
					<date-in-citation content-type="access-date" iso-8601-date="2021-08-06">2021 Aug 6</date-in-citation>
					<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.paho.org/bra/index.php?option=com_content&amp;view=article&amp;id=6101:covid19&amp;Itemid=875">https://www.paho.org/bra/index.php?option=com_content&amp;view=article&amp;id=6101:covid19&amp;Itemid=875</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Quadros A, Fernandes TCM, Araujo BR, Caregnato RCA. Desafios da Enfermagem Brasileira no Combate da COVID-19: uma reflexão. Enferm Foco [Internet]. 2020 [cited 2021 Aug 6];11(1):78-83. Available from: <ext-link ext-link-type="uri" xlink:href="http://revista.cofen.gov.br/index.php/enfermagem/article/view/3748/807">http://revista.cofen.gov.br/index.php/enfermagem/article/view/3748/807</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Quadros</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Fernandes</surname>
							<given-names>TCM</given-names>
						</name>
						<name>
							<surname>Araujo</surname>
							<given-names>BR</given-names>
						</name>
						<name>
							<surname>Caregnato</surname>
							<given-names>RCA</given-names>
						</name>
					</person-group>
					<article-title>Desafios da Enfermagem Brasileira no Combate da COVID-19: uma reflexão</article-title>
					<source>Enferm Foco</source>
					<comment>Internet</comment>
					<year>2020</year>
					<date-in-citation content-type="access-date" iso-8601-date="2021-08-06">2021 Aug 6</date-in-citation>
					<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://revista.cofen.gov.br/index.php/enfermagem/article/view/3748/807">http://revista.cofen.gov.br/index.php/enfermagem/article/view/3748/807</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Freitas ARR, Napimoga M, Donalisio MR. Assessing the severity of COVID-19. Epidemiol Serv Saúde. 2020;29(2):e2020119. doi: https://doi.org/10.5123/s1679-49742020000200008</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Freitas</surname>
							<given-names>ARR</given-names>
						</name>
						<name>
							<surname>Napimoga</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Donalisio</surname>
							<given-names>MR</given-names>
						</name>
					</person-group>
					<article-title>Assessing the severity of COVID-19</article-title>
					<source>Epidemiol Serv Saúde</source>
					<year>2020</year>
					<volume>29</volume>
					<issue>2</issue>
					<elocation-id>e2020119</elocation-id>
					<pub-id pub-id-type="doi">10.5123/s1679-49742020000200008</pub-id>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Agência Nacional de Vigilância Sanitária (BR). Nota Técnica nº 04/2020 GVIMS/GGTES/ANVISA. Orientações para Serviços de Saúde: medidas de prevenção e controle que devem ser adotadas durante a assistência aos casos suspeitos ou confirmados de infecção pelo novo coronavírus (SARS-CoV-2) [Internet]. Brasília: ANVISA; 2021 [cited 2021 Aug 6]. 118p. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/notas-tecnicas/nota-tecnica-gvims_ggtes_anvisa-04_2020-25-02-para-o-site.pdf">https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/notas-tecnicas/nota-tecnica-gvims_ggtes_anvisa-04_2020-25-02-para-o-site.pdf</ext-link>
				</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<collab>Agência Nacional de Vigilância Sanitária</collab>
					</person-group>
					<source>Nota Técnica nº 04/2020 GVIMS/GGTES/ANVISA. Orientações para Serviços de Saúde: medidas de prevenção e controle que devem ser adotadas durante a assistência aos casos suspeitos ou confirmados de infecção pelo novo coronavírus (SARS-CoV-2)</source>
					<year>2021</year>
					<publisher-loc>Brasília</publisher-loc>
					<publisher-name>ANVISA</publisher-name>
					<date-in-citation content-type="access-date" iso-8601-date="2021-08-06">2021 Aug 6</date-in-citation>
					<size units="pages">118</size>
					<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/notas-tecnicas/nota-tecnica-gvims_ggtes_anvisa-04_2020-25-02-para-o-site.pdf">https://www.gov.br/anvisa/pt-br/centraisdeconteudo/publicacoes/servicosdesaude/notas-tecnicas/nota-tecnica-gvims_ggtes_anvisa-04_2020-25-02-para-o-site.pdf</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Yan Y, Chen H, Chen L, Cheng B, Diao P, Dong L, et al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Derm Therapy. 2020;33(4):e13310. doi: https://doi.org/10.1111/dth.13310</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Yan</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Cheng</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Diao</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Dong</surname>
							<given-names>L</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019</article-title>
					<source>Derm Therapy</source>
					<year>2020</year>
					<volume>33</volume>
					<issue>4</issue>
					<elocation-id>e13310</elocation-id>
					<pub-id pub-id-type="doi">10.1111/dth.13310</pub-id>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Darlenski R, Tsankov N. Covid-19 pandemic and the skin-What should dermatologists know? Clin Dermat. 2020;38(6):785-7. doi: https://doi.org/10.1016/j.clindermatol.2020.03.012</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Darlenski</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Tsankov</surname>
							<given-names>N</given-names>
						</name>
					</person-group>
					<article-title>Covid-19 pandemic and the skin-What should dermatologists know?</article-title>
					<source>Clin Dermat</source>
					<year>2020</year>
					<volume>38</volume>
					<issue>6</issue>
					<fpage>785</fpage>
					<lpage>787</lpage>
					<pub-id pub-id-type="doi">10.1016/j.clindermatol.2020.03.012</pub-id>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Gefen A, Ousey K. Update to device-related pressure ulcers: SECURE prevention. COVID-19, face masks and skin damage. J. Wound Care. 2020;29(5):245-59. doi: https://doi.org/10.12968/jowc.2020.29.5.245</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gefen</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Ousey</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<article-title>Update to device-related pressure ulcers: SECURE prevention. COVID-19, face masks and skin damage</article-title>
					<source>J. Wound Care</source>
					<year>2020</year>
					<volume>29</volume>
					<issue>5</issue>
					<fpage>245</fpage>
					<lpage>259</lpage>
					<pub-id pub-id-type="doi">10.12968/jowc.2020.29.5.245</pub-id>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Chowdhury MM, Bevan N, Ryan K. Covid-19: virtual occupational skin health clinics for healthcare workers. BMJ. 2020;369:m2281. doi: http://dx.doi.org/10.1136/bmj.m2281</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Chowdhury</surname>
							<given-names>MM</given-names>
						</name>
						<name>
							<surname>Bevan</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Ryan</surname>
							<given-names>K</given-names>
						</name>
					</person-group>
					<article-title>Covid-19: virtual occupational skin health clinics for healthcare workers</article-title>
					<source>BMJ</source>
					<year>2020</year>
					<volume>369</volume>
					<elocation-id>m2281</elocation-id>
					<pub-id pub-id-type="doi">http://dx.doi.org/10.1136/bmj.m2281</pub-id>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Silva LFM, Almeida AGA; Pascoal LM, Santos M Neto, Lima FET, Santos FS. Lesões de pele por equipamentos de proteção individual e medidas preventivas no contexto da COVID-19: revisão integrativa. FigShare. 2021 Oct 25. Preprint. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.16869497">https://doi.org/10.6084/m9.figshare.16869497</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Silva</surname>
							<given-names>LFM</given-names>
						</name>
						<name>
							<surname>Almeida</surname>
							<given-names>AGA</given-names>
						</name>
						<name>
							<surname>Pascoal</surname>
							<given-names>LM</given-names>
						</name>
						<name>
							<surname>Santos</surname>
							<given-names>M</given-names>
							<suffix>Neto</suffix>
						</name>
						<name>
							<surname>Lima</surname>
							<given-names>FET</given-names>
						</name>
						<name>
							<surname>Santos</surname>
							<given-names>FS</given-names>
						</name>
					</person-group>
					<article-title>Lesões de pele por equipamentos de proteção individual e medidas preventivas no contexto da COVID-19: revisão integrativa</article-title>
					<source>FigShare</source>
					<year>2021</year>
					<comment>Preprint</comment>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.16869497">https://doi.org/10.6084/m9.figshare.16869497</ext-link>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Whittemore R. Combining evidence in nursing research: methods and implications. Nursing Res. 2005;54(1):56-62. doi: https://doi.org/10.1097/00006199-200501000-00008</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Whittemore</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Combining evidence in nursing research: methods and implications</article-title>
					<source>Nursing Res</source>
					<year>2005</year>
					<volume>54</volume>
					<issue>1</issue>
					<fpage>56</fpage>
					<lpage>62</lpage>
					<pub-id pub-id-type="doi">10.1097/00006199-200501000-00008</pub-id>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. Lockwood C, Porrit K, Munn Z, Rittenmeyer L, Salmond S, Bjerrum M, et al. Chapter 2: Systematic reviews of qualitative evidence [Internet]. 2020 [cited 2021 Aug 06]. Available from: <ext-link ext-link-type="uri" xlink:href="https://jbi-global-wiki.refined.site/space/MANUAL/3283910681/Chapter+2%3A+Systematic+reviews+of+qualitative+evidence">https://jbi-global-wiki.refined.site/space/MANUAL/3283910681/Chapter+2%3A+Systematic+reviews+of+qualitative+evidence</ext-link>
				</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<name>
							<surname>Lockwood</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Porrit</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Munn</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Rittenmeyer</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Salmond</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Bjerrum</surname>
							<given-names>M</given-names>
						</name>
						<etal/>
					</person-group>
					<source>Chapter 2: Systematic reviews of qualitative evidence</source>
					<comment>Internet</comment>
					<year>2020</year>
					<date-in-citation content-type="access-date" iso-8601-date="2021-08-06">2021 Aug 06</date-in-citation>
					<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://jbi-global-wiki.refined.site/space/MANUAL/3283910681/Chapter+2%3A+Systematic+reviews+of+qualitative+evidence">https://jbi-global-wiki.refined.site/space/MANUAL/3283910681/Chapter+2%3A+Systematic+reviews+of+qualitative+evidence</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan - a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. doi: http://doi.org/10.1186/s13643-016- 0384-4</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Ouzzani</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Hammady</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Fedorowicz</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Elmagarmid</surname>
							<given-names>A</given-names>
						</name>
					</person-group>
					<article-title>Rayyan - a web and mobile app for systematic reviews</article-title>
					<source>Syst Rev</source>
					<year>2016</year>
					<volume>5</volume>
					<issue>1</issue>
					<fpage>210</fpage>
					<lpage>210</lpage>
					<pub-id pub-id-type="doi">http://doi.org/10.1186/s13643-016-</pub-id>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Marziale MH. Instrumento para recolección de datos: revisión integrativa [Internet]. 2015 [cited 2021 Aug 6]. Available from: <ext-link ext-link-type="uri" xlink:href="http://gruposdepesquisa.eerp.usp.br/sites/redenso/wp-content/uploads/sites/9/2019/09/Instrumiento_revision_litetarura_RedENSO_2015.pdf">http://gruposdepesquisa.eerp.usp.br/sites/redenso/wp-content/uploads/sites/9/2019/09/Instrumiento_revision_litetarura_RedENSO_2015.pdf</ext-link>
				</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Marziale</surname>
							<given-names>MH</given-names>
						</name>
					</person-group>
					<source>Instrumento para recolección de datos: revisión integrativa</source>
					<comment>Internet</comment>
					<year>2015</year>
					<date-in-citation content-type="access-date" iso-8601-date="2021-08-06">2021 Aug 6</date-in-citation>
					<comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://gruposdepesquisa.eerp.usp.br/sites/redenso/wp-content/uploads/sites/9/2019/09/Instrumiento_revision_litetarura_RedENSO_2015.pdf">http://gruposdepesquisa.eerp.usp.br/sites/redenso/wp-content/uploads/sites/9/2019/09/Instrumiento_revision_litetarura_RedENSO_2015.pdf</ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Peters MDJ, Godfrey CM, McInerney P, Soares CB, Khalil H, Parker D. The Joanna Briggs Institute reviewers' manual 2015: methodology for JBI scoping reviews [Internet]. Adelaide: Joanna Briggs Institute; 2015 [cited 2021 Aug 6]. Available from: https://nursing.lsuhsc.edu/JBI/docs/ReviewersManuals/Scoping-.pdf</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Peters</surname>
							<given-names>MDJ</given-names>
						</name>
						<name>
							<surname>Godfrey</surname>
							<given-names>CM</given-names>
						</name>
						<name>
							<surname>McInerney</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Soares</surname>
							<given-names>CB</given-names>
						</name>
						<name>
							<surname>Khalil</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Parker</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<source>The Joanna Briggs Institute reviewers' manual 2015: methodology for JBI scoping reviews</source>
					<year>2015</year>
					<publisher-loc>Adelaide</publisher-loc>
					<publisher-name>Joanna Briggs Institute</publisher-name>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Lockwood C, Porrit K, Munn Z, Rittenmeyer L, Salmond S, Bjerrum M, et al. Chapter 2: Systematic reviews of qualitative evidence. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis [Internet]. Adelaide: Joanna Briggs Institute; 2020 [cited 2021 Aug 6]. Available from https://synthesismanual.jbi.global. https://doi.org/10.46658 /JBIMES-20-03</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Lockwood</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Porrit</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Munn</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Rittenmeyer</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Salmond</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Bjerrum</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<person-group person-group-type="author">
						<name>
							<surname>Aromataris</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Munn</surname>
							<given-names>Z</given-names>
						</name>
					</person-group>
					<source>JBI Manual for Evidence Synthesis</source>
					<chapter-title>Chapter 2: Systematic reviews of qualitative evidence</chapter-title>
					<year>2020</year>
					<publisher-loc>Adelaide</publisher-loc>
					<publisher-name>Joanna Briggs Institute</publisher-name>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: https://doi.org/10.1371/journal.pmed.1000097</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Moher</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Liberati</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Tetzlaff</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Altman</surname>
							<given-names>DG</given-names>
						</name>
						<collab>Prisma Group</collab>
					</person-group>
					<article-title>Preferred reporting items for systematic reviews and meta-analyses the PRISMA statement</article-title>
					<source>PLoS Med</source>
					<year>2009</year>
					<volume>6</volume>
					<issue>7</issue>
					<elocation-id>e1000097</elocation-id>
					<pub-id pub-id-type="doi">10.1371/journal.pmed.1000097</pub-id>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17. Smart H, Opinion FB, Darwich I, Elnawasany MA, Kodange C. Preventing Facial Pressure Injury for Health Care Providers Adhering to COVID-19 Personal Protective Equipment Requirements. Adv Skin Wound Care. 2020;33(8):418-27. doi: https://doi.org/10.1097/01.ASW.0000669920.94084.c1</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Smart</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Opinion</surname>
							<given-names>FB</given-names>
						</name>
						<name>
							<surname>Darwich</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Elnawasany</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Kodange</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Preventing Facial Pressure Injury for Health Care Providers Adhering to COVID-19 Personal Protective Equipment Requirements</article-title>
					<source>Adv Skin Wound Care</source>
					<year>2020</year>
					<volume>33</volume>
					<issue>8</issue>
					<fpage>418</fpage>
					<lpage>427</lpage>
					<pub-id pub-id-type="doi">10.1097/01.ASW.0000669920.94084.c1</pub-id>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18. Yildiz A, Karadag A, Yildiz A, Çakar V. Determination of the effect of prophylactic dressing on the prevention of skin injuries associated with personal protective equipments in health care workers during COVID-19 pandemic. J Tissue Viability. 2021;30(1):21-7. doi: https://doi.org/10.1016/j.jtv.2020.10.005</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Yildiz</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Karadag</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Yildiz</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Çakar</surname>
							<given-names>V</given-names>
						</name>
					</person-group>
					<article-title>Determination of the effect of prophylactic dressing on the prevention of skin injuries associated with personal protective equipments in health care workers during COVID-19 pandemic</article-title>
					<source>J Tissue Viability</source>
					<year>2021</year>
					<volume>30</volume>
					<issue>1</issue>
					<fpage>21</fpage>
					<lpage>27</lpage>
					<pub-id pub-id-type="doi">10.1016/j.jtv.2020.10.005</pub-id>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>19. Hua W, Zuo Y, Wan R, Xiong L, Tang J, Zou L, et al. Short-term skin reactions following use of N95 respirators and medical masks. Contact Dermatitis. 2020;83(2):115-21. doi: https://doi.org/10.1111/cod.13601</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hua</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Zuo</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Wan</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Xiong</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Tang</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Zou</surname>
							<given-names>L</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Short-term skin reactions following use of N95 respirators and medical masks</article-title>
					<source>Contact Dermatitis</source>
					<year>2020</year>
					<volume>83</volume>
					<issue>2</issue>
					<fpage>115</fpage>
					<lpage>121</lpage>
					<pub-id pub-id-type="doi">10.1111/cod.13601</pub-id>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>20. Gasparino RC, Lima MHM, Souza Oliveira-Kumakura AR, Silva VA, Jesus Meszaros M, Antunes IR. Prophylactic dressings in the prevention of pressure ulcer related to the use of personal protective equipment by health professionals facing the COVID-19 pandemic: A randomized clinical trial. Wound Repair Regen. 2021;29(1):183-8. doi: https://doi.org/10.1111/wrr.12877</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Gasparino</surname>
							<given-names>RC</given-names>
						</name>
						<name>
							<surname>Lima</surname>
							<given-names>MHM</given-names>
						</name>
						<name>
							<surname>Souza Oliveira-Kumakura</surname>
							<given-names>AR</given-names>
						</name>
						<name>
							<surname>Silva</surname>
							<given-names>VA</given-names>
						</name>
						<name>
							<surname>Jesus Meszaros</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Antunes</surname>
							<given-names>IR</given-names>
						</name>
					</person-group>
					<article-title>Prophylactic dressings in the prevention of pressure ulcer related to the use of personal protective equipment by health professionals facing the COVID-19 pandemic: A randomized clinical trial</article-title>
					<source>Wound Repair Regen</source>
					<year>2021</year>
					<volume>29</volume>
					<issue>1</issue>
					<fpage>183</fpage>
					<lpage>188</lpage>
					<pub-id pub-id-type="doi">10.1111/wrr.12877</pub-id>
				</element-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation>21. Jiang Q, Liu Y, Wei W, Zhu D, Chen A, Liu H, et al. The prevalence, characteristics, and related factors of pressure injury in medical staff wearing personal protective equipment against COVID-19 in China: A multicentre cross-sectional survey. Int Wound J. 2020;17:1300-9. doi: https://doi.org/10.1111/iwj.13391</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jiang</surname>
							<given-names>Q</given-names>
						</name>
						<name>
							<surname>Liu</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Wei</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Zhu</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Liu</surname>
							<given-names>H</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>The prevalence, characteristics, and related factors of pressure injury in medical staff wearing personal protective equipment against COVID-19 in China: A multicentre cross-sectional survey</article-title>
					<source>Int Wound J</source>
					<year>2020</year>
					<volume>17</volume>
					<fpage>1300</fpage>
					<lpage>1309</lpage>
					<pub-id pub-id-type="doi">10.1111/iwj.13391</pub-id>
				</element-citation>
			</ref>
			<ref id="B22">
				<label>22</label>
				<mixed-citation>22. Hu K, Fan J, Li X, Gou X, Li X, Zhou X. The adverse skin reactions of health care workers using personal protective equipment for COVID-19. Medicine (Baltimore). 2020 Jun 12;99(24):e20603. doi: https://doi.org/10.1097/MD.0000000000020603</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Hu</surname>
							<given-names>K</given-names>
						</name>
						<name>
							<surname>Fan</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Gou</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>X</given-names>
						</name>
						<name>
							<surname>Zhou</surname>
							<given-names>X</given-names>
						</name>
					</person-group>
					<article-title>The adverse skin reactions of health care workers using personal protective equipment for COVID-19</article-title>
					<source>Medicine (Baltimore)</source>
					<year>2020</year>
					<volume>99</volume>
					<issue>24</issue>
					<elocation-id>e20603</elocation-id>
					<pub-id pub-id-type="doi">10.1097/MD.0000000000020603</pub-id>
				</element-citation>
			</ref>
			<ref id="B23">
				<label>23</label>
				<mixed-citation>23. Shanshal M, Ahmed HS, Asfoor H, Salih RI, Ali SA, Aldabouni YK. Impact of COVID-19 on medical practice: A nationwide survey of dermatologists and health care providers in Iraq. Clin Dermatol. 2020. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clindermatol.2020.11.010">https://doi.org/10.1016/j.clindermatol.2020.11.010</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Shanshal</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Ahmed</surname>
							<given-names>HS</given-names>
						</name>
						<name>
							<surname>Asfoor</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Salih</surname>
							<given-names>RI</given-names>
						</name>
						<name>
							<surname>Ali</surname>
							<given-names>SA</given-names>
						</name>
						<name>
							<surname>Aldabouni</surname>
							<given-names>YK</given-names>
						</name>
					</person-group>
					<article-title>Impact of COVID-19 on medical practice: A nationwide survey of dermatologists and health care providers in Iraq</article-title>
					<source>Clin Dermatol</source>
					<year>2020</year>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clindermatol.2020.11.010">https://doi.org/10.1016/j.clindermatol.2020.11.010</ext-link>
				</element-citation>
			</ref>
			<ref id="B24">
				<label>24</label>
				<mixed-citation>24. Xia W, Fu L, Liao H, Yang C, Guo H, Bian Z. The physical and psychological effects of personal protective equipment on health care workers in Wuhan, China: A Cross-Sectional Survey Study. J Emergency Nurs. 2020;46(6):791-801. doi: https://doi.org/10.1016/j.jen.2020.08.004</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Xia</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Fu</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Liao</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Yang</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Guo</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Bian</surname>
							<given-names>Z</given-names>
						</name>
					</person-group>
					<article-title>The physical and psychological effects of personal protective equipment on health care workers in Wuhan, China: A Cross-Sectional Survey Study</article-title>
					<source>J Emergency Nurs</source>
					<year>2020</year>
					<volume>46</volume>
					<issue>6</issue>
					<fpage>791</fpage>
					<lpage>801</lpage>
					<pub-id pub-id-type="doi">10.1016/j.jen.2020.08.004</pub-id>
				</element-citation>
			</ref>
			<ref id="B25">
				<label>25</label>
				<mixed-citation>25. Pacis M, Azor-Ocampo A, Burnett E, Tanasapphaisal C, Coleman B. Prophylactic Dressings for Maintaining Skin Integrity of Healthcare Workers When Using N95 Respirators While Preventing Contamination Due to the Novel Coronavirus: A Quality Improvement Project. J Wound Ostomy Continence Nurs. 2020;47(6):551-7. doi: https://doi.org/10.1097/WON.0000000000000713</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Pacis</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Azor-Ocampo</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Burnett</surname>
							<given-names>E</given-names>
						</name>
						<name>
							<surname>Tanasapphaisal</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Coleman</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<article-title>Prophylactic Dressings for Maintaining Skin Integrity of Healthcare Workers When Using N95 Respirators While Preventing Contamination Due to the Novel Coronavirus: A Quality Improvement Project</article-title>
					<source>J Wound Ostomy Continence Nurs</source>
					<year>2020</year>
					<volume>47</volume>
					<issue>6</issue>
					<fpage>551</fpage>
					<lpage>557</lpage>
					<pub-id pub-id-type="doi">10.1097/WON.0000000000000713</pub-id>
				</element-citation>
			</ref>
			<ref id="B26">
				<label>26</label>
				<mixed-citation>26. Agarwal A, Agarwal S, Motiani P. Difficulties Encountered While Using PPE Kits and How to Overcome Them: An Indian Perspective. Cureus. 2020;12(11):e11652. doi: https://doi.org/10.7759/cureus.11652</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Agarwal</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Agarwal</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Motiani</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Difficulties Encountered While Using PPE Kits and How to Overcome Them: An Indian Perspective</article-title>
					<source>Cureus</source>
					<year>2020</year>
					<volume>12</volume>
					<issue>11</issue>
					<elocation-id>e11652</elocation-id>
					<pub-id pub-id-type="doi">10.7759/cureus.11652</pub-id>
				</element-citation>
			</ref>
			<ref id="B27">
				<label>27</label>
				<mixed-citation>27. Yuan N, Yang WX, Lu JL, Lv ZH. Investigation of adverse reactions in healthcare personnel working in Level 3 barrier protection PPE to treat COVID-19. Postgrad Med J. 2020;(1148):351-4. doi: https://doi.org/10.1136/postgradmedj-2020-137854</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Yuan</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Yang</surname>
							<given-names>WX</given-names>
						</name>
						<name>
							<surname>Lu</surname>
							<given-names>JL</given-names>
						</name>
						<name>
							<surname>Lv</surname>
							<given-names>ZH</given-names>
						</name>
					</person-group>
					<article-title>Investigation of adverse reactions in healthcare personnel working in Level 3 barrier protection PPE to treat COVID-19</article-title>
					<source>Postgrad Med J</source>
					<year>2020</year>
					<issue>1148</issue>
					<fpage>351</fpage>
					<lpage>354</lpage>
					<pub-id pub-id-type="doi">10.1136/postgradmedj-2020-137854</pub-id>
				</element-citation>
			</ref>
			<ref id="B28">
				<label>28</label>
				<mixed-citation>28. Jiang Q, Song S, Zhou J, Liu Y, Chen A, et al. The Prevalence, Characteristics, and Prevention Status of Skin Injury Caused by Personal Protective Equipment Among Medical Staff in Fighting COVID-19: A Multicenter, Cross-Sectional Study Advances in Wound Care. 2020;9(7):357-64. doi: https://doi.org/10.1089/wound.2020.1212</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jiang</surname>
							<given-names>Q</given-names>
						</name>
						<name>
							<surname>Song</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Zhou</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Liu</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>A</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>The Prevalence, Characteristics, and Prevention Status of Skin Injury Caused by Personal Protective Equipment Among Medical Staff in Fighting COVID-19: A Multicenter, Cross-Sectional Study Advances in Wound</article-title>
					<source>Care</source>
					<year>2020</year>
					<volume>9</volume>
					<issue>7</issue>
					<fpage>357</fpage>
					<lpage>364</lpage>
					<pub-id pub-id-type="doi">10.1089/wound.2020.1212</pub-id>
				</element-citation>
			</ref>
			<ref id="B29">
				<label>29</label>
				<mixed-citation>29. Daye M, Cihan FG, Durduran Y. Evaluation of skin problems and dermatology life quality index in health care workers who use personal protection measures during COVID-19 pandemic. Dermatol Ther. 2020;33(6):e14346. doi: https://doi.org/10.1111/dth.14346</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Daye</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Cihan</surname>
							<given-names>FG</given-names>
						</name>
						<name>
							<surname>Durduran</surname>
							<given-names>Y</given-names>
						</name>
					</person-group>
					<article-title>Evaluation of skin problems and dermatology life quality index in health care workers who use personal protection measures during COVID-19 pandemic</article-title>
					<source>Dermatol Ther</source>
					<year>2020</year>
					<volume>33</volume>
					<issue>6</issue>
					<elocation-id>e14346</elocation-id>
					<pub-id pub-id-type="doi">10.1111/dth.14346</pub-id>
				</element-citation>
			</ref>
			<ref id="B30">
				<label>30</label>
				<mixed-citation>30. Atay S, Cura SÜ. Problems Encountered by Nurses Due to the Use of Personal Protective Equipment During the Coronavirus Pandemic: Results of a Survey. Wound Manag Prev. 2020;66(10):12-6. doi: https://doi.org/10.25270/wmp.2020.10.1216</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Atay</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Cura</surname>
							<given-names>SÜ</given-names>
						</name>
					</person-group>
					<article-title>Problems Encountered by Nurses Due to the Use of Personal Protective Equipment During the Coronavirus Pandemic: Results of a Survey</article-title>
					<source>Wound Manag Prev</source>
					<year>2020</year>
					<volume>66</volume>
					<issue>10</issue>
					<fpage>12</fpage>
					<lpage>16</lpage>
					<pub-id pub-id-type="doi">10.25270/wmp.2020.10.1216</pub-id>
				</element-citation>
			</ref>
			<ref id="B31">
				<label>31</label>
				<mixed-citation>31. Techasatian L, Lebsing S, Uppala R, Thaowandee W, Chaiyarit J, Supakunpinyo C, et al. The effects of the face mask on the skin underneath: A prospective survey during the COVID-19 Pandemic. J Prim Care Community Health. 2020;11:2150132720966167. doi: https://doi.org/10.1177/2150132720966167</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Techasatian</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Lebsing</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Uppala</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Thaowandee</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Chaiyarit</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Supakunpinyo</surname>
							<given-names>C</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>The effects of the face mask on the skin underneath: A prospective survey during the COVID-19 Pandemic</article-title>
					<source>J Prim Care Community Health</source>
					<year>2020</year>
					<volume>11</volume>
					<fpage>2150132720966167</fpage>
					<lpage>2150132720966167</lpage>
					<pub-id pub-id-type="doi">10.1177/2150132720966167</pub-id>
				</element-citation>
			</ref>
			<ref id="B32">
				<label>32</label>
				<mixed-citation>32. Masen MA, Chung A, Dawczyk JU, Dunning Z, Edwards L, Guyott C, et al. Evaluating lubricant performance to reduce COVID-19 PPE-related skin injury. PLoS One. 2020;15(9):e0239363. doi: https://doi.org/10.1371/journal.pone.0239363</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Masen</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Chung</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Dawczyk</surname>
							<given-names>JU</given-names>
						</name>
						<name>
							<surname>Dunning</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Edwards</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Guyott</surname>
							<given-names>C</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Evaluating lubricant performance to reduce COVID-19 PPE-related skin injury</article-title>
					<source>PLoS One</source>
					<year>2020</year>
					<volume>15</volume>
					<issue>9</issue>
					<elocation-id>e0239363</elocation-id>
					<pub-id pub-id-type="doi">10.1371/journal.pone.0239363</pub-id>
				</element-citation>
			</ref>
			<ref id="B33">
				<label>33</label>
				<mixed-citation>33. Erize-Herrera JA, García-Mireles V, Uh-Sánchez I, Felix-Téllez F, Encarnación-Martínez M, Estrada-Aguilar L. Dermatological manifestations in healthcare workers associated with the use of personal protective equipment when attending patients with COVID-19 infection in hospitals in the metropolitan area of Mexico city. Piel. 2020. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.piel.2020.10.004">https://doi.org/10.1016/j.piel.2020.10.004</ext-link>
				</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Erize-Herrera</surname>
							<given-names>JA</given-names>
						</name>
						<name>
							<surname>García-Mireles</surname>
							<given-names>V</given-names>
						</name>
						<name>
							<surname>Uh-Sánchez</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Felix-Téllez</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Encarnación-Martínez</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Estrada-Aguilar</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>Dermatological manifestations in healthcare workers associated with the use of personal protective equipment when attending patients with COVID-19 infection in hospitals in the metropolitan area of Mexico city</article-title>
					<source>Piel</source>
					<year>2020</year>
					<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.piel.2020.10.004">https://doi.org/10.1016/j.piel.2020.10.004</ext-link>
				</element-citation>
			</ref>
			<ref id="B34">
				<label>34</label>
				<mixed-citation>34. World Health Organization. Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19): Interim guidance [Internet]. Geneva: WHO; 2020 [cited 2021 Aug 6]. 7p. Available from: https://apps.who.int/iris/handle/10665/331498</mixed-citation>
				<element-citation publication-type="webpage">
					<person-group person-group-type="author">
						<collab>World Health Organization</collab>
					</person-group>
					<source>Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19): Interim guidance</source>
					<year>2020</year>
					<publisher-loc>Geneva</publisher-loc>
					<publisher-name>WHO</publisher-name>
					<date-in-citation content-type="access-date" iso-8601-date="2021-08-06">2021 Aug 6</date-in-citation>
					<size units="pages">7</size>
					<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://apps.who.int/iris/handle/10665/331498">https://apps.who.int/iris/handle/10665/331498 </ext-link>
					</comment>
				</element-citation>
			</ref>
			<ref id="B35">
				<label>35</label>
				<mixed-citation>35. Singh M, Bothra A, Pawar M, Maheswari A, Tiwari A, Adhicari P. Prevalence of cheilitis in health care workers treating patients with COVID-19. J Am Acad Dermatol. 2020;83(5):e373-e374. doi: https://doi.org/10.1016/j.jaad.2020.06.1025</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Singh</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Bothra</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Pawar</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Maheswari</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Tiwari</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Adhicari</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Prevalence of cheilitis in health care workers treating patients with COVID-19</article-title>
					<source>J Am Acad Dermatol</source>
					<year>2020</year>
					<volume>83</volume>
					<issue>5</issue>
					<fpage>e373</fpage>
					<lpage>e374</lpage>
					<pub-id pub-id-type="doi">10.1016/j.jaad.2020.06.1025</pub-id>
				</element-citation>
			</ref>
			<ref id="B36">
				<label>36</label>
				<mixed-citation>36. Haesler E, National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline. Osborne Park: Cambridge Media; 2014</mixed-citation>
				<element-citation publication-type="book">
					<person-group person-group-type="author">
						<name>
							<surname>Haesler</surname>
							<given-names>E</given-names>
						</name>
						<collab>National Pressure Ulcer Advisory Panel</collab>
						<collab>European Pressure Ulcer Advisory Panel</collab>
						<collab>Pan Pacific Pressure Injury Alliance</collab>
					</person-group>
					<source>Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline</source>
					<year>2014</year>
					<publisher-loc>Osborne Park</publisher-loc>
					<publisher-name>Cambridge Media</publisher-name>
				</element-citation>
			</ref>
			<ref id="B37">
				<label>37</label>
				<mixed-citation>37. Lansang P, Orrell KA, Tran J, Chen T. Skin Damage Prevention Strategies During COVID-19: Assessing Their Effect on N95 Mask Seal Integrity. J Cutan Med Surg. 2020;24(6):646-7. doi: https://doi.org/10.1177/1203475420943861</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lansang</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Orrell</surname>
							<given-names>KA</given-names>
						</name>
						<name>
							<surname>Tran</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>T</given-names>
						</name>
					</person-group>
					<article-title>Skin Damage Prevention Strategies During COVID-19: Assessing Their Effect on N95 Mask Seal Integrity</article-title>
					<source>J Cutan Med Surg</source>
					<year>2020</year>
					<volume>24</volume>
					<issue>6</issue>
					<fpage>646</fpage>
					<lpage>647</lpage>
					<pub-id pub-id-type="doi">10.1177/1203475420943861</pub-id>
				</element-citation>
			</ref>
			<ref id="B38">
				<label>38</label>
				<mixed-citation>38. Foo CCI, Goon ATJ, Leow YH, Goh CL. Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome - a descriptive study in Singapore. Contact Dermatitis. 2006;55(5):291-4. doi: https://doi.org/10.1111/j.1600-0536.2006.00953.x</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Foo</surname>
							<given-names>CCI</given-names>
						</name>
						<name>
							<surname>Goon</surname>
							<given-names>ATJ</given-names>
						</name>
						<name>
							<surname>Leow</surname>
							<given-names>YH</given-names>
						</name>
						<name>
							<surname>Goh</surname>
							<given-names>CL</given-names>
						</name>
					</person-group>
					<article-title>Adverse skin reactions to personal protective equipment against severe acute respiratory syndrome - a descriptive study in Singapore</article-title>
					<source>Contact Dermatitis</source>
					<year>2006</year>
					<volume>55</volume>
					<issue>5</issue>
					<fpage>291</fpage>
					<lpage>294</lpage>
					<pub-id pub-id-type="doi">10.1111/j.1600-0536.2006.00953.x</pub-id>
				</element-citation>
			</ref>
			<ref id="B39">
				<label>29</label>
				<mixed-citation>29. Long H, Zhao H, Chen A, Yao Z, Cheng B, Lu Q. Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China. J Eur Acad Dermatol Venereol. 2020;34(5):919-21. doi: https://doi.org/10.1111/jdv.16388</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Long</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Zhao</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Yao</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Cheng</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Lu</surname>
							<given-names>Q</given-names>
						</name>
					</person-group>
					<article-title>Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China</article-title>
					<source>J Eur Acad Dermatol Venereol</source>
					<year>2020</year>
					<volume>34</volume>
					<issue>5</issue>
					<fpage>919</fpage>
					<lpage>921</lpage>
					<pub-id pub-id-type="doi">10.1111/jdv.16388</pub-id>
				</element-citation>
			</ref>
			<ref id="B40">
				<label>40</label>
				<mixed-citation>40. Masood S, Tabassum S, Naveed S, Jalil P. COVID-19 Pandemic &amp; Skin Care Guidelines for Health Care Professionals. Pak J Med Sci. 2020;36(COVID19-S4):S115-S117. doi: https://doi.org/10.12669/pjms.36.COVID19-S4.2748</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Masood</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Tabassum</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Naveed</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Jalil</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>COVID-19 Pandemic &amp; Skin Care Guidelines for Health Care Professionals</article-title>
					<source>Pak J Med Sci</source>
					<year>2020</year>
					<volume>36</volume>
					<issue>COVID19-S4</issue>
					<fpage>S115</fpage>
					<lpage>S117</lpage>
					<pub-id pub-id-type="doi">10.12669/pjms.36.COVID19-S4.2748</pub-id>
				</element-citation>
			</ref>
			<ref id="B41">
				<label>41</label>
				<mixed-citation>41. Desai SR, Kovarik C, Brod B, James W, Fitzgerald ME, Preston A, et al. COVID-19 and personal protective equipment: Treatment and prevention of skin conditions related to the occupational use of personal protective equipment. J Am Acad Dermatol. 2020;83(2):675-7. doi: https://doi.org/10.1016/j.jaad.2020.05.073</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Desai</surname>
							<given-names>SR</given-names>
						</name>
						<name>
							<surname>Kovarik</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Brod</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>James</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Fitzgerald</surname>
							<given-names>ME</given-names>
						</name>
						<name>
							<surname>Preston</surname>
							<given-names>A</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>COVID-19 and personal protective equipment: Treatment and prevention of skin conditions related to the occupational use of personal protective equipment</article-title>
					<source>J Am Acad Dermatol</source>
					<year>2020</year>
					<volume>83</volume>
					<issue>2</issue>
					<fpage>675</fpage>
					<lpage>677</lpage>
					<pub-id pub-id-type="doi">10.1016/j.jaad.2020.05.073</pub-id>
				</element-citation>
			</ref>
			<ref id="B42">
				<label>42</label>
				<mixed-citation>42. Cabbarzade C. A Practical Way to Prevent Nose and Cheek Damage Due to the Use of N95 Masks in the COVID-19 Pandemic. Aesthet Surg J. 2020;40(10):608-10. doi: https://doi.org/10.1093/asj/sjaa167</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cabbarzade</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>A Practical Way to Prevent Nose and Cheek Damage Due to the Use of N95 Masks in the COVID-19 Pandemic</article-title>
					<source>Aesthet Surg J</source>
					<year>2020</year>
					<volume>40</volume>
					<issue>10</issue>
					<fpage>608</fpage>
					<lpage>610</lpage>
					<pub-id pub-id-type="doi">10.1093/asj/sjaa167</pub-id>
				</element-citation>
			</ref>
			<ref id="B43">
				<label>43</label>
				<mixed-citation>43. Long H, Zhao H, Chen A, Yao Z, Cheng B, Lu Q. Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China. J Eur Acad Dermatol Venereol. 2020;34(5):919-21. doi: https://doi.org/10.1111/jdv.16388</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Long</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Zhao</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Chen</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Yao</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Cheng</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Lu</surname>
							<given-names>Q</given-names>
						</name>
					</person-group>
					<article-title>Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China</article-title>
					<source>J Eur Acad Dermatol Venereol</source>
					<year>2020</year>
					<volume>34</volume>
					<issue>5</issue>
					<fpage>919</fpage>
					<lpage>921</lpage>
					<pub-id pub-id-type="doi">10.1111/jdv.16388</pub-id>
				</element-citation>
			</ref>
			<ref id="B44">
				<label>44</label>
				<mixed-citation>44. Masen MA, Chung A, Dawczyk JU, Dunning Z, Edwards L, Guyott C, et al. Evaluating lubricant performance to reduce COVID-19 PPE-related skin injury. PLoS One. 2020;15(9):e0239363. doi: https://doi.org/10.1371/journal.pone.0239363</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Masen</surname>
							<given-names>MA</given-names>
						</name>
						<name>
							<surname>Chung</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Dawczyk</surname>
							<given-names>JU</given-names>
						</name>
						<name>
							<surname>Dunning</surname>
							<given-names>Z</given-names>
						</name>
						<name>
							<surname>Edwards</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Guyott</surname>
							<given-names>C</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Evaluating lubricant performance to reduce COVID-19 PPE-related skin injury</article-title>
					<source>PLoS One</source>
					<year>2020</year>
					<volume>15</volume>
					<issue>9</issue>
					<elocation-id>e0239363</elocation-id>
					<pub-id pub-id-type="doi">10.1371/journal.pone.0239363</pub-id>
				</element-citation>
			</ref>
			<ref id="B45">
				<label>45</label>
				<mixed-citation>45. Rashid RS, Shim TN. Contact dermatitis. BMJ. 2016 Jun 30;353:3299. doi: https://doi.org/10.1136/bmj.i3299</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Rashid</surname>
							<given-names>RS</given-names>
						</name>
						<name>
							<surname>Shim</surname>
							<given-names>TN</given-names>
						</name>
					</person-group>
					<article-title>Contact dermatitis</article-title>
					<source>BMJ</source>
					<year>2016</year>
					<volume>353</volume>
					<fpage>3299</fpage>
					<lpage>3299</lpage>
					<pub-id pub-id-type="doi">10.1136/bmj.i3299</pub-id>
				</element-citation>
			</ref>
			<ref id="B46">
				<label>46</label>
				<mixed-citation>46. Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M, et al. Diagnosis and treatment of xerosis cutis - a position paper. J Dtsch Dermatol Ges. 2019;17(7):3-33. doi: https://doi.org/10.1111/ddg.13906</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Augustin</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Wilsmann-Theis</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Körber</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Kerscher</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Itschert</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Dippel</surname>
							<given-names>M</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Diagnosis and treatment of xerosis cutis - a position paper</article-title>
					<source>J Dtsch Dermatol Ges</source>
					<year>2019</year>
					<volume>17</volume>
					<issue>7</issue>
					<fpage>3</fpage>
					<lpage>33</lpage>
					<pub-id pub-id-type="doi">10.1111/ddg.13906</pub-id>
				</element-citation>
			</ref>
			<ref id="B47">
				<label>47</label>
				<mixed-citation>47. Lin P, Zhu S, Huang Y, Li L, Tao J, Lei T, et al. Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions. Br J Dermatol. 2020;183:190-2. doi: https://doi.org/10.1111/bjd.19089</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lin</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Zhu</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Huang</surname>
							<given-names>Y</given-names>
						</name>
						<name>
							<surname>Li</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Tao</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Lei</surname>
							<given-names>T</given-names>
						</name>
						<etal/>
					</person-group>
					<article-title>Adverse skin reactions among healthcare workers during the coronavirus disease 2019 outbreak: a survey in Wuhan and its surrounding regions</article-title>
					<source>Br J Dermatol</source>
					<year>2020</year>
					<volume>183</volume>
					<fpage>190</fpage>
					<lpage>192</lpage>
					<pub-id pub-id-type="doi">10.1111/bjd.19089</pub-id>
				</element-citation>
			</ref>
			<ref id="B48">
				<label>48</label>
				<mixed-citation>48. Whitehead F, Giampieri S, Graham T, Grocott P. Identifying, managing and preventing skin maceration: a rapid review of the clinical evidence. J Wound Care. 2017;26(4):159-65. doi: https://doi.org/10.12968/jowc.2017.26.4.159</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Whitehead</surname>
							<given-names>F</given-names>
						</name>
						<name>
							<surname>Giampieri</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Graham</surname>
							<given-names>T</given-names>
						</name>
						<name>
							<surname>Grocott</surname>
							<given-names>P</given-names>
						</name>
					</person-group>
					<article-title>Identifying, managing and preventing skin maceration: a rapid review of the clinical evidence</article-title>
					<source>J Wound Care</source>
					<year>2017</year>
					<volume>26</volume>
					<issue>4</issue>
					<fpage>159</fpage>
					<lpage>165</lpage>
					<pub-id pub-id-type="doi">10.12968/jowc.2017.26.4.159</pub-id>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="financial-disclosure" id="fn4">
				<p>O presente trabalho foi realizado com apoio da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Código de Financiamento 001. Apoio Financeiro da Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão, Processo 02424/21, Brasil.</p>
			</fn>
		</fn-group>
	</back>
	<sub-article article-type="translation" id="s1" xml:lang="en">
		<front-stub>
			<article-id pub-id-type="doi">10.1590/1518-8345.5636.3522</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Article Review</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Skin injuries due to Personal Protective Equipment and preventive measures in the COVID-19 context: an integrative review</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-3683-4969</contrib-id>
					<name>
						<surname>Silva</surname>
						<given-names>Lorrany Fontenele Moraes da</given-names>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff7"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-4411-0354</contrib-id>
					<name>
						<surname>Almeida</surname>
						<given-names>Alana Gomes de Araujo</given-names>
					</name>
					<xref ref-type="aff" rid="aff8"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-0876-3996</contrib-id>
					<name>
						<surname>Pascoal</surname>
						<given-names>Lívia Maia</given-names>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>1</sup></xref>
					<xref ref-type="corresp" rid="c2">*</xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-6105-1886</contrib-id>
					<name>
						<surname>Santos</surname>
						<given-names>Marcelino</given-names>
						<suffix>Neto</suffix>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-7543-6947</contrib-id>
					<name>
						<surname>Lima</surname>
						<given-names>Francisca Elisângela Teixeira</given-names>
					</name>
					<xref ref-type="aff" rid="aff9"><sup>4</sup></xref>
					<xref ref-type="aff" rid="aff10"><sup>5</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-7840-7642</contrib-id>
					<name>
						<surname>Santos</surname>
						<given-names>Floriacy Stabnow</given-names>
					</name>
					<xref ref-type="aff" rid="aff6"><sup>1</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff6">
				<label>1</label>
				<institution content-type="original"> Universidade Federal do Maranhão, Centro de Ciências Sociais, Saúde e Tecnologia, Imperatriz, MA, Brazil.</institution>
			</aff>
			<aff id="aff7">
				<label>2</label>
				<institution content-type="original"> Scholarship holder at the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.</institution>
			</aff>
			<aff id="aff8">
				<label>3</label>
				<institution content-type="original"> Universidade Federal do Maranhão, Centro de Ciências Humanas, Naturais, Saúde e Tecnologia, Pinheiro, MA, Brazil.</institution>
			</aff>
			<aff id="aff9">
				<label>4</label>
				<institution content-type="original"> Universidade Federal do Ceará, Departamento de Enfermagem, Fortaleza, CE, Brazil.</institution>
			</aff>
			<aff id="aff10">
				<label>5</label>
				<institution content-type="original"> Scholarship holder at the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil.</institution>
			</aff>
			<author-notes>
				<corresp id="c2">
					<label>*</label>Corresponding author: Lívia Maia Pascoal E-mail: <email>livia_mp@hotmail.com</email>
				</corresp>
				<fn fn-type="edited-by" id="fn5">
					<label>Associate Editor</label>
					<p>Maria Lúcia Zanetti.</p>
				</fn>
				<fn fn-type="con" id="fn6">
					<label>Authors’ contribution</label>
					<p><bold>Study concept and design:</bold> Lorrany Fontenele Moraes Da Silva, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Obtaining data:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida. <bold>Data analysis and interpretation:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Statistical analysis:</bold> Alana Gomes de Araujo Almeida, Lívia Maia Pascoal. <bold>Obtaining financing:</bold> Lívia Maia Pascoal. <bold>Drafting the manuscript:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Critical review of the manuscript as to its relevant intellectual content:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. All authors approved the final version of the text.</p>
				</fn>
				<fn fn-type="conflict" id="fn7">
					<label>Conflict of interest</label>
					<p>The authors have declared that there is no conflict of interest.</p>
				</fn>
			</author-notes>
			<abstract>
				<title>Abstract</title>
				<sec>
					<title>Objective</title>
					<p> to identify the diverse scientific evidence on the types of skin lesions caused due to the use of Personal Protective Equipment in health professionals during the COVID-19 pandemic and to verify the recommended prevention measures. </p>
				</sec>
				<sec>
					<title>Method</title>
					<p> this is an integrative review carried out in the MEDLINE, CINAHL, LILACS, SCOPUS, Science Direct, Web of Science and SciELO databases. The search was conducted in a paired manner, constituting a sample of 17 studies categorized according to the types of skin lesions and preventive measures. </p>
				</sec>
				<sec>
					<title>Results</title>
					<p> the main types of skin lesions related to mask use were stage 1 pressure ulcers, acne and cutaneous depression. Regarding the use of glasses and face shields, the most frequent were stage 1 and 2 pressure ulcers. Xerosis and irritant contact dermatitis occurred due to using gloves and protective clothing, respectively. The main preventive measures recommended were using hydrocolloid or foam dressing in the pressure regions, moisturizers and emollients. </p>
				</sec>
				<sec>
					<title>Conclusion</title>
					<p> a considerable number of skin lesions associated with using the equipment were noticed, and the data obtained can guide the professionals in identifying risks and promoting preventive measures to avoid their occurrence.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="en">
				<title>Descriptors:</title>
				<kwd>Personal Protective Equipment</kwd>
				<kwd>Skin</kwd>
				<kwd>Health Personnel</kwd>
				<kwd>Skin Diseases</kwd>
				<kwd>Disease Prevention</kwd>
				<kwd>COVID-19</kwd>
			</kwd-group>
			<funding-group>
				<award-group award-type="contract">
					<funding-source>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)</funding-source>
					<award-id>Finance Code 001</award-id>
				</award-group>
				<award-group award-type="contract">
					<funding-source>Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão</funding-source>
					<award-id>02424/21</award-id>
				</award-group>
				<funding-statement>This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Finance Code 001. Supported by Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão, Grant #02424/21, Brazil.</funding-statement>
			</funding-group>
		</front-stub>
		<body>
			<boxed-text id="bx2">
				<sec>
					<title>Highlights</title>
					<p>(1) The main PPE items responsible for the occurrence of skin injuries are masks.</p>
					<p>(2) Acne and stage 1 and 2 pressure ulcers are the main types of skin injury. </p>
					<p>(3) The main skin injury prevention measures involve routine care measures.</p>
					<p>(4) Health professionals usually do not adopt preventive measures when using PPE</p>
				</sec>
			</boxed-text>
			<sec sec-type="intro">
				<title>Introduction</title>
				<p>In January 2020, COVID-19, a disease caused by the new Coronavirus (SARS-CoV-2), was considered an international public health emergency and, in March 2020, the World Health Organization (WHO) declared it as a pandemic<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. Since then, health professionals have been dealing with many challenges, such as: prolonged exposure; work overload; lack of training; inadequate staffing; precariousness of the work environment; and Personal Protective Equipment (PPE) in insufficient quality and numbers, among other factors that jeopardize these professionals’ biosafety<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>. </p>
				<p>COVID-19 has stood out for its high transmissibility and clinical severity, and also for having a higher incidence among health professionals<xref ref-type="bibr" rid="B3"><sup>3</sup></xref>. To reduce the risk of exposure in the professionals who are on the front lines in the fight against COVID-19, in its Technical Note No. 04/2020, the National Health Surveillance Agency (<italic>Agência Nacional de Vigilância Sanitária</italic>, ANVISA) recommends wearing PPE according to the standard precautionary type for droplets, aerosols and/or contact. Thus, to care for suspected or confirmed COVID-19 cases, goggles or face shield, cap, surgical or N95/PFF2 mask or equivalent (depending on the type of precaution), apron and sterile-procedure gloves for non-invasive procedures must be used<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>. </p>
				<p>Although PPE use is intended for protection, the professionals are also prone to the occurrence of skin lesions caused by their prolonged use and frequent hand hygiene, which can progress to pressure ulcers, acute and chronic dermatitis and worsening of preexisting dermatosis, as well as being a gateway to secondary infections<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>.</p>
				<p>Prolonged contact with PPE affects the integrity of the skin barrier due to the force of continuous or sliding friction and the skin’s own structural condition, causing tissue deformation, which leads to the process of cell death and triggers tissue damage. It is also noteworthy that factors such as excessive sweating generated by mental stress and exhausting workdays and non-optimization of the PPE in the face of tissue deformation, in addition to the adaptation made by the professionals to improve sealing of the facial region, in search of overprotection, effectively contribute to tissue damage<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>. </p>
				<p>In this regard, it is important to highlight that tissue damage is a limiting factor for care, as health professionals, subjected to extensive working hours with physical and emotional exhaustion, have become a population at risk for the development of injuries and faced with the lack of adequate protective equipment, worsened signs and symptoms of skin lesions and/or pre-existing diseases and, in most cases, without access to prevention measures due to lack of knowledge and guidance as a result of scarcity of studies, the costs of such materials or even the lack of resources from hospital institutions<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>.</p>
				<p>Considering that the protective equipment used in health care is indispensable, it becomes necessary to implement measures that help to preserve skin integrity in the area exposed to risk, measures that will directly contribute to protecting the skin and, consequently, to ensure care quality and patient safety. Therefore, the justification for this review is based on the contribution to the health professionals’ practice, especially nurses, for providing information about skin lesions associated with using PPE and the measures that can be adopted to prevent their occurrence because, in addition to favoring safe professional practice and promoting effective care for the assisted population, it will guide the professionals in similar situations that may occur, allowing for the development of risk anticipation strategies for the maintenance of skin integrity.</p>
				<p>Therefore, the objective is to identify the diverse available scientific evidence on the types of skin lesions caused by PPE use in health professionals during the COVID-19 pandemic and to verify the recommended prevention measures.</p>
			</sec>
			<sec sec-type="methods">
				<title>Method</title>
				<sec>
					<title>Type of study</title>
					<p>This study consists of an integrative review filed on the FigShare platform<xref ref-type="bibr" rid="B9"><sup>9</sup></xref>. The study was conducted in six stages: 1) definition of the research question; 2) definition of the databases and criteria for inclusion and exclusion of studies; 3) definition of the information to be extracted from the studies selected; 4) assessment of the studies included in the review; 5) interpretation of the results; and 6) presentation of the review/knowledge synthesis<xref ref-type="bibr" rid="B10"><sup>10</sup></xref>. </p>
					<p>To guide the search, the research question was elaborated using the PICo (Population, Interest and Context) strategy: P - Health professionals; I - Types of injuries related to PPE use and Preventive measures; and Co - The COVID-19 Pandemic. This acronym allows reaching an effective search from the elaboration of an enlightening research question to direct the study according to the objectives proposed<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. This strategy allowed formulating the following guiding question: “What types of skin lesions are caused by PPE use in health professionals during the COVID-19 pandemic and which are the recommended prevention measures?”.</p>
					<p>An initial search was carried out in the Medical Literature Analysis and Retrieval System Online (MEDLINE) database, via the National Library of Medicine (PubMed), to verify the main descriptors or keywords used in the studies on the theme of the guiding question. Controlled vocabularies were selected from the Descriptors in Health Sciences (<italic>Descritores em Ciências da Saúde</italic>, DeCS), the Medical Subject Headings (MeSH) and MH Exact Subject Headings (CINAHL vocabulary), namely: <italic>COVID-19</italic>; <italic>occupational injury</italic>; <italic>facial injuries</italic>; <italic>personal protective equipment</italic>; <italic>protective devices</italic> and <italic>skin.</italic> As this is an incipient theme, it was decided to also use keywords (uncontrolled vocabularies) to obtain a targeted search strategy, namely: <italic>device related pressure injuries, skin injury</italic> and <italic>skin damage</italic>, used in the Spanish language for the LILACS and SciELO databases. To perform crossings among these words, the operators used were the Boolean operators <italic>AND</italic> and <italic>OR</italic> (<xref ref-type="table" rid="t5">Figure 1</xref>).</p>
					<p>
						<table-wrap id="t5">
							<label>Figure 1</label>
							<caption>
								<title>Search strategy for the studies according to the databases found. Imperatriz, MA, Brazil, 2021</title>
							</caption>
							<table>
								<colgroup>
									<col/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left">Database</th>
										<th align="left">Crossing</th>
										<th align="center">Number</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left">MEDLINE</td>
										<td align="left"><italic>COVID-19 AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
										<td align="center">99</td>
									</tr>
									<tr>
										<td align="left">CINAHL</td>
										<td align="left">(MH”<italic>protective devices</italic>”) <italic>OR</italic> (MH”<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> (MH”<italic>facial injuries</italic>”) <italic>OR</italic> (MH “<italic>occupational injury</italic>”) <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”)</td>
										<td align="center">45</td>
									</tr>
									<tr>
										<td align="left">LILACS</td>
										<td align="left"><italic>COVID-19 AND</italic> (“<italic>dispositivos de protección</italic>” <italic>OR</italic> “<italic>equipo de protección personal</italic>”) <italic>AND</italic> (<italic>piel OR</italic> “<italic>lesiones por presión relacionadas con el dispositivo</italic>” <italic>OR</italic> “<italic>lesiones faciales</italic>” <italic>OR</italic> “<italic>lesión ocupacional</italic>” <italic>OR</italic> “<italic>lesión cutánea</italic>” <italic>OR</italic> “<italic>daño cutáneo</italic>”)</td>
										<td align="center">1</td>
									</tr>
									<tr>
										<td align="left">SCOPUS</td>
										<td align="left"><italic>COVID-19 AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
										<td align="center">97</td>
									</tr>
									<tr>
										<td align="left">Science Direct</td>
										<td align="left"><italic>COVID-19 AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
										<td align="center">566</td>
									</tr>
									<tr>
										<td align="left">Web of Science</td>
										<td align="left"><italic>COVID-19 AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
										<td align="center">42</td>
									</tr>
									<tr>
										<td align="left">SciELO</td>
										<td align="left"><italic>COVID-19 AND</italic> (“<italic>dispositivos de protección</italic>” <italic>OR</italic> “<italic>equipo de protección personal</italic>”) <italic>AND</italic> (<italic>piel OR</italic> “<italic>lesiones por presión relacionadas con el dispositivo</italic>” <italic>OR</italic> “<italic>lesiones faciales</italic>” OR “<italic>lesión ocupacional</italic>” <italic>OR</italic> “<italic>lesión cutánea</italic>” <italic>OR</italic> “<italic>daño cutáneo</italic>”)</td>
										<td align="center">1</td>
									</tr>
									<tr>
										<td align="left" colspan="2">TOTAL</td>
										<td align="center">851</td>
									</tr>
								</tbody>
							</table>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Data collection</title>
					<p>The search was carried out in January 2021 through the CAPES Journal Portal, through access to the Federated Academic Community (<italic>Comunidade Acadêmica Federada</italic>, CAFe), with selection of <italic>Universidade Federal do Maranhão</italic>(UFMA) higher education institution, searching the following databases: Medical Literature Analysis and Retrieval System Online (MEDLINE) via the National Library of Medicine (PubMed); Cumulative Index to Nursing and Allied Health (CINAHL); <italic>Literatura Latino-Americana e do Caribe em Ciências da Saúde</italic>(LILACS); SCOPUS; Science Direct and Web of Science and Scientific Electronic Library Online (SciELO).</p>
					<p>To improve the quality of data collection, the Rayyan app was used, developed by the Qatar Computing Research Institute (QCRI)<xref ref-type="bibr" rid="B12"><sup>12</sup></xref>, to assist in the process of organizing and selecting the studies, as well as removing duplicates. In addition to that, the search was performed by two researchers, independently and simultaneously, following a search protocol directed to the guiding question and eligibility criteria. The inclusion criteria established for the selection of studies were original articles that answered the guiding question, covering injuries and/or preventive measures, published in English, Spanish or Portuguese. </p>
				</sec>
				<sec>
					<title>Instrument used to collect the information</title>
					<p>For data collection, categorization and interpretation, an adapted instrument was used<xref ref-type="bibr" rid="B13"><sup>13</sup></xref> with the following items: title of the publication; author(s); year of publication; journal; objective; type of study; level of evidence; types of injuries and preventive measures. </p>
				</sec>
				<sec>
					<title>Data analysis</title>
					<p>The level of evidence of the articles included was classified as follows: </p>
					<p>
						<list list-type="simple">
							<list-item>
								<p>Level 1 - Experimental research designs: 1.a) Systematic review of randomized controlled trials; 1.b) Systematic review of randomized, controlled trials and other study designs; 1.c) Randomized controlled trial; 1.d) Controlled, randomized pseudo-trials;</p>
							</list-item>
							<list-item>
								<p> Level 2 - Quasi-experiment designs: 2.a) Systematic review of quasi-experimental studies; 2.b) Systematic review of quasi-experiment and other less-evidence study designs; 2.c) Prospectively controlled quasi-experiment studies; 2.d) Pre- and post-test or retrospective historical controlled group studies; </p>
							</list-item>
							<list-item>
								<p>Level 3 - Observational - analytical designs: 3.a) Systematic review of comparable cohort studies; 3.b) Systematic review of comparable cohorts and other lower evidence study designs; 3.c) Cohort study with a control group; 3.d) Case-control study; 3.e) Observational studies without a control group; </p>
							</list-item>
							<list-item>
								<p>Level 4 - Observational - descriptive studies: 4.a) Systematic review of descriptive studies; 4.b) Cross-sectional study; 4.c) Case series; 4.d) Case study; </p>
							</list-item>
							<list-item>
								<p>Level 5 - Experts’ opinion - Laboratory bench research: 5.a) Systematic review of expert opinion; 5.b) Experts’ consensus; 5.c) Laboratory bench research/expert’s opinion<xref ref-type="bibr" rid="B14"><sup>14</sup></xref>.</p>
							</list-item>
						</list>
					</p>
					<p>In addition to that, an analysis of the methodological quality was carried out using the instruments proposed by the JBI<xref ref-type="bibr" rid="B15"><sup>15</sup></xref> that contain a checklist with questions for each type of study with the following answer options: Yes; No; Not applicable or Not clear. After categorization of the studies, the data were synthesized for the descriptive analysis according to year of publication, language, study locus, objective, type of study, level of evidence, types of skin lesions and preventive measures related to PPE use in health professionals. </p>
				</sec>
			</sec>
			<sec sec-type="results">
				<title>Results</title>
				<p>A total of 851 articles were identified and, after analyzing the titles and abstracts and applying the inclusion and exclusion criteria, 50 articles were pre-selected for full reading. Among the 50 articles analyzed, 17 were included in the final sample of this review. The path followed to search and select the studies observed the PRISMA group recommendations<xref ref-type="bibr" rid="B15"><sup>15</sup></xref> and can be seen in the flowchart below (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
				<p>
					<fig id="f2">
						<label>Figure 2</label>
						<caption>
							<title>Flowchart corresponding to the selection of the articles included in the study. Imperatriz, MA, Brazil, 2021</title>
						</caption>
						<graphic xlink:href="1518-8345-rlae-30-e3551-gf2.png"/>
						<attrib>Source: Adapted from PRISMA<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. </attrib>
					</fig>
				</p>
				<p>The 17 articles that comprised the final sample were published in 2020 and 2021, in English and Spanish. The studies were carried out in the following countries: Bahrain, Brazil, China, India, Iraq, Mexico, Paris (France), Thailand, Turkey and the United States, with China (35.5%) being the country with the highest number of publications. The types of study were as follows: prospective cohort<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref> (11.8%), randomized clinical trial<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref> (11.8%) and descriptive cross-sectional<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B33"><sup>33</sup></xref> (76.4%). When evaluating the level of evidence, 76.4% of the publications were classified as level 4b.</p>
				<p>
					<xref ref-type="table" rid="t6">Figure 3</xref> presents the characterization of the studies that were included in the final sample, considering objective, country where the study was carried out, language, level of evidence and methodological quality of the study.</p>
				<p>
					<table-wrap id="t6">
						<label>Figure 3</label>
						<caption>
							<title>Characterization of the primary studies included in the sample. Imperatriz, MA, Brazil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left">Authors</th>
									<th align="center">Objective</th>
									<th align="center">Language/Country</th>
									<th align="center">Level of Evidence</th>
									<th align="center">Methodological quality of the study</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left">Smart, et al. (2020)<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
									</td>
									<td align="left">To determine whether a silicone-based dressing worn under an N95 mask is safe and beneficial for preventing facial skin injury without compromising the mask’s seal.</td>
									<td align="center">English/Bahrain</td>
									<td align="center">3.c</td>
									<td align="left">Seven out of 11 points in the JBI* checklist for <italic>Cohort studies</italic></td>
								</tr>
								<tr>
									<td align="left">Yildiz, et al. (2021)<xref ref-type="bibr" rid="B18"><sup>18</sup></xref>
									</td>
									<td align="left">To determine the effect of the prophylactic dressing on preventing skin lesions due to PPE use in health professionals working with COVID-19 patients.</td>
									<td align="center">English/Turkey</td>
									<td align="center">3.c</td>
									<td align="left">Eight out of 11 points in the JBI* checklist for <italic>Cohort studies</italic></td>
								</tr>
								<tr>
									<td align="left">Hua, et al. (2020)<xref ref-type="bibr" rid="B19"><sup>19</sup></xref>
									</td>
									<td align="left">To analyze the short-term effects of N95 respirators and medical masks on the physiological properties of the skin and to report adverse skin reactions.</td>
									<td align="center">English/China</td>
									<td align="center">1.c</td>
									<td align="left">Eight out of 13 points in the JBI* checklist for <italic>Randomized controlled trials</italic></td>
								</tr>
								<tr>
									<td align="left">Gasparino, et al. (2021)<xref ref-type="bibr" rid="B20"><sup>20</sup></xref>
									</td>
									<td align="left">To compare the use of foam and extra-thin hydrocolloid dressing in the prevention of pressure ulcers associated with the use of PPE by health professionals working on the front line against the Coronavirus.</td>
									<td align="center">English/Brazil</td>
									<td align="center">1.c</td>
									<td align="left">Eight out of 13 points in the JBI* checklist for <italic>Randomized controlled trials</italic></td>
								</tr>
								<tr>
									<td align="left">Jiang, et al. (2020)<xref ref-type="bibr" rid="B21"><sup>21</sup></xref>
									</td>
									<td align="left">To investigate the prevalence and characteristics of pressure ulcers among health team members.</td>
									<td align="center">English/China</td>
									<td align="center">4.b</td>
									<td align="left">Six out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Hu, et al. (2020)<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>
									</td>
									<td align="left">To explore adverse skin reactions among health professionals who use PPE.</td>
									<td align="center">English/China</td>
									<td align="center">4.b</td>
									<td align="left">Six out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Shanshal, et al. (2020)<xref ref-type="bibr" rid="B23"><sup>23</sup></xref>
									</td>
									<td align="left">To comprehensively examine the effect of COVID-19 on different aspects of the medical practice.</td>
									<td align="center">English/Iraq</td>
									<td align="center">4.b</td>
									<td align="left">Four out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Xia, et al. (2020)<xref ref-type="bibr" rid="B24"><sup>24</sup></xref>
									</td>
									<td align="left">To identify physical and psychological effects of using PPE and its related safety measures on health care workers in Wuhan, China, in response to the pandemic.</td>
									<td align="center">English/China</td>
									<td align="center">4.b</td>
									<td align="left">Six out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Pacis, et al. (2020)<xref ref-type="bibr" rid="B25"><sup>25</sup></xref>
									</td>
									<td align="left">To formulate procedures to protect the integrity of health care workers’ facial skin when caring for COVID-19 patients.</td>
									<td align="center">English/United States</td>
									<td align="center">4.b</td>
									<td align="left">Five out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Agarwal, et al. (2020)<xref ref-type="bibr" rid="B26"><sup>26</sup></xref>
									</td>
									<td align="left">To identify the difficulties encountered by health professionals during PPE use and to propose ways and means to help them overcome such difficulties.</td>
									<td align="center">English/India</td>
									<td align="center">4.b</td>
									<td align="left">Four out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Yuan, et al. (2020)<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>
									</td>
									<td align="left">To understand the possible skin, respiratory, nervous and digestive reactions in Chinese health professionals who use PPE in the fight against COVID-19.</td>
									<td align="center">English/China</td>
									<td align="center">4.b</td>
									<td align="left">Six out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Jiang, et al. (2020)<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>
									</td>
									<td align="left">To investigate the prevalence, characteristics and preventive status of skin lesions caused by PPE in the health team.</td>
									<td align="center">English/China</td>
									<td align="center">4.b</td>
									<td align="left">Six out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Daye, et al. (2020)<xref ref-type="bibr" rid="B29"><sup>29</sup></xref>
									</td>
									<td align="left">To evaluate the skin problems and dermatological quality of life of health professionals due to PPE use.</td>
									<td align="center">English/Turkey</td>
									<td align="center">4.b</td>
									<td align="left">Four out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Atay, et al. (2020)<xref ref-type="bibr" rid="B30"><sup>30</sup></xref>
									</td>
									<td align="left">To examine the physical issues related to PPE and prolonged wear time experienced by nurses during the COVID-19 pandemic.</td>
									<td align="center">English/Turkey</td>
									<td align="center">4.b</td>
									<td align="left">Six out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Techasatian, et al. (2020)<xref ref-type="bibr" rid="B31"><sup>31</sup></xref>
									</td>
									<td align="left">To analyze the prevalence and possible risk factors to prevent face mask-related skin reactions during COVID-19.</td>
									<td align="center">English/Thailand</td>
									<td align="center">4.b</td>
									<td align="left">Six out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Masen, et al. (2020)<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>
									</td>
									<td align="left">To provide a practical lubricating solution for COVID-19 front line health care workers working a four-hour shift or longer wearing PPE.</td>
									<td align="center">English/Paris (France)</td>
									<td align="center">4.b</td>
									<td align="left">Six out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
								<tr>
									<td align="left">Erize-Herrera, et al. (2020)<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>
									</td>
									<td align="left">To describe the frequency of cutaneous manifestations caused by PPE use in health professionals and the risk factors for developing them.</td>
									<td align="center">Spanish/Mexico</td>
									<td align="center">4.b</td>
									<td align="left">Four out of eight points in the JBI* checklist for <italic>Analytical cross-sectional studies</italic></td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN3">
								<label><sup>*</sup></label>
								<p>In the checklist some answers were rated as Not Applicable or Not Clear.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>
					<xref ref-type="table" rid="t7">Table 1</xref> shows the types of injuries related to PPE use. The main PPE items associated with the occurrence of skin injuries were as follows: surgical or N95 mask, goggles, face shield, gloves and protective clothing. The most frequent injuries caused by mask use were the following pressure ulcer (stage 1)<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (35.2%); acne<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref> (23.5%); skin depression<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref> (23.5%); irritant contact dermatitis<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref> (17.6%); rash<xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref> (17.6%); pressure ulcer (stage 2)<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref> (11.7%) and injuries associated with moisture<xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref> (11.7%).</p>
				<p>Regarding the injuries associated with using protective eyewear, stage 1 pressure ulcers stood out<xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref>(23.5%), followed by stage 2<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (17.6%). The injuries related to face shield use that showed higher frequency were stage 1 pressure ulcers<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (23.5%). Regarding the use of gloves, xerosis<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref> (23.5%) and fissures<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref> (17.6%) stood out. As for the injuries associated with using protective clothing, irritant contact dermatitis stood out<xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref> (11.7%).</p>
				<p>
					<table-wrap id="t7">
						<label>Table 1</label>
						<caption>
							<title>Frequency of the types of injuries related to using a surgical or N95 mask, goggles, face shield, gloves and protective clothing according to the studies found. Imperatriz, MA, Brazil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left">Personal Protective Equipment</th>
									<th align="left">Types of injuries</th>
									<th align="center">Frequency n (%)*</th>
									<th align="center">Studies found</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left" rowspan="15">Surgical or N95 mask</td>
									<td align="left">Pressure ulcer (stage 1)<sup>†</sup></td>
									<td align="center">6 (35.2)</td>
									<td align="center">17,18,21,23,24,28</td>
								</tr>
								<tr>
									<td align="left">Acne</td>
									<td align="center">4 (23.5)</td>
									<td align="center">22,29,31,33</td>
								</tr>
								<tr>
									<td align="left">Skin depression</td>
									<td align="center">4 (23.5)</td>
									<td align="center">17,19,22,27</td>
								</tr>
								<tr>
									<td align="left">Irritant contact dermatitis</td>
									<td align="center">3 (17.6)</td>
									<td align="center">22,29,33</td>
								</tr>
								<tr>
									<td align="left">Cutaneous rash</td>
									<td align="center">3 (17.6)</td>
									<td align="center">23,26,31</td>
								</tr>
								<tr>
									<td align="left">Pressure ulcer (stage 2)<sup>†</sup></td>
									<td align="center">2 (11.7)</td>
									<td align="center">21,23</td>
								</tr>
								<tr>
									<td align="left">Injuries associated with moisture</td>
									<td align="center">2 (11.7)</td>
									<td align="center">18,24</td>
								</tr>
								<tr>
									<td align="left">Maceration</td>
									<td align="center">1 (5.8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left">Cheilitis</td>
									<td align="center">1 (5.8)</td>
									<td align="center">30</td>
								</tr>
								<tr>
									<td align="left">Pressure ulcer (stage 3)<sup>†</sup></td>
									<td align="center">1 (5.8)</td>
									<td align="center">21</td>
								</tr>
								<tr>
									<td align="left">Urticaria</td>
									<td align="center">1 (5.8)</td>
									<td align="center">22</td>
								</tr>
								<tr>
									<td align="left">Pustule</td>
									<td align="center">1 (5.8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left">Papule</td>
									<td align="center">1 (5.8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left">Xerosis</td>
									<td align="center">1 (5.8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left">Bubbles</td>
									<td align="center">1 (5.8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left" rowspan="7">Safety goggles</td>
									<td align="left">Pressure ulcer (stage 1)<sup>‡</sup></td>
									<td align="center">4 (23.5)</td>
									<td align="center">18,23,24,28</td>
								</tr>
								<tr>
									<td align="left">Pressure ulcer (stage 2)<sup>‡</sup></td>
									<td align="center">3 (17.6)</td>
									<td align="center">21,23,28</td>
								</tr>
								<tr>
									<td align="left">Cutaneous rash</td>
									<td align="center">2 (11.7)</td>
									<td align="center">23,33</td>
								</tr>
								<tr>
									<td align="left">Skin depression</td>
									<td align="center">1 (5.8)</td>
									<td align="center">27</td>
								</tr>
								<tr>
									<td align="left">Pressure ulcer (stage 3)<sup>‡</sup></td>
									<td align="center">1 (5.8)</td>
									<td align="center">21</td>
								</tr>
								<tr>
									<td align="left">Papule</td>
									<td align="center">1 (5.8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left">Pustule</td>
									<td align="center">1 (5.8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left" rowspan="10">Face shield</td>
									<td align="left">Pressure ulcer (stage 1)<sup>§</sup></td>
									<td align="center">4 (23.5)</td>
									<td align="center">21,23,24,28</td>
								</tr>
								<tr>
									<td align="left">Pressure ulcer (stage 2)<sup>§</sup></td>
									<td align="center">2 (11.7)</td>
									<td align="center">23,28</td>
								</tr>
								<tr>
									<td align="left">Cutaneous rash</td>
									<td align="center">2 (11.7)</td>
									<td align="center">20,23</td>
								</tr>
								<tr>
									<td align="left">Skin depression</td>
									<td align="center">1 (5.8)</td>
									<td align="center">27</td>
								</tr>
								<tr>
									<td align="left">Injuries associated with moisture</td>
									<td align="center">1 (5.8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Folliculitis</td>
									<td align="center">1 (5.8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Friction injury</td>
									<td align="center">1 (5.8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Pressure ulcer (stage 3)<sup>§</sup></td>
									<td align="center">1 (5.8)</td>
									<td align="center">21</td>
								</tr>
								<tr>
									<td align="left">Papule</td>
									<td align="center">1 (5.8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left">Pustule</td>
									<td align="center">1 (5.8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left" rowspan="12">Gloves</td>
									<td align="left">Xerosis </td>
									<td align="center">4 (23.5)</td>
									<td align="center">22,30,31,33</td>
								</tr>
								<tr>
									<td align="left">Fissures</td>
									<td align="center">3 (17.6)</td>
									<td align="center">22,29,30</td>
								</tr>
								<tr>
									<td align="left">Flaking</td>
									<td align="center">2 (11.7)</td>
									<td align="center">29,33</td>
								</tr>
								<tr>
									<td align="left">Cutaneous rash</td>
									<td align="center">2 (11.7)</td>
									<td align="center">22,26</td>
								</tr>
								<tr>
									<td align="left">Irritant contact dermatitis </td>
									<td align="center">1 (5.8)</td>
									<td align="center">26</td>
								</tr>
								<tr>
									<td align="left">Maceration</td>
									<td align="center">1 (5.8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left">Bubbles</td>
									<td align="center">1 (5.8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left">Worsening of preexisting dermatosis</td>
									<td align="center">1 (5.8)</td>
									<td align="center">29</td>
								</tr>
								<tr>
									<td align="left">Friction injury </td>
									<td align="center">1 (5.8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Injuries associated with moisture</td>
									<td align="center">1 (5.8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Urticaria</td>
									<td align="center">1 (5.8)</td>
									<td align="center">22</td>
								</tr>
								<tr>
									<td align="left">Lichenification</td>
									<td align="center">1 (5.8)</td>
									<td align="center">29</td>
								</tr>
								<tr>
									<td align="left" rowspan="4">Protective clothing</td>
									<td align="left">Irritant contact dermatitis</td>
									<td align="center">2 (11.7)</td>
									<td align="center">23,26</td>
								</tr>
								<tr>
									<td align="left">Cutaneous rashes</td>
									<td align="center">1 (5.8)</td>
									<td align="center">26</td>
								</tr>
								<tr>
									<td align="left">Injuries associated with moisture</td>
									<td align="center">1 (5.8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Xerosis</td>
									<td align="center">1 (5.8)</td>
									<td align="center">22</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN4">
								<p>*Total “n” value corresponding to the sample of 17 articles. The percentage exceeds 100% as there was more than one type of lesion in the same article included in the sample; <sup>†</sup>Frontal, Nasal Bridge, Auricular and/or Mandibular; <sup>‡</sup>Frontal, Nasal Bridge, Auricular; <sup>§</sup>Frontal</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>The main preventive measures related to injuries caused by PPE use were grouped according to the type of PPE. For injuries resulting from using a mask, goggles and face shield, most of the articles<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (27.7%) recommended using a hydrocolloid or foam dressing in the pressure regions, but other recommendations were also mentioned, such as using moisturizers and emollients for protection, especially when the professionals are not treating patients, in addition to correct adjustment of the mask and to using a protective ear strap.</p>
				<p>As recommendations for the use of gloves, the studies cited the following: washing and drying the hands and feet well; applying a barrier cream before and after using the PPE; avoiding wearing gloves for a long time; and using cotton gloves or a layer of plastic gloves inside the latex gloves. Regarding the use of protective clothing to avoid injuries, the recommendation is to apply a barrier cream before and after using PPE items to avoid skin peeling and drying (<xref ref-type="table" rid="t8">Figure 4</xref>).</p>
				<p>
					<table-wrap id="t8">
						<label>Figure 4</label>
						<caption>
							<title>Preventive measures for the occurrence of skin injuries related to the use of Personal Protective Equipment. Imperatriz, MA, Brazil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left">Recommendations for the prevention of injuries related to the use of masks, glasses and face shields</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left">- Use an alcohol-free liquid protective barrier in areas of direct contact with PPE (e.g.: nose, cheeks, forehead, behind the ears) to protect the skin from moisture and friction. Before applying, make sure that the area is free of makeup. Do not apply to eyes or eyelids and allow to dry for 90 seconds before putting on the PPE<xref ref-type="bibr" rid="B25"><sup>25</sup></xref>. </td>
								</tr>
								<tr>
									<td align="left">- Apply a thin hydrocolloid or foam dressing and adjust the material to the skin without tensioning it on the bridge of the nose, cheeks and forehead, covering the area where the mask, face shield and goggles rest<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Use acrylate-based moisturizers frequently, especially when not in direct patient care<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Fit the N95 mask correctly by fixing the clip and add a surgical mask for alignment<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Use a protective ear strap attached to the mask elastic<xref ref-type="bibr" rid="B23"><sup>23</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left"><bold>Recommendations for the prevention of injuries related to the use of gloves and protective clothing</bold></td>
								</tr>
								<tr>
									<td align="left">- Wash hands with soap, detergent, soaps or light oils, without perfume and with the least number of preservatives, dry them well and apply talc powder to the hands and feet before putting on gloves and boots, in order to protect the skin from friction and excessive hydration. If the gloves are dry, do not put too much talc powder on them<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Apply specific hand cream regularly and avoid wearing gloves for a long time. Wearing cotton gloves or a layer of plastic gloves inside latex gloves helps protect against itching or irritation in people with a latex allergy<xref ref-type="bibr" rid="B21"><sup>21</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Apply a barrier cream before and after using PPE to prevent skin flaking and dryness<xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref>.</td>
								</tr>
							</tbody>
						</table>
					</table-wrap>
				</p>
				<p>In addition to the recommendations directed to each PPE category, some studies listed recommendations for general care measures in the prevention of injuries. They were as follows: PPE removal<xref ref-type="bibr" rid="B26"><sup>26</sup></xref> and not using emollients or moisturizing creams when the PPE is used for a period longer than four hours, as they can result in excessive shear forces on the skin and, in such cases, they must be replaced by talc, lanolin containing vaseline or a mixture of coconut oil, cocoa butter and beeswax, as they provide excellent long-lasting lubrication<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>.</p>
			</sec>
			<sec sec-type="discussion">
				<title>Discussion</title>
				<p>The COVID-19 pandemic required prolonged PPE use not only by the team of health professionals, but also by the entire hospital staff. Therefore, the number of professional service providers who needed to use PPE increased considerably, as did the skin lesions associated with the intensive use of these materials. Given the lack of studies with in-depth and updated information on the occurrence of skin lesions associated with PPE use and prevention strategies, there was a growing concern in researchers to produce knowledge on the theme to assist the multiprofessional team<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>. </p>
				<p>In the studies identified in this review, surgical or N95 masks, goggles, face shields and gloves were the main factors responsible for the onset of injuries. A survey carried out in China identified that 95.1% of the health professionals who regularly used N95 masks more than 12 hours a day for a mean of 3.5 months complained of some type of skin involvement<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Another study observed that 47.3% of the interviewees, who used PPE items for more than four hours, also presented some type of impairment<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. These data indicate that, in addition to the type of PPE, use time is also a risk factor for the onset of injuries. </p>
				<p>The WHO indicates that N95, PFF2 or equivalent masks should not be used for a period longer than four hours due to the risk of discomfort and pain. However, in times of a public health emergency and when there is shortage of equipment, they can be used, without removing them and without losing their protective effectiveness, for a long period, when caring for several patients who have the same diagnosis<xref ref-type="bibr" rid="B34"><sup>34</sup></xref>.</p>
				<p>Persistent PPE use over the recommended time requires measures to avoid or minimize the occurrence of injuries. However, this recommendation was not observed in a study carried out in China, as only 17.7% of the interviewees used prophylactic dressings or lotions on the skin during the assistance provided. The authors believe that the fact that 42.8% of the evaluated professionals had skin lesions is related to the lack of training or to the fear of using dressings for protection, which prevented correct fixation of the PPE<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>.</p>
				<p>Among the types of skin injuries, stage 1 pressure ulcers were among the most frequent in those who used PPE items. In China, a study identified pressure ulcers in 30% of the professionals interviewed and, of these, 81.1% were in stage 1 and 18.3% were in stage 2<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. Another study identified that 25.58% of the health professionals presented pressure ulcers on the face<xref ref-type="bibr" rid="B35"><sup>35</sup></xref>, while another study evidenced that 68.9% had pressure ulcers on the nasal bridge associated with prolonged PPE use<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</p>
				<p>Such lesions are formed from a sustained mechanical load that is applied to soft tissues near a bony prominence. It is noted that magnitude of the load depends on the time it is used to cause harms; therefore, a low load applied for a prolonged period causes as much tissue damage as a high load for a short period<xref ref-type="bibr" rid="B36"><sup>36</sup></xref>. In the case of health professionals working on the front lines against COVID-19 and in an attempt to avoid respiratory infection by the Coronavirus, it was common for them to adjust their N95 masks so that the edge was in excessively close contact with the skin and the metal clip fitted firmly over the nose to ensure a complete seal<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. This fact may have contributed to the formation of lesions on the face and nasal bridge of these professionals.</p>
				<p>A study that evaluated the protective measures for skin lesions found that mild emollients, silicone cream and film dressing applied in the region of greater mechanical pressure between the mask and the skin were more accepted to the detriment of using foam dressings, as these require greater skill to apply and adhere them correctly. However, the authors highlighted that using creams and emollients in large amounts can facilitate adhesion of dirt, making it difficult to reuse the mask in a context of scarcity, while the film dressing needs to be removed carefully to avoid pain<xref ref-type="bibr" rid="B37"><sup>37</sup></xref>. </p>
				<p>Foam dressings with a silicone edge are beneficial when used correctly, as shown in a study developed by nurses in Bahrain. The professionals who used the dressing presented fewer skin reactions after one hour of continuous use when compared to those who did not use any protection. Before using the face mask, it is recommended to properly prepare and cut the foam dressing and place it on the nose, on the side of the face, below the chin, central region of the forehead and close to the ears, as well as use moisturizers after removal<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. A number of research studies have shown that the dressing does not interfere with sealing of the masks<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B37"><sup>37</sup></xref>.</p>
				<p>Facial acne was also among the most frequent types of lesions in the studies analyzed. A survey carried out in Singapore with professionals who were assisting in the fight against the Severe Acute Respiratory Syndrome (SARS) infection in 2003 identified acne as the main skin reaction (65%) associated with prolonged use of N95 masks<xref ref-type="bibr" rid="B38"><sup>38</sup></xref>. Another research study carried out in India pointed to acne as the fifth most common dermatosis among health professionals who used PPE items for more than eight hours a day, behind irritant contact dermatitis, allergic dermatitis, pressure and friction marks and sweat dermatitis<xref ref-type="bibr" rid="B35"><sup>35</sup></xref>. </p>
				<p>The onset of acne can be explained by the obstruction of the pilosebaceous ducts caused by prolonged occlusion and local pressure on the skin due to using the mask which, together with mental stress, extremely heavy workload and sleep deprivation, contributes to the emergence of acne or to aggravation of the existing problem. For acne control, in addition to general skin care, it is recommended to wash the face twice a day, choose suitable facial cleansers, use light cosmetics or avoid them and, in mild to severe cases, use an appropriate drug treatment with topical antibiotics and/or retinoid ointment to systemic treatment, with monocycline or isotretinoin, as directed by a physician<xref ref-type="bibr" rid="B39"><sup>39</sup></xref>.</p>
				<p>Another type of skin lesion that stood out in the studies included in this review was skin depression, which can occur due to prolonged use of masks, glasses and face shields<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. This type of lesion usually regresses spontaneously<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref>; however, a recommended treatment for redness and swelling consists of using a hydropathic compress with three to four layers of gauze soaked in cold water or saline every two hours, followed by the application of moisturizers<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Prevention of this type of injury, in addition to those already mentioned, is about the correct use of facial PPE, with the proper size, well-fitted and not tight<xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B41"><sup>41</sup></xref> and using N95 mask straps over the head<xref ref-type="bibr" rid="B41"><sup>41</sup></xref>, in addition to using cotton disks fixed with hypoallergenic surgical tape in the nasal and zygomatic region to avoid friction<xref ref-type="bibr" rid="B42"><sup>42</sup></xref>.</p>
				<p>The presence of dermatitis was identified in health professionals who used PPE items, mainly due to using masks and alcohol gel<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B44"><sup>44</sup></xref>. Such dermatitis cases can be divided into two types: allergic contact dermatitis and irritant contact dermatitis. The latter comprises a non-immunological response that commonly affects the hands and face and occurs as a result of direct damage to the skin by chemical or physical agents in a way that the skin cannot repair itself quickly. Allergic contact dermatitis is a delayed type IV hypersensitivity reaction to an external allergen that occurs only in an individual who has been previously sensitized. This re-exposure to the allergen results in circulating memory T cells that travel to the skin and trigger an immune reaction that causes skin inflammation, typically within 48 hours<xref ref-type="bibr" rid="B45"><sup>45</sup></xref>.</p>
				<p>Generally, the exposure time to allergen content and/or moisture has been identified as the main risk factor for contact dermatitis; therefore, wearing a mask and glasses for more than six hours or washing the hands more than ten times a day can increase the risk of local dermatitis. It is also important to consider additional exposure to the mask’s material, as well as repeated hand washing outside the work environment as a way to prevent SARS-CoV-2 infection<xref ref-type="bibr" rid="B44"><sup>44</sup></xref>. </p>
				<p>Preventive measures for contact dermatitis include the application of emollients before using masks and not using them with the material responsible for burning and itching. However, if this is not possible, it is recommended to use preventive covers and/or dressings that prevent the mask from coming into direct contact with the skin, in addition to extra care such as avoiding using 75% ethanol for skin cleaning and using too hot water. Mild cutaneous rashes may spontaneously improve after three to five days without further treatment<xref ref-type="bibr" rid="B43"><sup>43</sup></xref>. In turn, aggravation of pre-existing conditions such as psoriasis, atopic dermatitis and allergic reactions may require more complex management, including temporary distancing of these health professionals from work<xref ref-type="bibr" rid="B44"><sup>44</sup></xref>.</p>
				<p>Regarding the use of gloves and protective clothing, injuries such as dry skin, itching and cutaneous rashes were present in professionals who used these PPE items for more than ten hours a day for a mean of 3.5 months<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Xerosis was identified in a Mexican survey as one of the main lesions found in health professionals (90.35%), followed by desquamation, erythema, fissures, vesicles and maceration, whose main affected area was the hands. The data obtained showed a significant association between lesions and using alcohol gel, with a 1.81-fold increase in the risk of xerosis<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>. This lesion is characterized by a reduction in the amount and/or quality of lipids and hydrophilic substances on the skin. Management of xerosis is based on the regular use of a combination of topical substances that are intended to improve hydration, compensate for the lack of lipids and improve the skin barrier function<xref ref-type="bibr" rid="B46"><sup>46</sup></xref>.</p>
				<p>A research study, which evaluated the main skin lesions and their risk factors in the COVID-19 pandemic context in the health team, found that maceration was present in 52.9% of the sample<xref ref-type="bibr" rid="B47"><sup>47</sup></xref>. This type of injury results from prolonged exposure to moisture, which causes the skin to soften and break down so that the conjunctival fiber pulls away and the skin often appears white. Generally, this injury can be prevented by using semipermeable materials, which allow water vapor to escape, and the indicated treatment consists of using superabsorbent dressings to reduce excess moisture<xref ref-type="bibr" rid="B48"><sup>48</sup></xref>. </p>
				<p>With regard, specifically, to PPE use by health professionals, other preventive measures are recommended, such as choosing the appropriate size of gloves and rubber boots, applying ostomy powder on hands and feet, waiting, after hand washing and/or using alcohol gel on the skin, that it dries completely before using PPE items, as well as frequently exchanging these materials. These measures help protect the skin against friction and excessive hydration. In the case of persistent maceration, using an astringent cream, such as zinc oxide, helps to treat this type of lesion<xref ref-type="bibr" rid="B43"><sup>43</sup></xref>. </p>
				<p>Adverse skin reactions due to using coats and protective clothing are less common; however, their occurrence can be associated with the moisture generated by heavy fabrics and with the need to use them for long periods of time. Strategies such as removing the clothes for a few minutes or changing them frequently can help reduce those reactions<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</p>
				<p>A paper developed by nurses in Bahrain used a mnemonic with the word HELP to help health professionals incorporate skin care before, during and after using PPE items. In general, it was recommended to drink water regularly, keep the skin clean and hydrated (especially hands and face), observe the PPE use time, maintain a balanced diet of calories and proteins, use barrier creams ten minutes before using PPE items and protective coverings in the areas of greatest skin contact with them<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. </p>
				<p>Despite the growing number of publications on the prevalence of injuries, prevention and treatment guidelines, studies that used a methodological approach that provided high levels of scientific evidence are still incipient. As this is an emerging topic from a new disease, the lack of a common term, descriptors or specific keywords for this, which may have left some study out the research result, stands out as a limitation of this study. In addition to that, the low number of randomized clinical trials precludes generalization of the results.</p>
				<p>The results obtained can help health professionals, especially nurses, to know the types of skin lesions frequently associated with PPE use and which measures can be taken to prevent their occurrence. And also to support managers in carrying out training sessions for the prevention of possible injuries and incorporation of recommendations into the institution’s routine.</p>
			</sec>
			<sec sec-type="conclusions">
				<title>Conclusion</title>
				<p>Skin lesions caused by PPE use in health professionals were more notorious during the COVID-19 pandemic, when it was possible to observe the consequences of their prolonged use on a larger scale. Most of the professionals who worked in direct care for patients infected with the new Coronavirus presented some type of skin impairment, especially those who used PPE items for a daily period of more than six hours. Masks, especially those of the N95 type, were the main factor responsible for the occurrence of skin injuries, followed by goggles, face shields and gloves. As for the injury types, acne, pressure ulcers (stages 1 and 2), skin depression and xerosis were more frequently observed in the professionals.</p>
				<p>The main measures to prevent skin damage involve routine care, such as keeping the skin hydrated, consumption of liquids and using moisturizers and emollients, instituting the habit of skin hygiene and avoiding using excessive makeup, in addition to using protective pads on bony prominences of the face, preferably with foam and silicone edges to facilitate removal, use properly adjusted PPE items and, if possible, avoid continuous use of PPE items for prolonged periods of time.</p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="financial-disclosure" id="fn8">
					<p>This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Finance Code 001. Supported by Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão, Grant #02424/21, Brazil.</p>
				</fn>
			</fn-group>
		</back>
	</sub-article>
	<sub-article article-type="translation" id="s2" xml:lang="es">
		<front-stub>
			<article-id pub-id-type="doi">10.1590/1518-8345.5636.3550</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Artículo de Revisión</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Lesiones cutáneas por Equipos de Protección Individual y medidas preventivas en el contexto del COVID-19: revisión integradora*</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-3683-4969</contrib-id>
					<name>
						<surname>Silva</surname>
						<given-names>Lorrany Fontenele Moraes da</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>1</sup></xref>
					<xref ref-type="aff" rid="aff12"><sup>2</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-4411-0354</contrib-id>
					<name>
						<surname>Almeida</surname>
						<given-names>Alana Gomes de Araujo</given-names>
					</name>
					<xref ref-type="aff" rid="aff13"><sup>3</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0003-0876-3996</contrib-id>
					<name>
						<surname>Pascoal</surname>
						<given-names>Lívia Maia</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>1</sup></xref>
					<xref ref-type="corresp" rid="c3">*</xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-6105-1886</contrib-id>
					<name>
						<surname>Santos</surname>
						<given-names>Marcelino</given-names>
						<suffix>Neto</suffix>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>1</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0002-7543-6947</contrib-id>
					<name>
						<surname>Lima</surname>
						<given-names>Francisca Elisângela Teixeira</given-names>
					</name>
					<xref ref-type="aff" rid="aff14"><sup>4</sup></xref>
					<xref ref-type="aff" rid="aff15"><sup>5</sup></xref>
				</contrib>
				<contrib contrib-type="author">
					<contrib-id contrib-id-type="orcid">0000-0001-7840-7642</contrib-id>
					<name>
						<surname>Santos</surname>
						<given-names>Floriacy Stabnow</given-names>
					</name>
					<xref ref-type="aff" rid="aff11"><sup>1</sup></xref>
				</contrib>
			</contrib-group>
			<aff id="aff11">
				<label>1</label>
				<institution content-type="original"> Universidade Federal do Maranhão, Centro de Ciências Sociais, Saúde e Tecnologia, Imperatriz, MA, Brasil.</institution>
			</aff>
			<aff id="aff12">
				<label>2</label>
				<institution content-type="original"> Becaria de la Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brasil.</institution>
			</aff>
			<aff id="aff13">
				<label>3</label>
				<institution content-type="original"> Universidade Federal do Maranhão, Centro de Ciências Humanas, Naturais, Saúde e Tecnologia, Pinheiro, MA, Brasil.</institution>
			</aff>
			<aff id="aff14">
				<label>4</label>
				<institution content-type="original"> Universidade Federal do Ceará, Departamento de Enfermagem, Fortaleza, CE, Brasil.</institution>
			</aff>
			<aff id="aff15">
				<label>5</label>
				<institution content-type="original"> Becaria del Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brasil.</institution>
			</aff>
			<author-notes>
				<corresp id="c3">
					<label>*<bold>Autor de correspondencia</bold></label> Lívia Maia Pascoal E-mail: <email>livia_mp@hotmail.com</email>
				</corresp>
				<fn fn-type="edited-by" id="fn9">
					<label>Editora Asociada</label>
					<p> Maria Lúcia Zanetti</p>
				</fn>
				<fn fn-type="conflict" id="fn10">
					<label>Conflicto de intereses</label>
					<p> Los autores han declarado que no existe ningún conflicto de intereses.</p>
				</fn>
				<fn fn-type="con" id="fn11">
					<label>Contribución de los autores</label>
					<p><bold>Concepción y dibujo de la pesquisa:</bold> Lorrany Fontenele Moraes Da Silva, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Obtención de datos:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida. <bold>Análisis e interpretación de los datos:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Análisis estadístico:</bold> Alana Gomes de Araujo Almeida, Lívia Maia Pascoal. <bold>Obtención de financiación:</bold> Lívia Maia Pascoal. <bold>Redacción del manuscrito:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. <bold>Revisión crítica del manuscrito en cuanto al contenido intelectual importante:</bold> Lorrany Fontenele Moraes Da Silva, Alana Gomes de Araujo Almeida, Lívia Maia Pascoal, Marcelino Santos Neto, Francisca Elisângela Teixeira Lima, Floriacy Stabnow Santos. Todos los autores aprobaron la versión final del texto.</p>
				</fn>
			</author-notes>
			<abstract>
				<title>Resumen</title>
				<sec>
					<title>Objetivo</title>
					<p>identificar que evidencia científica hay sobre los tipos de lesiones cutáneas provocadas por el uso de Equipos de Protección Individual en los profesionales sanitarios durante la pandemia del COVID-19 y verificar las medidas de prevención recomendadas. </p>
				</sec>
				<sec>
					<title>Método</title>
					<p> se trata de una revisión integradora realizada en las bases de datos MEDLINE, CINAHL, LILACS, SCOPUS, <italic>Science Direct, Web of Science</italic> y la biblioteca electrónica SciELO. La búsqueda se realizó de forma pareada, la muestra estuvo conformada por 17 estudios categorizados según los tipos de lesiones cutáneas y medidas preventivas. </p>
				</sec>
				<sec>
					<title>Resultados</title>
					<p> los principales tipos de lesiones cutáneas relacionadas con el uso de mascarillas fueron las lesiones por presión estadio 1, el acné y la depresión cutánea. En cuanto al uso de gafas y pantalla facial, las más frecuentes fueron las lesiones por presión estadios 1 y 2. Se detectó xerosis y dermatitis irritante de contacto por el uso de guantes y ropa de protección, respectivamente. Las principales medidas preventivas recomendadas fueron el uso de apósitos de hidrocoloide o espuma en las regiones de presión, humectantes y emolientes. </p>
				</sec>
				<sec>
					<title>Conclusión</title>
					<p> hubo un número considerable de lesiones cutáneas asociadas al uso de equipos y los datos obtenidos pueden orientar a los profesionales para que identifiquen los riesgos y promuevan medidas preventivas para evitar su aparición.</p>
				</sec>
			</abstract>
			<kwd-group xml:lang="es">
				<title>Descriptores:</title>
				<kwd>Equipo de Protección Personal</kwd>
				<kwd>Piel</kwd>
				<kwd>Personal de Salud</kwd>
				<kwd>Enfermedades de la Piel</kwd>
				<kwd>Prevención de Enfermedades</kwd>
				<kwd>COVID-19</kwd>
			</kwd-group>
			<funding-group>
				<award-group award-type="contract">
					<funding-source>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)</funding-source>
					<award-id>Código de Financiamiento 001</award-id>
				</award-group>
				<award-group award-type="contract">
					<funding-source>Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão</funding-source>
					<award-id>02424/21</award-id>
				</award-group>
				<funding-statement>El presente trabajo fue realizado con apoyo de la Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Código de Financiamiento 001. Apoyo Financiero de la Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão, Proceso 02424/21, Brasil.</funding-statement>
			</funding-group>
		</front-stub>
		<body>
			<boxed-text id="bx3">
				<sec>
					<title>Destacados</title>
					<p>(1) El principal EPI responsable de la aparición de lesiones cutáneas es la mascarilla.</p>
					<p>(2) El acné y las úlceras por presión en estadio 1 y 2 son los principales tipos de lesiones cutáneas.</p>
					<p>(3) Las principales medidas de prevención de lesiones cutáneas implican cuidados de rutina.</p>
					<p>(4) Los profesionales sanitarios no suelen adoptar medidas preventivas a la hora de utilizar los EPI. </p>
				</sec>
			</boxed-text>
			<sec sec-type="intro">
				<title>Introducción</title>
				<p>En enero de 2020, el COVID-19, enfermedad causada por el nuevo Coronavirus (SARS-CoV-2), fue considerada una emergencia de salud pública internacional y, en marzo de 2020, la Organización Mundial de la Salud (OMS) la declaró pandemia<xref ref-type="bibr" rid="B1"><sup>1</sup></xref>. Desde entonces, los profesionales de la salud se han enfrentado a muchos desafíos, como: exposición prolongada; sobrecarga de trabajo; falta de capacitación; cálculo inadecuado de personal; precariedad del ambiente de trabajo; calidad y cantidad insuficientes de Equipos de Protección Individual (EPI), entre otros factores que comprometen la bioseguridad de esos profesionales<xref ref-type="bibr" rid="B2"><sup>2</sup></xref>.</p>
				<p>El COVID-19 se ha destacado por su alta transmisibilidad y gravedad clínica, y también por tener una mayor incidencia entre los profesionales de la salud<xref ref-type="bibr" rid="B3"><sup>3</sup></xref>. Para reducir el riesgo de exposición de los profesionales que están en la primera línea de la lucha contra el COVID-19, la Agencia Nacional de Vigilancia Sanitaria (ANVISA), en su Nota Técnica n.º 04/2020, recomienda usar EPI de acuerdo con el tipo de precaución estándar para gotas, aerosoles y/o contacto. Por ende, para la atención de casos sospechosos o confirmados de COVID-19 se deberá utilizar gafas de protección o pantalla facial, gorro, mascarilla quirúrgica o N95/PFF2 o equivalente (dependiendo del tipo de precaución), delantal y guantes para procedimientos no estériles<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>.</p>
				<p>Aunque los EPI se utilicen para proteger a los profesionales, estos también pueden sufrir lesiones cutáneas provocadas por el uso prolongado del equipo y la frecuente higiene de manos, que pueden evolucionar a lesiones por presión, dermatitis agudas y crónicas, empeoramiento de dermatosis preexistentes y ser la puerta de entrada a infecciones secundarias<xref ref-type="bibr" rid="B5"><sup>5</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B6"><sup>6</sup></xref>.</p>
				<p>El contacto prolongado con EPI afecta la integridad de la barrera cutánea debido a la fuerza de la fricción continua o deslizante y a la condición estructural de la piel, provocando la deformación del tejido, lo que lleva al proceso de muerte celular y desencadena el daño tisular. También vale la pena señalar que factores como la sudoración excesiva generada por el estrés mental y las jornadas laborales extenuantes, la falta de optimización de los EPI ante la deformación de los tejidos, además de la adecuación que realizan los profesionales para mejorar el sellado de la región facial, en búsqueda de mayor protección, contribuyen, de hecho, al daño tisular<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>. </p>
				<p>Al respecto, es importante destacar que el daño tisular es un factor limitante para la atención, ya que los profesionales de la salud, sometidos a jornadas laborales extensas con agotamiento físico y emocional, se han convertido en una población de riesgo para el desarrollo de lesiones y se enfrentan a la falta de equipo de protección adecuado, al empeoramiento de los signos y síntomas de lesiones cutáneas y/o enfermedades preexistentes y, en la mayoría de los casos, no tienen acceso a medidas de prevención por falta de conocimiento y orientación debido a la escasez de estudios, a los costos de estos materiales o incluso a la falta de recursos de las instituciones hospitalarias<xref ref-type="bibr" rid="B8"><sup>8</sup></xref>.</p>
				<p>Dado que el equipo de protección utilizado en el cuidado de la salud es fundamental, es necesario implementar medidas que ayuden a preservar la integridad de la piel en la zona expuesta a riesgo, que contribuirán directamente a proteger la piel, y, por ende, a garantizar la calidad de la atención y la seguridad del paciente. Por lo tanto, la justificación de esta revisión se basa en la contribución que realiza a la práctica de los profesionales de la salud, especialmente de enfermería, al brindar información sobre las lesiones cutáneas asociadas al uso de EPI y las medidas que se pueden adoptar para prevenir su aparición, porque, además para favorecer la práctica profesional segura y promover una atención eficaz a la población asistida, orientará a los profesionales en situaciones similares, permitiendo el desarrollo de estrategias de anticipación de riesgos para mantener la integridad de la piel.</p>
				<p>Por lo tanto, el objetivo es identificar la evidencia científica disponible sobre los tipos de lesiones cutáneas que provocó el uso de EPI en los profesionales sanitarios durante la pandemia de COVID-19 y verificar las medidas de prevención recomendadas.</p>
			</sec>
			<sec sec-type="methods">
				<title>Método</title>
				<sec>
					<title>Tipo de estudio</title>
					<p>Este estudio consiste en una revisión integradora protocolizada en la plataforma <italic>FigShare</italic><xref ref-type="bibr" rid="B9"><sup>9</sup></xref>. El estudio se realizó en seis etapas: 1) elaboración de la pregunta de investigación; 2) definición de las bases de datos y de los criterios de inclusión y exclusión de estudios; 3) definición de la información a extraer de los estudios seleccionados; 4) evaluación de los estudios incluidos en la revisión; 5) interpretación de resultados; 6) presentación de la revisión/síntesis de conocimientos<xref ref-type="bibr" rid="B10"><sup>10</sup></xref>.</p>
					<p>Para orientar la búsqueda, la pregunta de investigación fue elaborada utilizando la estrategia PICo (Población, Interés y Contexto): P - Profesionales de la salud; I - Tipos de lesiones relacionadas con el uso de EPI y Medidas preventivas; Co - Pandemia de COVID-19. Este acrónimo posibilita lograr una búsqueda eficaz a partir de la elaboración de una pregunta de investigación esclarecedora que conduzca el estudio en función de los objetivos propuestos<xref ref-type="bibr" rid="B11"><sup>11</sup></xref>. Esta estrategia nos permitió formular la siguiente pregunta orientadora: “¿Cuáles son los tipos de lesiones cutáneas provocadas por el uso de EPI en los profesionales de la salud durante la pandemia de COVID-19 y cuáles son las medidas de prevención recomendadas?”.</p>
					<p>Se realizó una búsqueda inicial en la base de datos <italic>Medical Literature Analysis and Retrieval System Online</italic> (MEDLINE), a través de la <italic>National Library of Medicine</italic> (PubMed), para verificar los principales descriptores o palabras clave utilizadas en los estudios sobre el tema de la pregunta orientadora. Los términos controlados se seleccionaron de los Descriptores de Ciencias de la Salud (DeCS), <italic>Medical Subject Heading</italic> (MeSH) y MH <italic>Exact Subject Heading</italic> (vocabulario CINAHL), a saber: COVID-19; <italic>occupational injury</italic>; <italic>facial injuries</italic>; <italic>personal protective equipment</italic>; <italic>protective devices</italic> y <italic>skin</italic>. Como aún es un tema incipiente, se decidió utilizar también palabras clave (vocabulario no controlado) para obtener una estrategia de búsqueda dirigida, a saber: <italic>device related pressure injuries, skin injury</italic> y <italic>skin damage</italic>, y en idioma español para la base de datos LILACS y la biblioteca electrónica SciELO. Para realizar los cruces entre estas palabras se utilizaron los operadores <italic>booleanos AND</italic> y <italic>OR</italic> (<xref ref-type="table" rid="t9">Figura 1</xref>).</p>
					<p>
						<table-wrap id="t9">
							<label>Figura 1</label>
							<caption>
								<title>Estrategia de búsqueda de estudios según las bases de datos/bibliotecas electrónicas encontradas. Imperatriz, MA, Brasil, 2021</title>
							</caption>
							<table>
								<colgroup>
									<col/>
									<col/>
									<col/>
								</colgroup>
								<thead>
									<tr>
										<th align="left">Base de datos/biblioteca electrónica</th>
										<th align="left">Cruce</th>
										<th align="center">Cantidad</th>
									</tr>
								</thead>
								<tbody>
									<tr>
										<td align="left">MEDLINE</td>
										<td align="left">COVID-19 <italic>AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
										<td align="center">99</td>
									</tr>
									<tr>
										<td align="left">CINAHL</td>
										<td align="left">(MH”<italic>protective devices</italic>”) <italic>OR</italic> (MH”<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> (MH”<italic>facial injuries</italic>”) <italic>OR</italic> (MH “<italic>occupational injury</italic>”) <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”)</td>
										<td align="center">45</td>
									</tr>
									<tr>
										<td align="left">LILACS</td>
										<td align="left">COVID-19 <italic>AND</italic> (“<italic>dispositivos de protección</italic>” <italic>OR</italic> “<italic>equipo de protección personal</italic>”) <italic>AND</italic> (<italic>piel OR</italic> “<italic>lesiones por presión relacionadas con el dispositivo</italic>” <italic>OR</italic> “<italic>lesiones faciales</italic>” <italic>OR</italic> “<italic>lesión ocupacional</italic>” <italic>OR</italic> “<italic>lesión cutánea</italic>” <italic>OR</italic> “<italic>daño cutáneo</italic>”)</td>
										<td align="center">1</td>
									</tr>
									<tr>
										<td align="left">SCOPUS</td>
										<td align="left">COVID-19 <italic>AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
										<td align="center">97</td>
									</tr>
									<tr>
										<td align="left"><italic>Science Direct</italic></td>
										<td align="left">COVID-19 <italic>AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
										<td align="center">566</td>
									</tr>
									<tr>
										<td align="left"><italic>Web of Science</italic></td>
										<td align="left">COVID-19 <italic>AND</italic> (“<italic>protective devices</italic>” <italic>OR</italic> “<italic>personal protective equipment</italic>”) <italic>AND</italic> (<italic>skin OR</italic> “<italic>device related pressure injuries</italic>” <italic>OR</italic> “<italic>facial injuries</italic>” <italic>OR</italic> “<italic>occupational injury</italic>” <italic>OR</italic> “<italic>skin injury</italic>” <italic>OR</italic> “<italic>skin damage</italic>”).</td>
										<td align="center">42</td>
									</tr>
									<tr>
										<td align="left">SciELO</td>
										<td align="left">COVID-19 <italic>AND</italic> (“<italic>dispositivos de protección</italic>” <italic>OR</italic> “<italic>equipo de protección personal</italic>”) <italic>AND</italic> (<italic>piel OR</italic> “<italic>lesiones por presión relacionadas con el dispositivo</italic>” <italic>OR</italic> “<italic>lesiones faciales</italic>” OR “<italic>lesión ocupacional</italic>” <italic>OR</italic> “<italic>lesión cutánea</italic>” <italic>OR</italic> “<italic>daño cutáneo</italic>”)</td>
										<td align="center">1</td>
									</tr>
									<tr>
										<td align="left" colspan="2">TOTAL</td>
										<td align="center">851</td>
									</tr>
								</tbody>
							</table>
						</table-wrap>
					</p>
				</sec>
				<sec>
					<title>Recolección de datos</title>
					<p>La búsqueda se realizó en enero de 2021 a través del Portal de Periódicos de la CAPES, mediante el acceso a la Comunidad Académica Federada (CAFe), con la selección de la institución de educación superior Universidad Federal de Maranhão (UFMA), buscando en las siguientes bases de datos: <italic>Medical Literature Analysis and Retrieval System Online</italic> (MEDLINE) a través de <italic>National Library of Medicine</italic> (PubMed); <italic>Cumulative Index to Nursing and Allied Health</italic> (CINAHL); Literatura Latinoamericana y del Caribe en Ciencias de la Salud (LILACS); SCOPUS; <italic>Science Direct</italic> y <italic>Web of Science</italic> y la <italic>Scientific Electronic Library Online</italic> (SciELO).</p>
					<p>Para mejorar la calidad de la recopilación de los datos y colaborar en el proceso de organización y selección de estudios y de eliminación de duplicados, se utilizó la aplicación <italic>Rayyan</italic>, desarrollada por el <italic>Qatar Computing Research Institute</italic> (QCRI)<xref ref-type="bibr" rid="B12"><sup>12</sup></xref>. Además, la búsqueda fue realizada por dos investigadores, de forma independiente y simultánea, siguiendo un protocolo de búsqueda en función de la pregunta orientadora y los criterios de elegibilidad. Los criterios de inclusión establecidos para la selección de estudios fueron artículos originales que respondieran a la pregunta orientadora, que abordasen las lesiones y/o medidas preventivas, publicados en inglés, español o portugués. </p>
				</sec>
				<sec>
					<title>Instrumento utilizado para recopilar información</title>
					<p>Para la recolección, categorización e interpretación de los datos, se utilizó un instrumento adaptado<xref ref-type="bibr" rid="B13"><sup>13</sup></xref> con los siguientes ítems: título de la publicación; autor(es); año de publicación; periódico; objetivo; tipo de estudio; nivel de evidencia; tipos de lesiones y medidas preventivas.</p>
				</sec>
				<sec>
					<title>Análisis de los datos</title>
					<p>El nivel de evidencia de los artículos incluidos se clasificó de la siguiente manera: </p>
					<p>
						<list list-type="simple">
							<list-item>
								<p>Nivel 1 - Diseños de investigación experimental: 1.a) Revisión sistemática de ensayos aleatorizados controlados; 1.b) Revisión sistemática de ensayos aleatorizados, controlados y otros diseños de estudio; 1.c) Ensayo controlado aleatorizado; 1.d - Pseudoensayos aleatorizados controlados; </p>
							</list-item>
							<list-item>
								<p>Nivel 2 - Diseños cuasi experimentales: 2.a) Revisión sistemática de estudios cuasiexperimentales; 2.b) Revisión sistemática de cuasiexperimentos y otros diseños de estudios con menos evidencia; 2.c) Estudios prospectivamente controlados de cuasiexperimentos; 2.d) Pretest y postest o estudios de grupos controlados históricos retrospectivos; </p>
							</list-item>
							<list-item>
								<p>Nivel 3 - Observacional - Diseños analíticos: 3.a) Revisión sistemática de estudios de cohortes comparables; 3.b) Revisión sistemática de cohortes comparables y otros diseños de estudio con menos evidencia; 3.c) Estudio de cohorte con grupo control; 3.d) Estudio de casos y controles; 3.e) Estudios observacionales sin grupo control; </p>
							</list-item>
							<list-item>
								<p>Nivel 4 - Observacional - Estudios descriptivos: 4.a) Revisión sistemática de estudios descriptivos; 4.b) Estudio transversal; 4.c) Serie de casos; 4.d) Estudio de caso; </p>
							</list-item>
							<list-item>
								<p>Nivel 5 - Opinión de especialistas - Investigación de laboratorio: 5.a) Revisión sistemática de la opinión de especialistas; 5.b) Consenso de especialistas; 5.c) Investigación de laboratorio/opinión de un especialista<xref ref-type="bibr" rid="B14"><sup>14</sup></xref>.</p>
							</list-item>
						</list>
					</p>
					<p>Además, se realizó un análisis de la calidad metodológica utilizando los instrumentos propuestos por el JBI<xref ref-type="bibr" rid="B15"><sup>15</sup></xref> que contienen una <italic>checklist</italic> de preguntas para cada tipo de estudio con las siguientes opciones de respuesta: Sí; No; No aplicable o No clara. Después de la categorización de los estudios, los datos fueron sintetizados para el análisis descriptivo según año de publicación, idioma, lugar donde se realizó el estudio, objetivo, tipo de estudio, nivel de evidencia, tipos de lesiones cutáneas y medidas preventivas relacionadas con el uso de EPI en profesionales de la salud.</p>
				</sec>
			</sec>
			<sec sec-type="results">
				<title>Resultados</title>
				<p>Se identificaron un total de 851 artículos y, tras analizar el título, el resumen y aplicar los criterios de inclusión y exclusión, se preseleccionaron 50 artículos para su lectura completa. Entre los 50 artículos analizados, 17 fueron incluidos en la muestra final de esta revisión. La trayectoria de búsqueda y selección de estudios siguió las recomendaciones del grupo PRISMA<xref ref-type="bibr" rid="B15"><sup>15</sup></xref> y se puede ver en el diagrama de flujo a continuación (<xref ref-type="fig" rid="f3">Figura 2</xref>).</p>
				<p>
					<fig id="f3">
						<label>Figura 2</label>
						<caption>
							<title>Diagrama de flujo de la selección de los artículos incluidos en el estudio. Imperatriz, MA, Brasil, 2021</title>
						</caption>
						<graphic xlink:href="1518-8345-rlae-30-e3551-gf3.png"/>
						<attrib>Fuente: adaptado de PRISMA<xref ref-type="bibr" rid="B16"><sup>16</sup></xref>. </attrib>
					</fig>
				</p>
				<p>Los 17 artículos que conformaron la muestra final fueron publicados en 2020 y 2021 en inglés y español. Los estudios se realizaron en los siguientes países: Baréin, Brasil, China, Estados Unidos, India, Irak, México, París (Francia), Tailandia y Turquía, siendo China (35,5%) el país con mayor número de publicaciones. Los tipos de estudio fueron: cohorte prospectivo<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref> (11,8%), ensayo clínico aleatorizado<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref> (11,8%) y transversal descriptivo<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B33"><sup>33</sup></xref> (76,4%). Al evaluar el nivel de evidencia, el 76,4% de las publicaciones fueron clasificadas como nivel 4b.</p>
				<p>La <xref ref-type="table" rid="t10">Figura 3</xref> presenta la caracterización de los estudios que formaron parte de la muestra final, considerando objetivo, país donde se realizó el estudio, idioma, nivel de evidencia y calidad metodológica del estudio.</p>
				<p>
					<table-wrap id="t10">
						<label>Figura 3</label>
						<caption>
							<title>Caracterización de los estudios primarios incluidos en la muestra. Imperatriz, MA, Brasil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col/>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left">Autores</th>
									<th align="left">Objetivo</th>
									<th align="center">Idioma/ País</th>
									<th align="center">Nivel de Evidencia</th>
									<th align="left">Calidad metodológica del estudio</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left">Smart, et al. (2020)<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>
									</td>
									<td align="left">Determinar si usar un apósito a base de silicona debajo de una mascarilla N95 es seguro y beneficioso para prevenir lesiones en la piel del rostro sin comprometer el sellado de la mascarilla.</td>
									<td align="center">Inglés/Baréin</td>
									<td align="center">3.c</td>
									<td align="left">Siete de 11 puntos de la <italic>checklist</italic> para <italic>Cohort studies</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Yildiz, et al. (2021)<xref ref-type="bibr" rid="B18"><sup>18</sup></xref>
									</td>
									<td align="left">Determinar el efecto del apósito profiláctico en la prevención de lesiones cutáneas que provoca el uso de EPI en los profesionales de la salud que trabajan con pacientes con COVID-19.</td>
									<td align="center">Inglés/Turquía</td>
									<td align="center">3.c</td>
									<td align="left">Ocho de 11 puntos de la <italic>checklist</italic> para <italic>Cohort studies</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Hua, et al. (2020)<xref ref-type="bibr" rid="B19"><sup>19</sup></xref>
									</td>
									<td align="left">Analizar los efectos a corto plazo de los respiradores N95 y las mascarillas médicas sobre las propiedades fisiológicas de la piel e informar reacciones cutáneas adversas.</td>
									<td align="center">Inglés/China</td>
									<td align="center">1.c</td>
									<td align="left">Ocho de 13 puntos de la <italic>checklist</italic> para <italic>Randomized controlled trials</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Gasparino, et al. (2021)<xref ref-type="bibr" rid="B20"><sup>20</sup></xref>
									</td>
									<td align="left">Comparar el uso de apósitos de espuma e hidrocoloides extrafinos en la prevención de lesiones por presión asociadas al uso de EPI por profesionales de la salud que trabajan en la primera línea contra el Coronavirus.</td>
									<td align="center">Inglés/Brasil</td>
									<td align="center">1.c</td>
									<td align="left">Ocho de 13 puntos de la <italic>checklist</italic> para <italic>Randomiz ed controlled trials</italic> el JBI*</td>
								</tr>
								<tr>
									<td align="left">Jiang, et al. (2020)<xref ref-type="bibr" rid="B21"><sup>21</sup></xref>
									</td>
									<td align="left">Investigar la prevalencia y características de las lesiones por presión en el equipo de salud.</td>
									<td align="center">Inglés/China</td>
									<td align="center">4.b</td>
									<td align="left">Seis de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Hu, et al. (2020)<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>
									</td>
									<td align="left">Investigar las reacciones cutáneas adversas en los profesionales de la salud que usan EPI.</td>
									<td align="center">Inglés/China</td>
									<td align="center">4.b</td>
									<td align="left">Seis de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Shanshal, et al. (2020)<xref ref-type="bibr" rid="B23"><sup>23</sup></xref>
									</td>
									<td align="left">Analizar exhaustivamente el efecto del COVID-19 en diferentes aspectos de la práctica médica.</td>
									<td align="center">Inglés/Irak</td>
									<td align="center">4.b</td>
									<td align="left">Cuatro de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Xia, et al. (2020)<xref ref-type="bibr" rid="B24"><sup>24</sup></xref>
									</td>
									<td align="left">Identificar los efectos físicos y psicológicos del uso de EPI y sus respectivas medidas de seguridad en los trabajadores de la salud en Wuhan, China, debido a la pandemia.</td>
									<td align="center">Inglés/China</td>
									<td align="center">4.b</td>
									<td align="left">Seis de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Pacis, et al. (2020)<xref ref-type="bibr" rid="B25"><sup>25</sup></xref>
									</td>
									<td align="left">Formular procedimientos para proteger la integridad de la piel del rostro de los trabajadores de la salud al atender a pacientes con COVID-19.</td>
									<td align="center">Inglés/Estados Unidos</td>
									<td align="center">4.b</td>
									<td align="left">Cinco de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Agarwal, et al. (2020)<xref ref-type="bibr" rid="B26"><sup>26</sup></xref>
									</td>
									<td align="left">Identificar las dificultades que encontraron los profesionales de la salud al usar EPI y proponer formas y medios de ayudarlos a superar estas dificultades.</td>
									<td align="center">Inglés/India</td>
									<td align="center">4.b</td>
									<td align="left">Cuatro de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Yuan, et al. (2020)<xref ref-type="bibr" rid="B27"><sup>27</sup></xref>
									</td>
									<td align="left">Comprender las posibles reacciones cutáneas, respiratorias, nerviosas y digestivas en los profesionales de la salud chinos que utilizan EPI en la lucha contra el COVID-19.</td>
									<td align="center">Inglés/China</td>
									<td align="center">4.b</td>
									<td align="left">Seis de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Jiang, et al.(2020)<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>
									</td>
									<td align="left">Investigar la prevalencia, características y estado preventivo de las lesiones cutáneas provocadas por los EPI en el equipo de salud.</td>
									<td align="center">Inglés/China</td>
									<td align="center">4.b</td>
									<td align="left">Seis de ocho puntos en la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Daye, et al. (2020)<xref ref-type="bibr" rid="B29"><sup>29</sup></xref>
									</td>
									<td align="left">Evaluar los problemas de la piel y la calidad de vida dermatológica de los profesionales de la salud por el uso de EPI.</td>
									<td align="center">Inglés/Turquía</td>
									<td align="center">4.b</td>
									<td align="left">Cuatro de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Atay, et al. (2020)<xref ref-type="bibr" rid="B30"><sup>30</sup></xref>
									</td>
									<td align="left">Analizar los problemas físicos relacionados con los EPI y el tiempo de uso prolongado que experimentaron las enfermeras durante la pandemia de COVID-19.</td>
									<td align="left">Inglés/Turquía</td>
									<td align="center">4.b</td>
									<td align="left">Seis de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Techasatian, et al. (2020)<xref ref-type="bibr" rid="B31"><sup>31</sup></xref>
									</td>
									<td align="left">Analizar la prevalencia y los posibles factores de riesgo para prevenir las reacciones cutáneas relacionadas con las mascarillas durante el COVID-19.</td>
									<td align="center">Inglés/Tailandia</td>
									<td align="center">4.b</td>
									<td align="left">Seis de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Masen, et al. (2020)<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>
									</td>
									<td align="left">Proporcionar una solución lubricante práctica para los trabajadores de la atención médica de la primera línea contra el COVID-19 que trabajan en turnos de cuatro horas o más usando EPI.</td>
									<td align="center">Inglés/Paris (Francia)</td>
									<td align="center">4.b</td>
									<td align="left">Seis de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
								<tr>
									<td align="left">Erize-Herrera, et al. (2020)<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>
									</td>
									<td align="left">Describir la frecuencia de las manifestaciones cutáneas provocadas por el uso de EPI en los profesionales de la salud y los factores de riesgo de desarrollarlas.</td>
									<td align="center">Español/México</td>
									<td align="center">4.b</td>
									<td align="left">Cuatro de ocho puntos de la <italic>checklist</italic> para <italic>Analytical cross-sctional</italic> del JBI*</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN5">
								<label><sup>*</sup></label>
								<p>En la <italic>checklist</italic>, algunas respuestas se calificaron como No aplicable o No clara.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>La <xref ref-type="table" rid="t11">Tabla 1</xref> presenta los tipos de lesiones relacionadas con el uso de EPI. Los principales EPI que se asociaron a la aparición de lesiones cutáneas fueron: mascarilla quirúrgica o N95, gafas de protección, pantalla facial, guantes y ropa de protección. Las lesiones más frecuentes provocadas por el uso de mascarillas fueron: lesión por presión (estadio 1)<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (35,2%); acné<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref> (23,5%); depresión cutánea<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref> (23,5%); dermatitis de contacto irritante<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B32"><sup>32</sup></xref> (17,6%); erupción cutánea<xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref> (17,6%); lesión por presión (estadio 2)<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref> (11,7%) y lesiones asociadas a la humedad<xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref> (11,7%).</p>
				<p>En cuanto a las lesiones asociadas al uso de gafas de protección, se destacaron las lesiones por presión estadio 1<xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (23,5%) y estadio 2<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (17,6%). Las lesiones relacionadas con el uso de protectores faciales más frecuentes fueron las lesiones por presión estadio 1<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (23,5%). En lo que respecta al uso de guantes, se destacaron la xerosis<xref ref-type="bibr" rid="B21"><sup>21</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B24"><sup>24</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref> (23,5%) y las fisuras<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B30"><sup>30</sup></xref> (17,6%). En cuanto a las lesiones asociadas al uso de ropa de protección, se destacó la dermatitis de contacto irritante<xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B26"><sup>26</sup></xref> (11,7%).</p>
				<p>
					<table-wrap id="t11">
						<label>Tabla 1</label>
						<caption>
							<title>Frecuencia de tipos de lesiones relacionadas con el uso de mascarilla quirúrgica o N95, gafas de protección, pantalla facial, guantes y ropa de protección según los estudios encontrados. Imperatriz, MA, Brasil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col/>
								<col/>
								<col/>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="left">Equipo de Protección Individual</th>
									<th align="left">Tipos de lesiones</th>
									<th align="center">Frecuencia n (%)*</th>
									<th align="center">Estudios encontrados</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left" rowspan="15">Mascarilla quirúrgica o N95</td>
									<td align="left">Lesión por presión (estadio 1)<sup>†</sup></td>
									<td align="center">6 (35,2)</td>
									<td align="center">17,18,21,23,24,28</td>
								</tr>
								<tr>
									<td align="left">Acné</td>
									<td align="center">4 (23,5)</td>
									<td align="center">22,29,31,33</td>
								</tr>
								<tr>
									<td align="left">Depresión cutánea</td>
									<td align="center">4 (23,5)</td>
									<td align="center">17,19,22,27</td>
								</tr>
								<tr>
									<td align="left">Dermatitis de contacto irritante</td>
									<td align="center">3 (17,6)</td>
									<td align="center">22,29,33</td>
								</tr>
								<tr>
									<td align="left">Erupción cutánea</td>
									<td align="center">3 (17,6)</td>
									<td align="center">23,26,31</td>
								</tr>
								<tr>
									<td align="left">Lesión por presión (estadio 2)<sup>†</sup></td>
									<td align="center">2 (11,7)</td>
									<td align="center">21,23</td>
								</tr>
								<tr>
									<td align="left">Lesiones asociadas a la humedad</td>
									<td align="center">2 (11,7)</td>
									<td align="center">18,24</td>
								</tr>
								<tr>
									<td align="left">Maceración</td>
									<td align="center">1 (5,8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left">Queilitis</td>
									<td align="center">1 (5,8)</td>
									<td align="center">30</td>
								</tr>
								<tr>
									<td align="left">Lesión por presión (estadio 3)<sup>†</sup></td>
									<td align="center">1 (5,8)</td>
									<td align="center">21</td>
								</tr>
								<tr>
									<td align="left">Urticaria</td>
									<td align="center">1 (5,8)</td>
									<td align="center">22</td>
								</tr>
								<tr>
									<td align="left">Pústula</td>
									<td align="center">1 (5,8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left">Pápula</td>
									<td align="center">1 (5,8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left">Xerosis</td>
									<td align="center">1 (5,8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left">Ampollas</td>
									<td align="center">1 (5,8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left" rowspan="7">Gafas de protección</td>
									<td align="left">Lesión por presión (estadio 1)<sup>‡</sup></td>
									<td align="center">4 (23,5)</td>
									<td align="center">18,23,24,28</td>
								</tr>
								<tr>
									<td align="left">Lesión por presión (estadio 2)<sup>‡</sup></td>
									<td align="center">3 (17,6)</td>
									<td align="center">21,23,28</td>
								</tr>
								<tr>
									<td align="left">Erupción cutánea</td>
									<td align="center">2 (11,7)</td>
									<td align="center">23,33</td>
								</tr>
								<tr>
									<td align="left">Depresión cutánea</td>
									<td align="center">1 (5,8)</td>
									<td align="center">27</td>
								</tr>
								<tr>
									<td align="left">Lesión por presión (estadio 3)<sup>‡</sup></td>
									<td align="center">1 (5,8)</td>
									<td align="center">21</td>
								</tr>
								<tr>
									<td align="left">Pápula</td>
									<td align="center">1 (5,8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left">Pústula</td>
									<td align="center">1 (5,8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left" rowspan="10">Protector facial</td>
									<td align="left">Lesión por presión (estadio 1)<sup>§</sup></td>
									<td align="center">4 (23,5)</td>
									<td align="center">21,23,24,28</td>
								</tr>
								<tr>
									<td align="left">Lesión por presión (estadio 2)<sup>§</sup></td>
									<td align="center">2 (11,7)</td>
									<td align="center">23, 28</td>
								</tr>
								<tr>
									<td align="left">Erupción cutánea</td>
									<td align="center">2 (11,7)</td>
									<td align="center">20, 23</td>
								</tr>
								<tr>
									<td align="left">Depresión cutánea</td>
									<td align="center">1 (5,8)</td>
									<td align="center">27</td>
								</tr>
								<tr>
									<td align="left">Lesiones asociadas a la humedad</td>
									<td align="center">1 (5,8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Foliculitis</td>
									<td align="center">1 (5,8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Lesión por fricción</td>
									<td align="center">1 (5,8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Lesión por presión (estadio 3)<sup>§</sup></td>
									<td align="center">1 (5,8)</td>
									<td align="center">21</td>
								</tr>
								<tr>
									<td align="left">Pápula</td>
									<td align="center">1 (5,8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left">Pústula</td>
									<td align="center">1 (5,8)</td>
									<td align="center">23</td>
								</tr>
								<tr>
									<td align="left" rowspan="12">Guantes</td>
									<td align="left">Xerosis </td>
									<td align="center">4 (23,5)</td>
									<td align="center">22, 30,31,33</td>
								</tr>
								<tr>
									<td align="left">Fisuras</td>
									<td align="center">3 (17,6)</td>
									<td align="center">22,29,30</td>
								</tr>
								<tr>
									<td align="left">Descamación</td>
									<td align="center">2 (11,7)</td>
									<td align="center">29,33</td>
								</tr>
								<tr>
									<td align="left">Erupción cutánea</td>
									<td align="center">2 (11,7)</td>
									<td align="center">22, 26</td>
								</tr>
								<tr>
									<td align="left">Dermatitis de contacto irritante </td>
									<td align="center">1 (5,8)</td>
									<td align="center">26</td>
								</tr>
								<tr>
									<td align="left">Maceración</td>
									<td align="center">1 (5,8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left">Ampollas</td>
									<td align="center">1 (5,8)</td>
									<td align="center">33</td>
								</tr>
								<tr>
									<td align="left">Agravamiento de dermatosis preexistente</td>
									<td align="center">1 (5,8)</td>
									<td align="center">29</td>
								</tr>
								<tr>
									<td align="left">Lesión por fricción</td>
									<td align="center">1 (5,8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Lesiones asociadas a la humedad</td>
									<td align="center">1 (5,8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Urticaria</td>
									<td align="center">1 (5,8)</td>
									<td align="center">22</td>
								</tr>
								<tr>
									<td align="left">Liquenificación</td>
									<td align="center">1 (5,8)</td>
									<td align="center">29</td>
								</tr>
								<tr>
									<td align="left" rowspan="4">Ropa de protección</td>
									<td align="left">Dermatitis de contacto irritante</td>
									<td align="center">2 (11,7)</td>
									<td align="center">23,26</td>
								</tr>
								<tr>
									<td align="left">Erupciones cutáneas</td>
									<td align="center">1 (5,8)</td>
									<td align="center">26</td>
								</tr>
								<tr>
									<td align="left">Lesiones asociadas a la humedad</td>
									<td align="center">1 (5,8)</td>
									<td align="center">18</td>
								</tr>
								<tr>
									<td align="left">Xerosis</td>
									<td align="center">1 (5,8)</td>
									<td align="center">22</td>
								</tr>
							</tbody>
						</table>
						<table-wrap-foot>
							<fn id="TFN6">
								<p>*El valor total de “n” corresponde a la muestra de 17 artículos. El porcentaje está por encima del 100%, debido a que se encontró más de un tipo de lesión en el mismo artículo incluido en la muestra; <sup>†</sup>Frontal, Puente Nasal, Auricular y/o mandibular; <sup>‡</sup>Frontal, Puente Nasal, Auricular; <sup>§</sup>Frontal.</p>
							</fn>
						</table-wrap-foot>
					</table-wrap>
				</p>
				<p>Las principales medidas preventivas relacionadas con las lesiones provocadas por el uso de EPI se agruparon según el tipo de EPI utilizado. Para las lesiones resultantes del uso de mascarilla, gafas de protección y pantalla facial, la mayoría de los artículos<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref> (27,7%) recomendaba el uso de apósitos de hidrocoloide o espuma en las zonas de presión, pero, además, se formularon otras recomendaciones para protegerse, como el uso de humectantes y emolientes, especialmente cuando no se están atendiendo pacientes, además del correcto ajuste de la máscara y el uso de una correa protectora auricular.</p>
				<p>Como recomendaciones para el uso de guantes, los estudios citaron: lavarse y secarse bien las manos y los pies; aplicar una crema protectora antes y después de usar el EPI; evitar usar guantes durante mucho tiempo y usar guantes de algodón o una capa de guantes de plástico dentro de los guantes de látex. En cuanto al uso de ropa de protección para evitar lesiones, la recomendación es aplicar una crema protectora antes y después de usar EPI para evitar la descamación y resequedad de la piel (<xref ref-type="table" rid="t12">Figura 4</xref>).</p>
				<p>
					<table-wrap id="t12">
						<label>Figura 4</label>
						<caption>
							<title>Medidas preventivas de la aparición de lesiones cutáneas relacionadas con el uso de Equipos de Protección Individual. Imperatriz, MA, Brasil, 2021</title>
						</caption>
						<table>
							<colgroup>
								<col/>
							</colgroup>
							<thead>
								<tr>
									<th align="center">Recomendaciones para la prevención de lesiones relacionadas con el uso de mascarilla, gafas y pantalla facial</th>
								</tr>
							</thead>
							<tbody>
								<tr>
									<td align="left">- Utilizar barrera protectora líquida sin alcohol en las zonas de contacto directo con el EPI (por ejemplo, nariz, mejillas, frente, detrás de las orejas) para proteger la piel de la humedad y el roce. Antes de aplicar, asegúrese de que el área esté libre de maquillaje. No aplicar en ojos o párpados y dejar secar por 90 segundos antes de ponerse el EPI<xref ref-type="bibr" rid="B25"><sup>25</sup></xref>. </td>
								</tr>
								<tr>
									<td align="left">- Aplicar un apósito fino de hidrocoloide o espuma y ajustar el material a la piel sin tensarlo en el puente nasal, mejillas y frente, cubriendo el área donde descansan la máscara, el protector facial y las gafas<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B28"><sup>28</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Usar humectantes a base de acrilato con frecuencia, especialmente cuando no se esté atendiendo directamente al paciente<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Ajustar correctamente la mascarilla N95 fijando el clip y añadir una mascarilla quirúrgica para la alineación<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Usar una correa protectora auricular unida al elástico de la mascarilla<xref ref-type="bibr" rid="B23"><sup>23</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left"><bold>Recomendaciones para la prevención de lesiones relacionadas con el uso de guantes y ropa de protección</bold></td>
								</tr>
								<tr>
									<td align="left">- Lavarse las manos con jabón, detergente, jabones o aceites ligeros, sin perfume y con el menor número de conservantes, secárselas bien y aplicar talco en manos y pies antes de ponerse guantes y botas, para proteger la piel del roce y la hidratación excesiva. Si los guantes están secos, no poner demasiado talco<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Aplicar crema de manos específica con regularidad y evitar usar guantes durante mucho tiempo. El uso de guantes de algodón o una capa de guantes de plástico dentro de los guantes de látex ayuda a proteger contra la picazón o irritación a las personas con alergia al látex<xref ref-type="bibr" rid="B21"><sup>21</sup></xref>.</td>
								</tr>
								<tr>
									<td align="left">- Aplicar una crema protectora antes y después del uso de EPI para evitar la descamación y resequedad de la piel<xref ref-type="bibr" rid="B28"><sup>28</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B29"><sup>29</sup></xref>.</td>
								</tr>
							</tbody>
						</table>
					</table-wrap>
				</p>
				<p>Además de las recomendaciones dirigidas a cada categoría de EPI, algunos estudios enumeraron recomendaciones para el cuidado general en la prevención de lesiones. Las mismas eran retirar el EPI<xref ref-type="bibr" rid="B26"><sup>26</sup></xref> y no utilizar emolientes y cremas humectantes cuando se utiliza el EPI por más de cuatro horas, ya que pueden generar fuerzas de cizallamiento excesivas sobre la piel y, en estos casos, deben ser reemplazados por talco, lanolina que contenga vaselina o una mezcla de aceite de coco, manteca de cacao y cera de abeja porque proporcionan una excelente lubricación de larga duración<xref ref-type="bibr" rid="B32"><sup>32</sup></xref>.</p>
			</sec>
			<sec sec-type="discussion">
				<title>Discusión</title>
				<p>La pandemia de COVID-19 requirió el uso prolongado de EPI no solo por parte del equipo de profesionales de la salud, sino también por parte de todo el personal del hospital. Por lo tanto, aumentó considerablemente el número de profesionales prestadores de servicios que necesitaban utilizar EPI, así como también las lesiones cutáneas asociadas al uso intensivo de estos materiales. Ante la falta de estudios con información detallada y actualizada sobre la aparición de lesiones cutáneas asociadas al uso de EPI y estrategias de prevención, se ve que surgió en los investigadores una preocupación creciente por producir conocimiento sobre el tema para ayudar al equipo multidisciplinario<xref ref-type="bibr" rid="B7"><sup>7</sup></xref>.</p>
				<p>En los estudios identificados en esta revisión, las mascarillas quirúrgicas o N95, las gafas de protección, la pantalla facial y los guantes fueron los principales factores responsables de la aparición de lesiones. Una investigación realizada en China detectó que el 95,1% de los profesionales de la salud que usaban regularmente la mascarilla N95 más de 12 horas al día durante un promedio de 3,5 meses se quejaron de algún tipo de alteración en la piel<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Otro estudio observó que el 47,3% de los entrevistados que usaron EPI por más de cuatro horas, también presentaron algún tipo de afección<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. Estos datos indican que, además del tipo de EPI, el tiempo de uso también es un factor de riesgo para la aparición de lesiones.</p>
				<p>La OMS recomienda que no se utilicen las mascarillas N95, PFF2 o equivalentes por un período superior a cuatro horas debido al riesgo de molestias y dolor. Sin embargo, en tiempos de emergencia de salud pública y cuando hay escasez de equipos, pueden ser utilizados, sin quitárselos, sin perder su eficacia protectora, por un período prolongado, cuando se atiende a varios pacientes que tienen el mismo diagnóstico<xref ref-type="bibr" rid="B34"><sup>34</sup></xref>.</p>
				<p>El uso continuo de EPI, por más tiempo del recomendado, requiere que se tomen medidas para evitar o minimizar la aparición de lesiones. Sin embargo, esta recomendación no fue observada en un estudio realizado en China, dado que sólo el 17,7% de los encuestados utilizaba apósitos o lociones profilácticas en la piel durante el cuidado. Los autores creen que el hecho de que el 42,8% de los profesionales evaluados tuviera lesiones en la piel está relacionado con la falta de capacitación o con el temor de utilizar almohadillas protectoras que impidan la correcta fijación de los EPI<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>.</p>
				<p>En quienes usaban EPI, los tipos de lesiones cutáneas más frecuentes fueron las lesiones por presión estadio 1. En China, un estudio identificó lesiones por presión en 30% de los profesionales entrevistados y, de estos, 81,1% estaba en estadio 1 y 18,3% en estadio 2<xref ref-type="bibr" rid="B28"><sup>28</sup></xref>. Otro estudio identificó que 25,58% de los profesionales de la salud presentaba lesiones por presión en el rostro<xref ref-type="bibr" rid="B35"><sup>35</sup></xref>, mientras que otro estudio reveló que 68,9% presentaba lesiones por presión en el puente nasal asociadas al uso prolongado de EPI<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</p>
				<p>Tales lesiones se forman debido a la aplicación de una carga mecánica prolongada sobre los tejidos blandos que se encuentran cerca de una prominencia ósea. Cabe destacar que la magnitud de la carga depende del tiempo de duración de la aplicación para causar daño, por lo tanto, una carga baja aplicada por un período prolongado causa tanto daño tisular como una carga alta por un período corto<xref ref-type="bibr" rid="B36"><sup>36</sup></xref>. Los profesionales de la salud que trabajan en la primera línea contra el COVID-19, en un intento por evitar la infección respiratoria provocada por el Coronavirus, habitualmente ajustaban sus mascarillas N95 de forma que el borde estuviera en contacto excesivamente estrecho con la piel y el clip de metal firmemente fijado sobre la nariz para asegurar el sellado total<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. Este hecho pudo haber contribuido a la formación de lesiones en el rostro y el puente nasal de estos profesionales.</p>
				<p>Un estudio que evaluó las medidas de protección para lesiones cutáneas encontró que los emolientes suaves, la crema de silicona y el apósito con película aplicados en la región de mayor presión mecánica entre la mascarilla y la piel fueron más aceptados, en detrimento del uso de apósitos de espuma, ya que estos requieren mayor habilidad para aplicarlos y adherirlos correctamente. Sin embargo, los autores destacaron que el uso de cremas y emolientes en grandes cantidades puede facilitar la adherencia de la suciedad, lo que dificulta la reutilización de la mascarilla en un contexto de escasez, mientras que el apósito con película debe retirarse con cuidado para evitar el dolor<xref ref-type="bibr" rid="B37"><sup>37</sup></xref>.</p>
				<p>Los apósitos de espuma con un borde de silicona son beneficiosos cuando se usan correctamente, como se demostró en un estudio realizado por enfermeros en Baréin. Los profesionales que usaron el apósito presentaron menos reacciones en la piel después de una hora de uso continuo en comparación con los que no usaron protección. Antes de usar la mascarilla facial, se recomienda preparar y cortar adecuadamente el apósito de espuma y colocarlo en la nariz, al costado del rostro, debajo del mentón, en la región central de la frente y cerca de las orejas y usar humectantes después de retirarlo<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>. Las investigaciones han demostrado que el apósito no interfiere con el sellado de las mascarillas<xref ref-type="bibr" rid="B17"><sup>17</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B37"><sup>37</sup></xref>.</p>
				<p>El acné facial también estuvo entre los tipos de lesiones más frecuentes en los estudios analizados. Una investigación realizada en Singapur con profesionales que asistían en la lucha contra la infección del Síndrome Respiratorio Agudo Severo (SARS), en 2003, identificó el acné como la principal reacción cutánea (65%) asociada al uso prolongado de la mascarilla N95<xref ref-type="bibr" rid="B38"><sup>38</sup></xref>. Otra investigación realizada en India señaló que el acné era la quinta dermatosis más común entre los profesionales de la salud que usan EPI por más de ocho horas al día, después de la dermatitis de contacto irritante, la dermatitis alérgica, las marcas de presión y fricción y la dermatitis por sudor<xref ref-type="bibr" rid="B35"><sup>35</sup></xref>.</p>
				<p>La aparición de acné puede explicarse por la obstrucción de los conductos pilosebáceos por oclusión prolongada y presión local sobre la piel por el uso de la mascarilla que, junto con el estrés mental, la sobrecarga de trabajo y la privación del sueño, contribuye a la aparición de acné o al agravamiento del problema existente. Para el control del acné, además del cuidado general de la piel, se recomienda lavarse la cara dos veces al día, elegir limpiadores faciales adecuados, utilizar cosméticos ligeros o evitarlos y, en casos leves a severos, utilizar un tratamiento farmacológico adecuado con antibióticos tópicos y/o ungüento de retinoide para tratamiento sistémico, con minociclina o isotretinoína, dependiendo de lo que indique el médico<xref ref-type="bibr" rid="B39"><sup>39</sup></xref>.</p>
				<p>Otro tipo de lesión cutánea que se destacó en los estudios de esta revisión fue la depresión cutánea, que puede ocurrir por el uso prolongado de mascarillas, gafas y protectores faciales<xref ref-type="bibr" rid="B19"><sup>19</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref>. Este tipo de lesión suele remitir espontáneamente<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B27"><sup>27</sup></xref>, sin embargo, un tratamiento recomendado para el enrojecimiento y la hinchazón es el uso de una compresa hidropática con tres o cuatro capas de gasa empapada en agua fría o solución salina cada dos horas, seguida de la aplicación de humectantes<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. La prevención de este tipo de lesiones, además de las mencionadas anteriormente, pasa por el uso correcto de los EPI faciales, del tamaño adecuado, bien ajustados y no apretados<xref ref-type="bibr" rid="B18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B40"><sup>40</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B41"><sup>41</sup></xref>, el uso de las tiras de la mascarilla N95 sobre el cabeza<xref ref-type="bibr" rid="B41"><sup>41</sup></xref>, además del uso de discos de algodón fijados con cinta quirúrgica hipoalergénica en la región nasal y cigomática para evitar la fricción<xref ref-type="bibr" rid="B42"><sup>42</sup></xref>.</p>
				<p>Se identificó la presencia de dermatitis en profesionales de la salud que utilizaban EPI, principalmente por el uso de mascarillas y alcohol en gel<xref ref-type="bibr" rid="B22"><sup>22</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B43"><sup>43</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B44"><sup>44</sup></xref>. Dicha dermatitis se puede dividir en dos tipos: dermatitis de contacto alérgica y dermatitis de contacto irritante. Este último comprende una respuesta no inmunológica que afecta comúnmente las manos y la cara y se produce como resultado del daño directo en la piel por agentes químicos o físicos de manera que la piel no puede repararse a sí misma rápidamente. La dermatitis alérgica de contacto es una reacción de hipersensibilidad retardada de tipo IV a un alérgeno externo que ocurre solo en individuos que han sido sensibilizados previamente. Esta reexposición al alérgeno da como resultado células T de memoria circulantes que viajan a la piel y provocan una reacción inmunológica que causa inflamación de la piel, generalmente dentro de las 48 horas<xref ref-type="bibr" rid="B45"><sup>45</sup></xref>.</p>
				<p>En general, la duración de la exposición a los alérgenos y/o a la humedad se ha identificado como el principal factor de riesgo para la dermatitis de contacto, por lo que llevar mascarilla y gafas durante más de seis horas o lavarse las manos más de diez veces al día puede aumentar el riesgo de dermatitis localizada. También es importante considerar la exposición adicional al material de la mascarilla, así como el lavado repetido de manos fuera del entorno laboral como una forma de prevenir la infección por SARS-CoV-2<xref ref-type="bibr" rid="B44"><sup>44</sup></xref>. </p>
				<p>Las medidas preventivas para la dermatitis de contacto incluyen la aplicación de emolientes antes de usar mascarillas y no usarlas con el material responsable del ardor y la picazón. Sin embargo, si esto no es posible, se recomienda utilizar almohadillas y/o apósitos protectores que eviten que la mascarilla entre en contacto directo con la piel, además de cuidados extras como evitar el uso de etanol al 75% para limpiar la piel y agua demasiado caliente. Las erupciones cutáneas leves pueden mostrar una mejoría espontánea después de tres a cinco días sin tratamiento adicional<xref ref-type="bibr" rid="B43"><sup>43</sup></xref>. A su vez, el agravamiento de enfermedades preexistentes, como la psoriasis, la dermatitis atópica y las reacciones alérgicas, pueden requerir un manejo más complejo, incluso que estos profesionales de la salud se ausenten temporalmente del trabajo<xref ref-type="bibr" rid="B44"><sup>44</sup></xref>.</p>
				<p>En lo que respecta al uso de guantes y ropa de protección, se registraron lesiones como piel seca, picazón y erupciones en los profesionales que usaron estos EPI por más de diez horas al día por un promedio de 3,5 meses<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>. La xerosis fue identificada en una investigación mexicana como una de las principales lesiones encontradas en los profesionales de la salud (90,35%), seguida de la descamación, eritema, fisuras, vesículas y maceración, y la principal zona afectada fueron las manos. Los datos obtenidos demostraron que hay una asociación significativa entre las lesiones y el uso de alcohol en gel, y que aumentaba 1,81 veces el riesgo de xerosis<xref ref-type="bibr" rid="B33"><sup>33</sup></xref>. Esta lesión se caracteriza por una disminución en la cantidad y/o calidad de lípidos y sustancias hidrofílicas en la piel. El manejo de la xerosis se basa en el uso regular de una combinación de sustancias tópicas que tienen como objetivo mejorar la hidratación, compensar la falta de lípidos y mejorar la función de barrera de la piel<xref ref-type="bibr" rid="B46"><sup>46</sup></xref>.</p>
				<p>Una investigación, que evaluó las principales lesiones cutáneas y sus factores de riesgo en el contexto de la pandemia de COVID-19 en el equipo de salud, constató que la maceración estaba presente en el 52,9% de la muestra<xref ref-type="bibr" rid="B47"><sup>47</sup></xref>. Este tipo de lesión resulta de la exposición prolongada a la humedad, lo que hace que la piel se ablande y se descomponga, de modo que la fibra conjuntiva se desprende y la piel a menudo se ve blanca. En general, esta lesión se puede prevenir mediante el uso de materiales semipermeables, que permiten la salida del vapor de agua, y el tratamiento indicado consiste en el uso de apósitos superabsorbentes para reducir el exceso de humedad<xref ref-type="bibr" rid="B48"><sup>48</sup></xref>. </p>
				<p>Con respecto al uso de EPI específicamente, se recomiendan que los profesionales de la salud tomen otras medidas preventivas, como elegir la talla adecuada de guantes y botas de goma, aplicar polvo de ostomía en manos y pies, esperar que se seque completamente la piel, después del lavado de manos y/o el uso de alcohol en gel, antes de usar el EPI, y cambiar con frecuencia los materiales. Estas medidas ayudan a proteger la piel contra el roce y la hidratación excesiva. En caso de maceración continua, el uso de cremas astringentes, como el óxido de zinc, ayuda a tratar este tipo de lesiones<xref ref-type="bibr" rid="B43"><sup>43</sup></xref>.</p>
				<p>Las reacciones adversas en la piel por el uso de batas y ropa de protección son menos comunes, sin embargo, su aparición puede estar asociada a la humedad generada por las telas pesadas y la necesidad de usarlas por largos períodos de tiempo. Estrategias, como quitarse la ropa durante unos minutos o cambiarla con frecuencia, pueden ayudar a reducir estas reacciones<xref ref-type="bibr" rid="B22"><sup>22</sup></xref>.</p>
				<p>Un trabajo desarrollado por enfermeros en Baréin utilizó una mnemotécnica con la palabra HELP para ayudar a los profesionales de la salud a incorporar el cuidado de la piel antes, durante y después del uso de EPI. En general se recomendaba consumir agua regularmente, mantener la piel limpia e hidratada (especialmente manos y rostro), controlar el tiempo de uso de los EPI, mantener una dieta balanceada de calorías y proteínas, usar cremas protectoras diez minutos antes de usar los EPI y almohadillas protectoras en los lugares donde hay mayor contacto con la piel<xref ref-type="bibr" rid="B17"><sup>17</sup></xref>.</p>
				<p>A pesar del creciente número de publicaciones sobre prevalencia de lesiones, pautas de prevención y tratamiento, aún son incipientes los estudios que utilizaron un enfoque metodológico que produjeran altos niveles de evidencia científica. Como se trata de un tema emergente derivado de una nueva enfermedad, se considera una limitación de este estudio el hecho de que no haya un término común, descriptores o palabras clave específicas para el mismo, lo que puede haber dejado algún estudio fuera del resultado de la búsqueda. Además, el bajo número de ensayos clínicos aleatorizados impide la generalización de los resultados.</p>
				<p>Los resultados obtenidos pueden ayudar a los profesionales de la salud, especialmente a los enfermeros, a conocer los tipos de lesiones cutáneas frecuentemente asociadas al uso de EPI y qué medidas se pueden tomar para prevenir su aparición. Y también ayudar a los directivos a realizar capacitaciones para prevenir posibles lesiones e incorporar recomendaciones a la rutina de la institución.</p>
			</sec>
			<sec sec-type="conclusions">
				<title>Conclusión</title>
				<p>Las lesiones cutáneas provocadas por el uso de EPI en los profesionales de la salud fueron más notorias durante la pandemia de COVID-19, cuando fue posible observar a mayor escala las consecuencias del uso prolongado de los mismos. La mayoría de los profesionales que trabajaban en la atención directa de pacientes contagiados con el nuevo Coronavirus presentaban algún tipo de alteración en la piel, especialmente aquellos que utilizaban EPI durante un periodo diario superior a las seis horas. La mascarilla, especialmente la N95, fue la principal responsable de la aparición de lesiones en la piel, seguida de las gafas de protección, el protector facial y los guantes. En cuanto a los tipos de lesión, el acné, las lesiones por presión (estadios 1 y 2), la depresión cutánea y la xerosis fueron las que se observaron con mayor frecuencia en los profesionales.</p>
				<p>Las principales medidas para prevenir daños en la piel involucran cuidados de rutina, como mantener la piel hidratada, consumir líquidos y usar humectantes y emolientes, instituir el hábito de la higiene de la piel, evitar el uso de maquillaje excesivo, usar almohadillas protectoras en las prominencias óseas de la cara, preferentemente con bordes de espuma y silicona para facilitar su extracción, utilizar EPI correctamente ajustados y, si es posible, evitar el uso continuo de EPI durante un período prolongado </p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="financial-disclosure" id="fn12">
					<p>El presente trabajo fue realizado con apoyo de la Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - Código de Financiamiento 001. Apoyo Financiero de la Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão, Proceso 02424/21, Brasil.</p>
				</fn>
			</fn-group>
		</back>
	</sub-article>
</article>